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Abstract 
Altered inhibitory function is an important facet of epileptic pathology.  A key concept 
is that GABAergic activity can become excitatory, if intraneuronal chloride [Cl-]i rises. It 
has proved difficult, however, to separate out the role of raised [Cl-]i from other 
contributory factors in complex network phenomena such as epileptic pathology. To 
address this, in this thesis I used Halorhodopsin to load clusters of pyramidal cells 
artificially with Cl-, to explore the implication of raised [Cl-]i in the generation of 
epileptic activity and seizure initiation.  
Brief Halorhodopsin activation caused substantial positive shifts in the GABAergic 
reversal potential (EGABA).  At the network level, these positive shifts in EGABA produced 
a transient rise in network excitability, with many distinctive features of epileptic foci, 
including high frequency oscillations with evidence of out-of-phase firing.  Such firing 
patterns can arise from quite small shifts in the mean [Cl-]i level, within heterogeneous 
neuronal populations.  Notably, however, chloride-loading by itself did not trigger full 
ictal events, even with additional electrical stimulation to the underlying white matter. 
In contrast, when performed in combination with low, sub-epileptic levels of 4-
aminopyridine, Halorhodopsin activation rapidly induced full ictal activity.  These 
results suggest that in vitro, chloride-loading has an adjunctive role in ictogenesis.  
Additionally, in this thesis an optogenetic approach to extrude Cl- was also explored, as 
a potential way to correct the raised [Cl-]i issue in epilepsy.  A strategy that was proved 
to be successful was the combination of ArchaerhodopsinT (ArchT) hyperpolarizing 
effect and the opening of light activated Cl- channel (ChloC), which together provides a 
driving force and a conductance for an outward Cl- flow. Co-activation of the two 
opsins consistently induced a negative shift in EGABA indicative of Cl
- extrusion 
mechanism, which in the future could be tested as a new optogenetic approach to 
control epilepsy.   
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Chapter 1.  Introduction 
 
The brain is one of the most complex machineries ever to have existed, comprising 
over 100 billion neurons, each making hundreds to thousands of connections to other 
neurons (Shepherd, 2004; Buzsaki, 2006).  It is only fair to begin with a sincere 
acknowledgment that there is too much that we do not yet understand. To begin 
teasing apart how a complex system works, there is not much option than to start with 
investigating the simpler components of the system. All brain functions ultimately 
depend on the processing at the level of neuronal networks and single neurons, where 
there is a permanent interplay between excitation and inhibition. This is mediated by 
excitatory and inhibitory neurotransmitters respectively; with glutamate being the 
main excitatory one and gamma amino butyric acid (GABA) and glycine being the main 
inhibitory ones. Excitatory neurotransmitters are released by the principal cells that 
account for approximately 80% of the neuronal population in cortical networks, 
whereas the inhibitory neurotransmitters are released mainly by the remaining 20% of 
the population called the interneurons (Hendry et al., 1987). 
Healthy brain function requires precise combinations and adequate levels of both 
excitation and inhibition. When precise interplay between excitation and inhibition 
breaks down, pathological states can arise, such as an epileptic seizure. The 
International League Against Epilepsy (ILAE) defines an epileptic seizure as a transient 
occurrence of signs and or symptoms due to abnormal excessive or synchronous 
neuronal activity in the brain (Fisher et al., 2014).  Epileptic seizures have been 
extensively described and studied from as early as the 17th century by prominent 
neurologists and scientists such as John Hughlings Jackson (Jackson, 1879). However, 
even today, how an epileptic seizure is initiated and terminated is still a puzzling 
question without a definitive answer. A more comprehensive understanding of these 
phenomena is still acutely needed as this might help  the development of new 
treatment options for the approximately 30% of patients with epilepsy, who remain 
resistant to current anti-epileptic medication (Moshé et al., 2014). 
 
 2 
 
One of the most important facets of epilepsy pathophysiology is the altered GABA 
inhibition as the main mechanism that controls the spread of activity in the brain. Fast-
acting GABA inhibition works by opening GABAA channels that are mainly permeable to 
Cl-. Consequently Cl- distribution across the membrane becomes an important 
determinant of GABA inhibitory activity.  There is an increasing evidence showing that 
Cl- dysregulation could be a key pathology in epilepsy (Huberfeld et al., 2007c; Ellender 
et al., 2014; Pallud et al., 2014). Accordingly, studying the role of Cl- in the modulation 
of GABA inhibitory activity, both at the neuronal level and at the network level, could 
provide an important insight into understanding how epileptic seizures are initiated.    
Considering the involvement of Cl- dysregulation in epilepsy, a way to manipulate 
neuronal Cl- concentration is desired, both as a research tool, but also as a possible 
way to control epileptic seizures. To achieve this, the potential use of different 
optogenetic proteins will be explored. Optogenetics is a technique that allows cell-type 
specific manipulation of neuronal activity using light. This is made possible by 
expressing channels or pumps of bacterial or algae origin, which are activated by light 
(Deisseroth et al., 2006). This technique has allowed neuroscientists to artificially 
trigger a depolarizing or hyperpolarizing current in a neuron or neuronal population 
using light activation.  
I will start this chapter by describing how GABA inhibition works in the brain and how 
Cl- regulation is such an important determinant for GABAergic activity. I will also 
describe how alterations in Cl- regulation have been linked to hyperexcitability states 
in the epileptic brain. I will then review the potential use of optogenetics as a way of 
controlling epileptic seizure activity. Lastly I will list the aims of my PhD project, which 
will be explored in the following chapters of this thesis. 
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1.1 GABA inhibition at a single neuron level 
GABA neurotransmitter is produced and released by inhibitory interneurons pre-
synaptically. GABA will then bind to its receptors in the post-synaptic cells and induce a 
conformational change in the receptors necessary to conduct ionic flow. GABA mainly 
affects 2 different types of receptors, namely GABAA and GABAB. GABA inhibitory 
activity via GABAA receptors works in 2 different modes of action: fast-acting and tonic 
inhibition. Fast-acting inhibition is exerted by the opening of GABAA receptors that are 
expressed at the synapses. The GABAA receptor is a ligand operated ion channel, 
mainly permeable to Cl- and to a lesser extent to bicarbonate (HCO3
-) (Bormann et al., 
1987). GABAA activation at the synapse allows a sudden flow of Cl
- into the cells that 
generate an instantaneous inhibitory post-synaptic potential (IPSP) (Nicoll et al., 1990). 
In contrast, tonic inhibition is mediated by the opening of extra-synaptic GABAA 
receptors, which gives rise to a tonic current that influences the basal excitability of 
the cells over long time scales (Farrant & Nusser, 2005). Additionally, GABA can also 
activate extra synaptic GABAB receptors, which are G-protein coupled receptors 
(Bowery et al., 1980; Craig & McBain, 2014). GABA activation of GABAB receptors 
reduces cell excitability both pre-synaptically and post-synaptically. This is mediated by 
the inhibition of voltage-gated calcium channel that consequently reduces 
neurotransmitter release from the pre-synaptic neuron and by activation of inward 
rectifying potassium channels on the post-synaptic neuron (Gassmann & Bettler, 2012; 
Craig & McBain, 2014).  
Fast-acting GABAA-mediated inhibition has 2 facets of inhibitory effect namely shunting 
inhibition and hyperpolarising inhibition. The shunting inhibition effect on post-
synaptic neurons is mainly due to the reduction of the membrane input resistance by 
GABAA channels opening, which makes the cell membrane more ‘leaky’ and hence  
‘short-circuiting’ the incoming excitatory input to the cell (Coombs et al., 1955; Staley 
& Mody, 1992). In contrast, the hyperpolarising effect of GABA is due to the anion 
inward flow that brings the membrane potential to a more negative level, hence more 
excitation is needed to depolarise the cell (Kahle et al., 2008). This could be measured 
as the inhibitory postsynaptic current (IPSC) that based on the Ohm’s law is equal to 
V/R, which  can also be formulated as a function of conductance (gIPSC) x driving force 
(Jack et al., 1975).  
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𝐼𝑃𝑆𝐶 = 𝑔𝐼𝑃𝑆𝐶 𝑥 𝑑𝑟𝑖𝑣𝑖𝑛𝑔 𝑓𝑜𝑟𝑐𝑒 
𝑑𝑟𝑖𝑣𝑖𝑛𝑔 𝑓𝑜𝑟𝑐𝑒 = 𝐸𝑚 − 𝐸𝐺𝐴𝐵𝐴 
 
The strength of GABA hyperpolarising current (IPSC) is therefore directly proportional 
to the gIPSC and the driving force for its corresponding permeable ion. The gIPSC 
represents the individual conductance for each GABAA receptors and the number of 
GABAA channels opening at the membrane that is  affected by 3 factors: the number of 
neurotransmitter molecules released pre-synaptically, the number of functional 
channels expressed post-synaptically, and the sensitivity of the channel to its ligand 
(Thompson & Gahwiler, 1989b). The driving force for GABA on the other hand is set by 
the electrochemical gradient for the main permeable ions, namely Cl-. This could be 
calculated as the difference between the membrane potential (Em) and the Cl
- reversal 
potential (ECl-) (Thompson & Gahwiler, 1989a).  
By definition, ion reversal potential is the point of equilibrium for both ion fluxes 
driven by concentration gradient and electric charge gradient, whereby no net ion flux 
will take place and this follows the thermodynamics principle as described in the 
Nernst equation. The two variables involve in the Nernst equation are the temperature 
and the ratio between ion outside and inside the cell. As temperature tends to remain 
constant, the ion reversal potential is mostly dependent on the distribution of ions 
inside and outside the cell.  
 
 
𝐸𝑖𝑜𝑛 =  
𝑅𝑇
𝑧𝐹
log 𝑒
[𝑖𝑜𝑛 𝑜𝑢𝑡𝑠𝑖𝑑𝑒 𝑐𝑒𝑙𝑙]
[𝑖𝑜𝑛 𝑖𝑛𝑠𝑖𝑑𝑒 𝑐𝑒𝑙𝑙]
 
R = universal gas constant, T = temperature (K), 
z = valence of the ionic species, F = Faraday’s constant 
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Accordingly, the driving force of GABA activity is therefore largely affected by the basal 
distribution of Cl- inside and outside the cell. It should be noted however that the 
GABAA channel is also permeable to HCO3
- hence EHCO3- also has an effect on the GABA 
activity.  In mature neurons EHCO3- is around -10 mV and this is due to a nearly 
unlimited supply of HCO3
- within the neuron that is dependent on the carbonic 
anhydrase (CA) activity, as part of the pH buffer mechanism of the cell (Kaila et al., 
1993; Rivera et al., 2005). Extracellularly, HCO3
- concentration is relatively low, 
favouring an outward flow of the ion. Despite the bicarbonate depolarising reversal 
potential, GABA is still very often hyperpolarising as GABAA channels is permeable to 
chloride 3.3-5 times more than to bicarbonate (Bormann et al., 1987), and since 
Cl- tends to be kept low inside the cells and high outside, it gives a relatively 
hyperpolarising reversal potential. Interestingly when CA is blocked, reducing the 
outward flow of bicarbonate through GABAA channel, inward flow of chloride is 
attenuated. This suggests that bicarbonate outward flow could actually assist the 
inward flow of Cl- for its hyperpolarising effect (Kaila et al., 1997). Although there 
seems to be a delicate interaction between Cl- and HCO3
- and consequently between 
pH and inhibition, further discussion of this thesis will focus only on Cl- in GABA 
inhibition. 
 
1.2 Chloride regulation at neuronal level 
The Cl- driving force is dependent on the ECl- that is determined by the Cl
- distribution 
inside and outside the cell; and the Em which depends on the resting membrane 
potential (ERest) that is affected by the expression of all ion channels in the membrane 
and synaptic events. When ECl- is more negative than Em, Cl
- will enter the cell, while 
when it is more positive than Em, Cl
- will leave the cell. Accordingly, the polarity of 
GABA events become hugely dependent on Cl- regulation of the post-synaptic cell that 
determines the ECl-.     
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1.2.1 Chloride-coupled co-transporters’ activity regulate intraneuronal Cl- level 
The main mechanism that sets basal intraneuronal Cl- has traditionally been 
considered to be the activity of co-transporters (Rivera et al., 1999; Yamada et al., 
2004; Kaila et al., 2014). Neurons express different types of chloride-coupled co-
transporters. The main importer of Cl- is the sodium potassium chloride co-transporter 
(NKCC1) that brings 2 Cl- together with 1 potassium ion (K+) and 1 sodium ion (Na+) into 
the cell (Plotkin et al., 1997). NKCC1 uses the driving force from Na+ concentration 
gradient that is actively maintained to be low inside and high outside by Na+/K+ATPase 
(Plotkin et al., 1997; Pfeffer et al., 2009). To extrude Cl- on the other hand, neurons 
express potassium chloride co-transporter (KCC2) that brings a single Cl- out together 
with a single K+, driven by the concentration gradient of K
+ that is high inside and low 
outside (Rivera et al., 1999). On top of these, neurons also express sodium chloride 
bicarbonate co-transporter and chloride bicarbonate co-transporter that could also 
contribute to the basal intraneuronal level of Cl- (Somjen, 2004).  
    
1.2.2 Developmental shift from depolarizing GABA to hyperpolarizing GABA 
Neuronal Cl- regulation changes throughout development. In immature neurons, [Cl-]i 
is found to be higher compared to the mature neuron (Rivera et al., 2005). This is 
consistent with the tendency of GABAA activation to give an outward flow of Cl
-
, hence 
exerting a depolarising effect, in immature neurons. On the other hand, in mature 
neurons [Cl-]i is maintained low, that consequently results in a GABA hyperpolarising 
effect (Rivera et al., 1999). These differences could be explained by the developmental 
up-regulation of KCC2 that is part of neuronal differentiation during maturation (Rivera 
et al., 1999). Immature neurons dominantly express NKCC1 over KCC2, which 
consequently promotes Cl- influx (figure1.1A). However, as the neurons mature, KCC2 
is drastically up-regulated while NKCC1 is only slightly if at all up-regulated, explaining 
the developmental shift from depolarizing GABA towards hyperpolarizing GABA (Rivera 
et al., 2005; Kaila et al., 2014). During development depolarizing GABA together with 
glutamatergic drive is thought to be essential in the development of neuronal 
connection especially in somatosensory cortex (Balakrishnan et al., 2003; Luhmann et 
al., 2014b).  While in a mature brain, low [Cl-]i is preferable to provide a driving force 
for GABA hyperpolarizing current.  
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Figure 1.1 Chloride regulations in immature and mature neurons. A. In immature 
neurons, NKCC1 activity dominates [Cl-]i regulation due to the low expression of KCC2. 
This results in a relatively high amount of Cl- inside the cell that consequently gives a 
depolarizing EGABA, allowing outward Cl
- flow (depolarizing) when GABAA channel opens 
(blue). B. During maturation, KCC2 is up-regulated to outnumber NKCC1 favouring Cl- 
extrusion to maintain low [Cl-]i. This gives a more negative EGABA that allows Cl
- to move 
into the cells (hyperpolarizing) when GABAA channel opens.  
 
 
 
1.2.3 Possible effect of local impermeant anions in regulating intraneuronal Cl- 
A recent study has claimed that intraneuronal Cl- could actually be regulated by the 
local impermeant anion concentration inside [A-]i and outside the cell [A
-]o; this mainly 
arises from the phosphate group of the DNA backbone and the negative charges 
associated in the extracellular matrix respectively (Glykys et al., 2014a). This 
suggestion was based on the Gibbs-Donnan effect that explains how charged particles 
sometimes cannot be distributed evenly across a semi-permeable membrane due to 
the presence of impermeable charged particles that introduced an imbalance of 
electrical charges across the membrane (Ricka & Tanaka, 1984).  
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In this case, Cl- as a permeable charged particle is distributed unevenly across cell 
membrane with low [Cl-]i and high [Cl
-]o due to the imbalance of negative charges 
across the membrane set by the ratio between impermeable anions inside and outside 
the cell. Glykys et al (2014) suggested that [Cl-]i is actually determined by the ratio 
between the local [A-]i and [A
-]o to maintain the Gibbs-Donnan equilibrium, while co-
transporters only assists the transport of Cl- when there is transient change of the [Cl-]i  
away from the baseline. This however is still a matter of debate (Glykys et al., 2014b; 
Luhmann et al., 2014a; Voipio et al., 2014) and further studies are needed for 
clarification.  
 
1.2.4 Activity dependent disinhibition 
Although a cell’s preferred [Cl-]i  is mainly set by co-transporter activity or possibly by 
the Gibbs-Donnan effect introduced by the impermeable anions, in actual fact 
neuronal [Cl-]i is dynamic. [Cl
-]i could change at any given time depending on the on-
going synaptic activities. A neuron that is involved in a network activity will be exposed 
to both glutamatergic synapses as well as GABAergic synapses. Glutamatergic activity 
exerts a strong depolarization in a neuron that brings its Em towards 0 mV (Eglutamate). 
Positive value of Em will create a big driving force for Cl
- uptake by the cell when the 
conductance is increased by the opening of GABAA channel (Buzsáki et al., 2007). 
Indeed, neurons are equipped with Cl- extrusion mechanism such as KCC2 that will 
clear Cl- back towards its initial [Cl-]i, however this process is not as fast as synaptic 
events (Jin et al., 2005). Study by Thompson and Gahwiler in 1989 showed that after 
repetitive electrical stimulations, the amplitude of GABA mediated IPSPs were 
significantly reduced (Thompson & Gahwiler, 1989a). They then showed that this is 
mainly due to an accumulation of Cl- intracellularly by GABA conductance that shifts 
ECl- to a more depolarized level hence reducing the driving force of Cl
- inward flow. This 
sometimes even results in a switch of GABA polarity from hyperpolarizing to 
depolarizing. This phenomenon is also known as activity dependent disinhibition.  
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1.2.5 Summary 
To summarize, studies have shown that neuron [Cl-]i is set by NKCC1 and KCC2 activity, 
however [Cl-]i is dynamic depending on the on-going synaptic events. When exposed to 
both glutamate and GABA repetitively, neuron will undergo an activity dependent 
disinhibition that could be explained by the accumulation of Cl- intracellularly.  
 
1.3  The main inhibitory interneurons in the cortex 
 
In the network level, inhibition system also depends on the connections or synapses 
between principal cells and the interneurons (Shepherd, 2004; Klausberger & Somogyi, 
2008). Inhibition then becomes even more complex due to a wide variability of 
interneuronal subclasses that differ not only in their connectivity with the principal 
cells but also in their firing behaviour (Buzsáki et al., 2007; Klausberger & Somogyi, 
2008). In neocortex, the two main subclasses of interneurons are the parvalbumin 
positive interneuron (PV) and somatostatin positive interneuron (SOM), which 
accounts for ~40% and ~30% of the interneuronal population respectively (Markram et 
al., 2004; Rudy et al., 2011; Pfeffer et al., 2013). The remaining ~30% of the 
interneurons were found to express 5-hydroxytryptamine-3a (5HR3aR) in which 40% of 
them are vasointestinal petide (VIP) positive (Rudy et al., 2011).  
 
In neocortex, PV positive cells mainly consist of basket cells and chandelier cells 
interneuron while SOM positive cells are mainly Martinotti cells (Markram et al., 2004). 
These two subclasses differ in both their synapses target onto the post-synaptic cells 
and their firing pattern that equips them to serve different functions in the system. 
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1.3.1 Somatostatin positive interneuron 
SOM positive interneurons make synapses on the dendritic shaft or dendritic spines of 
the post-synaptic neurons (Markram et al., 2004). Their axon could project into a 
distant column horizontally, hence providing inhibition across cortical columns 
(Markram et al., 2004). As dendrites are the site of most excitatory synapses, by gating 
the excitatory inputs in the dendrites, SOM inhibitory effect could significantly shift the 
input-output function of a neuron (Lovett-Barron et al., 2012; Pouille et al., 2013). 
Excitatory synapses onto SOM interneurons are known to be facilitating (Rudy et al., 
2011), meaning that with repeated activation, the post-synaptic effect will increase 
supralinearly, resulting in an increase of inhibition onto the post-synaptic pyramidal 
cells (Kapfer et al., 2007). This make SOM interneurons best activated when there is an 
increasing activity of the network. 
 
1.3.2 Parvalbumin positive interneuron 
In contrast, PV positive basket cells are known to target the soma and proximal 
dendrites of pyramidal cells and interneurons, while the chandelier cells are known to 
specifically target the axon initial segment (AIS) (Markram et al., 2004). The strategic 
location of PV synapses on pyramidal cells enables them to directly suppress the 
output of the pyramidal cell (Pouille et al., 2013). Excitatory synapses on PV 
interneurons however tends to be depressing (Rudy et al., 2011); or in other words 
multiple excitatory inputs onto PV will not result in a proportional output of PV cells.  
 
PV cells also have been termed fast-spiking as they are capable to sustain high 
frequency trains of action potential. The fast-spiking characteristic could be explained 
by the ion-channel profiles that are expressed by these cells (Markram et al., 2004). 
For instance, PV interneurons are known to express powerful delayed rectifying 
voltage-gated potassium channel Kv3.1 and Kv3.2, more densely than PV negative 
interneurons or pyramidal cells (Martina et al., 1998; Rudy & McBain, 2001). These 
allow a stronger repolarisation after each action potential enabling the generation of 
successive action potentials with only a very short delay. These potassium channels are 
sensitive to the potassium channel blocker 4-amynopyridine (4-AP), which triggers 
intense firing of these cells (Martina et al., 1998).  
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PV cells especially basket cells make a highly divergent contact to pyramidal cells but 
also to other PV interneurons in which 1 basket cell could make synapses with more 
than 1500 pyramidal cells and 60 other PV interneurons (Sik et al., 1995). Furthermore 
PV cells are also known to be electrically coupled to each other via gap junction 
(Galarreta & Hestrin, 1999; Gibson et al., 1999; Tamas et al., 2000). This means that 
activity in one PV cell could spread to other PV cell in close proximity without having to 
make synapses. Consequently PV interneuron activity could impose a widespread 
impact in the network. The divergent connectivity and the electrically coupled PV cells 
network allow synchronization of different PV interneurons activity in the network and 
also the post-synaptic pyramidal cells (Tamas et al., 2000). 
 
 
1.4 The role of PV interneurons in gamma-oscillation 
With all these characteristics, PV interneurons have been implicated in the 
synchronization of cortical network activity, playing an important role as a pacemaker 
in the generation of networks oscillations especially in the gamma frequency range (30 
– 90 Hz) (Traub et al., 2004; Bartos et al., 2007; Cardin et al., 2009). These studies have 
shown that basket cells are highly active during gamma oscillation with firing rates that 
lie close to the frequency of the gamma oscillation itself. Furthermore, basket cells are 
firing action potentials that are phase-locked to the gamma oscillation (Bragin et al., 
1995; Hájos et al., 2004), suggesting a correlation between basket cells outputs and 
the rhythm of the oscillation. Both synaptic and electrical coupling between basket 
cells synchronize their outputs that down the line impose a synchronizing effect on the 
post-synaptic pyramidal cells as well (Tamas et al., 2000). Basket cells’ outputs impose 
a time constraint for the firing of pyramidal cells, which can only occur when the 
basket cells are in the refractory period. This entrainment of pyramidal cells firing, 
together with the synchronizing effect of basket cells on the network, results in the 
generation of gamma oscillation (Traub et al., 1999).   
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1.5 Altered inhibition function in Epilepsy 
Altered inhibition has long been associated with epileptic seizures, a transient episode 
of abnormal excessive or synchronous neuronal activity in the brain (Fisher et al., 
2014). In a simple in vitro model of epilepsy, pyramidal cells are bombarded with 
inhibitory inputs just before the ictal wave (Trevelyan et al., 2006b; Trevelyan et al., 
2007a). Similar activity has also been recorded in vivo (Prince & Wilder, 1967b; Dichter 
& Spencer, 1969; Schwartz & Bonhoeffer, 2001) and also in human epileptic tissues 
recorded by implanted microelectrode (Schevon et al., 2012). This inhibitory 
mechanism, also known as the inhibitory restraint, appears to suppress the intense 
excitatory drives. It is believed that recruitment of new territories occurs when the 
local restraint fails. This may only happen many seconds after the glutamatergic 
barrages start, thus highlighting the important role of inhibition at this time.  Based on 
this, it is important to investigate the mechanism of how the inhibitory restraint fails in 
order to understand how a seizure starts and spreads.  
1.5.1 Depletion of GABA neurotransmitter 
There are several possibilities of how the inhibitory restraint could fail. The first 
possible mechanism is by a decreased GABA conductance after a period of inhibitory 
restraint against the glutamatergic barrages. There was a suggestion that seizures 
could be preceded by reduced GABA release from the pre-synaptic cells that 
consequently cause a reduction of GABA activation in the post-synaptic pyramidal cells 
(Zhang et al., 2012). However, many other studies show otherwise that GABA 
conductance exists even throughout the seizure (Fujiwara-Tsukamoto et al., 2006; 
Ellender et al., 2014). 
1.5.2 Depolarization block of interneurons 
A second possibility is a depolarization block phenomenon that could affect 
interneurons especially the fast-spiking interneurons, hindering them from firing 
during seizure activity. Depolarization block is a situation where cells are so strongly 
depolarized that it reaches a membrane potential in which voltage gated sodium 
channels fails to de-inactivate (Somjen, 2004). Consequently the cells are left incapable 
of generating action potentials until the membrane potential is recovered back to 
normal (Bragin et al., 1997). It has been shown that in a model of focal epilepsy where 
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NMDA was applied locally, ictal event only started invading wider territory once PV 
interneurons entered a depolarising block (Cammarota et al., 2013). It should be noted 
that in this study, 4-AP was used in the bath, and this is known to block potassium 
channels Kv3.1 and Kv3.2 typically expressed in PV cells. These potassium channels are 
important to strongly hyperpolarize the cell after an action potential to be ready to fire 
another action potential. With these channels compromised, PV cells become more 
susceptible to depolarization block due to its fast-spiking behaviour. Whether PV 
depolarization block happens in other epilepsy models or in naturally occurring 
seizures still requires further investigation.  
1.5.3 Raised intraneuronal Cl- 
Lastly, inhibitory restraints could also fail when there is an intraneuronal Cl- 
accumulation, which causes a reduction of Cl- driving force or even a switch of GABA 
polarity from hyperpolarizing to depolarizing such as explained earlier. Evidence that 
shows the involvement of Cl- in epilepsy will be elaborated in the next section. 
 
1.6 Raised intraneuronal chloride in Epilepsy 
There is good evidence that the phenomenon of compromised inhibition due to high 
intraneuronal chloride could be a key pathology in epilepsy. Intracellular Cl- 
accumulation or a depolarizing shift in EGABA has been shown both by gramicidin 
perforated patch (Fujiwara-Tsukamoto et al., 2006) and Cl- imaging (Isomura et al., 
2003; Dzhala et al., 2010b), in several different models of epilepsy such as the post-
tetanic stimulation seizures, spontaneous seizures developed by organotypic culture, 0 
Mg2+ and 4-AP induced seizures (Fujiwara-Tsukamoto et al., 2006; Ilie et al., 2012; Lillis 
et al., 2012).  
1.6.1 Increased Cl- uptake by NKCC1 
Several mechanisms could contribute to intracellular Cl- accumulation in epilepsy. First 
is by Cl- uptake by NKCC1. This is particularly important in neonatal seizures in which 
NKCC1 activity dominates the Cl- regulation system of neurons (Nardou et al., 2011; 
Kaila et al., 2014). Evidence has shown that during seizures, NKCC1 activity contributes 
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to intracellular Cl- accumulation. This is particularly strong after repeated seizures 
(Dzhala et al., 2010b).   
1.6.2 Reduced Cl- extrusion by KCC2 
Secondly, Cl- could accumulate inside the cell due to a compromised Cl- extrusion 
activity of KCC2. This could happen firstly via down-regulation of KCC2 expression. It 
has been shown that there is a reduction of KCC2 protein in human epileptic tissue 
resected from patients with mesial temporal lobe epilepsy or with glioma associated 
seizures, as detected by immunostaining against KCC2 (Huberfeld et al., 2007c; Pallud 
et al., 2014). Reduction of KCC2 expression was directly correlated with a more 
depolarizing IPSP recorded from pyramidal cells during interictal activity (Huberfeld et 
al., 2007c).  
KCC2 reduction could also be observed at the mRNA level (Huberfeld et al., 2007c), 
which suggests that there is a down-regulation of KCC2 production even at the pre-
translational level of epileptic tissue. It should be noted that this observation was 
made from resected human epileptic tissues that has been exposed to multiple 
number of seizures for a long period of time.  
Another mechanism that could lead to a compromised KCC2 activity is the post-
translational modification of KCC2, triggered by epileptic activities (Kaila et al., 2014). 
For instance, a recent study has shown that repetitive interictal discharges in vitro, 
could lead to a reduction of KCC2 activity. This is due to dephosphorylation of KCC2 at 
serine 940 that triggered calpain-mediated cleavage of the protein, leaving the 
remaining part of KCC2 dysfunctional (Puskarjov et al., 2012). Others have shown that 
seizure activity could rapidly trigger endocytosis of KCC2 from the membrane and 
proteolysis of the protein that results in the loss of hyperpolarizing effect of GABA 
(Rivera et al., 2004; Kaila et al., 2014).   
1.6.3 Cl- accumulation due to intense GABAA activation 
Lastly, Cl- could also accumulate due to intense GABAA activation that seems to 
dominate the activity of pyramidal cells just before the ictal wave (Trevelyan et al., 
2006a). Supporting evidence comes from a Cl- imaging study done in post-tetanic 
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seizure model (Isomura et al., 2003). In this study it was shown that Cl- rapidly rises 
within the neurons post-tetanic stimulation, which also resulted in a seizure like 
activity. Cl- accumulation was markedly reduced by approximately 75% when GABAA 
was blocked using bicuculline, which also abolished the seizure activity post-tetanic 
stimulation (Isomura et al., 2003). However, bicuculline did not completely abolish the 
Cl- influx (Isomura et al., 2003) indicating that there is indeed some other mechanism 
that could facilitate Cl- entry during seizure other than GABAA activation.     
1.6.4 High intraneuronal Cl- and depolarizing GABA contributes to the generation of 
epileptic afterdischarge  
During seizures, high intraneuronal Cl-, and so depolarizing GABA, has been implicated 
in the generation of epileptic afterdischarges. It has been shown that in a post-tetanic 
seizure model, local GABA application during seizure was actually triggering bursts of 
action potentials rather than inducing an IPSP (Fujiwara-Tsukamoto et al., 2006). A 
recent study also showed a similar phenomenon using an optogenetic approach, in a 
post-tetanic seizure model (Ellender et al., 2014). Ellender et al specifically targeted PV 
cells for expression of either channelrhodopsin (ChR2) for PV cells activation or 
archaerhodopsin (Arch) for PV cell inhibition. During ictal activity, PV cell activation 
using ChR2 led to an increased frequency of afterdischarges when recording from a 
pyramidal cell. In contrast, when PV cells were inhibited by Arch activation, a reduced 
number of afterdischarges was observed.   
1.6.5 Summary 
Together, it could be concluded that epileptic tissues are found to be associated with 
co-transporters dysregulation, which introduces a depolarizing shift in EGABA that 
compromises GABA inhibitory activity. More Cl- then accumulates inside the cells 
during epileptic activity such as interictal or ictal discharges due to GABAA activation. 
During ictal activity, depolarizing GABA has been suggested to contribute to the 
generation of afterdischarges or the clonic phase of ictal discharges. Conversely, 
repetitive epileptic activities such as interictal and ictal discharges could also 
contribute to the alteration of co-transporter regulation that further leads to the 
depolarizing shift of EGABA.   
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1.7 The need for new treatment 
Despite the increasing number of new anti-epileptic drugs being developed in the last 
decade, the number of patients with epilepsy resistant to the current anti-epileptic 
medication remains remarkably constant at around 30% (Moshé et al., 2014). Patients 
with drug resistant focal epilepsy sometimes could undergo surgery to remove the 
epileptic foci. This option however is highly dependent on the location of the epileptic 
focus, as surgery cannot be done in the eloquent region of the cortex that is important 
for sensory and movement processing for example. Surgery also does not guarantee 
sustained seizure freedom as about 42% of patients with intractable epilepsy who 
underwent surgery ended up developing seizures again later in life (Wiebe et al., 2001; 
Moshé et al., 2014).  
Other alternative treatment for drug resistant epilepsy, which is not suitable for 
surgery, is neurostimulation. The most common approach is vagal nerve stimulation, 
that indeed showed a reduction of seizure frequency by approximately 50% in half the 
number of treated patients (Englot et al., 2011). However, in most of the cases, vagal 
nerve stimulation did not result in seizure freedom (Moshé et al., 2014).  Another 
approach is by deep brain stimulation that is more invasive than vagal nerve 
stimulation. This is only applied as a last resort for drug resistant patients with severe 
epilepsy. Similarly, patients treated with deep brain stimulation showed some seizure 
reduction but with relatively small seizure free rate (Fisher et al., 2010; Moshé et al., 
2014). The mechanism of neurostimulation techniques as a treatment for epilepsy is 
still not clear and so future improvement for these approaches is not a simple matter. 
Based on the low seizure-free rate of the available treatment options, new approaches 
for drug-resistant epilepsy treatment are still desperately needed. 
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1.8 Optogenetics  
Recent technology that has been considered as a new candidate for epilepsy 
treatment is optogenetics. Optogenetics has been widely used as a research tool to 
manipulate neuronal activity using light. This is achieved by expressing light sensitive 
proteins, from algae and bacteria, in neurons (Deisseroth et al., 2006). When these 
proteins are expressed in neurons, temporally controlled depolarization or 
hyperpolarization could be induced by light illumination. Furthermore, different types 
of neuron could be targeted using cell-type specific promoter for optogenetic protein 
expression, allowing cell-specific modulation of neuronal activity (Peron & Svoboda, 
2011).   
Optogenetic proteins are divided into 2 main categories, those with excitatory and 
those with inhibitory actions. The most common excitatory protein being used is 
channelrhodopsin (ChR2), an algae derived channel that allows non-specific cations 
flow when illuminated with blue light (Cardin et al., 2010). Several genetic 
modifications of ChR2 have resulted in a variety of different ChR2 variants with certain 
characteristic properties such as slow-kinetic ChR2, which stays  open for longer than 
the light illumination (Haikala et al., 2013), calcium specific channel known as CatCH 
(Kleinlogel et al., 2011a), and a red-shifted ChR2 that is activated by red light rather 
than blue light (Zhang et al., 2008).  
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Figure 1.2 Different excitatory and inhibitory optogenetic proteins. 
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Inhibitory optogenetic proteins available are the bacterial origin inward Cl- pump 
halorhdopsin (HR) that is activated by orange light (Gradinaru et al., 2008) and the red-
activated Cl- pump known as Jaw (Chuong et al., 2014), the outward proton pumps 
archaerhodopsin (Arch) and the high-light sensitivity version archaerhodopsinT (ArchT) 
(Chow et al., 2010; Han et al., 2011), and also the light activated Cl- channel that is a 
genetically modified ChR2 namely iC1C2 and the slow-kinetic version of it called 
SwitChR (Berndt et al., 2014) and ChloC and the slow-kinetic version of it called slow-
ChloC (Wietek et al., 2014). 
 
1.9 Optogenetics in epilepsy 
Due to the transient and unpredictable nature of epileptic seizure, there is a need for 
an on-demand seizure control with high temporal precision. The possibility for cell 
type-specific targeting and the high temporal precision where light induced responses 
could be triggered within milliseconds, make optogenetics a promising new 
therapeutic candidate.  
Several different groups have conducted studies using different strategies of 
optogenetic application to control epilepsy, both in vitro and also in vivo models of 
epilepsy. The two main strategies that have been explored so far are the expression of 
the inhibitory protein HR in pyramidal cells under CamKII promoter in either neocortex, 
hippocampus, or thalamus (Tønnesen et al., 2009; Krook-Magnuson E et al., 2012; 
Wykes et al., 2012; Paz et al., 2013) and the expression of the excitatory protein ChR2 
in the interneurons (Krook-Magnuson E et al., 2012; Ledri et al., 2014). Furthermore, 
globally targeting all interneurons under GAD promotor and specifically targeting only 
parvalbumin positive interneurons or somatostatin positive interneurons have also 
been investigated (Ledri et al., 2014).  
A direct comparison between the two approaches was made by Krook-Magnuson et al 
(2012). Kainate was injected into the hippocampus of mice as a model of temporal 
lobe epilepsy. Injected mice started developing spontaneous seizures after several 
weeks. In the same mice, they expressed either HR in pyramidal cells or ChR2 in PV 
interneurons, locally to where the kainate injection was made. Optogenetic activation 
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and recording were made in vivo. Both approaches showed seizure suppressive effect 
of optogenetic activation as measured in a reduction of seizure duration by 57 ± 14% 
and 43 ± 11% for HR on pyramidal cells and ChR2 on PV interneurons group 
respectively (Krook-Magnuson E et al., 2012).    
Indeed optogenetic activation by light has shown effective seizure suppression in 
comparison to no light activation in the kainate acid epilepsy model. However with HR 
expressed on pyramidal cells and ChR2 expressed on PV interneurons, seizure duration 
was remain longer than 10 s in approximately 20%  and 60% of the total recorded 
seizures respectively, even when optogenetic activation was done  (Krook-Magnuson E 
et al., 2012). This suggests that there is still room for improvement that could enhance 
the effectivity of this technique as a tool to control epileptic seizures.  
Optogenetics is essentially an artificial way of altering certain ion/ions level inside and 
outside the cells. Inevitably, there could be some consequences on the neuronal 
system that are naturally regulated by a certain balanced state of the manipulated ions. 
This should be taken into consideration when designing the best strategy to apply 
optogenetics in epilepsy. One possible issue, for instance, is the effect of HR activation 
on neuronal Cl- level. As HR hyperpolarises the cells by pumping Cl- into the cell, there 
is a danger of inducing a positive shift in the ECl- that makes GABA activity more 
depolarising as intracellular Cl- level rises (Raimondo et al., 2012). This is also 
consistent with their observation that HR activation significantly increased the firing 
probability of pyramidal cells in healthy tissue (Raimondo et al., 2012). 
The same effect could also take place indirectly when activating ChR2 in the 
interneuronal population. As interneurons activation by ChR2 increases the release of 
GABA neurotransmitter, this too will eventually accumulate Cl- on the post-synaptic 
neurons through the activation of GABAA receptors. This has been observed by Ledri 
and colleagues, who showed that when ChR2 was expressed under interneuronal 
promotors such as GAD, SOM or PV, light activation briefly initiates action potentials 
firing on the CA3 pyramidal cells (Ledri et al., 2014); although this could also be 
explained by a reduced GABA release from the interneurons when a sustained 
activation of interneurons was introduced by long illumination of ChR2.   
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Rebound firing, following HR activation on pyramidal cells or ChR2 on interneurons 
activation could also be attributed to the IH current by the hyperpolarization-activated 
cyclic nucleotide-gated (HCN) channels. HCN channels are activated by 
hyperpolarization and the opening of these channels result in a depolarizing current (IH) 
due to an inflow of cations (Maccaferri et al., 1993; He et al., 2014). In their study, 
Raimondo et al has shown that IH contribution to the rebound firing post HR activation 
on pyramidal cells is rather weak, at least in a single cell level of organotypic cultures 
on post- natal day 14-17.  
This was shown by activating Arch optogenetic protein (outward H+ pump) that does 
not have chloride loading effect on cells but should still affect IH, and observing that 
the spike probability of a neuron does not increase significantly before and after Arch 
activation (Raimondo et al., 2012). It should be noted however that this effect could be 
marginally amplified when assessing multiple cells in the network level, as 
synchronized hyperpolarisation such those imposed by optogenetics could also 
synchronise the rebound firing of different cells and hence amplify its impact on the 
network excitability.  
The success of optogenetics will also depend on the illumination paradigm. Depending 
on the dynamic of the seizure activity, even with the Cl- loading effect, the illumination 
strategy could potentially undermine the issue. To give one instance, Chuong et al in 
their recent paper successfully reduced the rebound firing post HR activation by about 
60% simply by ramping down the light when terminating the light illumination, instead 
of using the standard square pulse light paradigm (Chuong et al., 2014). Another 
interesting question is whether extra Cl- loading from HR activation could do further 
harm once a seizure has been initiated, as intraneuronal Cl- is already high at the start 
of a seizure (Lillis et al., 2012). If no is the answer, then HR application will be safe if it 
is only activated when seizure has been initiated. The recent advance that allows this is 
the development of the close-loop optogenetic stimulation technique where 
illumination is set to be triggered by a computer algorithm that recognizes when a 
seizure is being initiated (Krook-Magnuson E et al., 2012; Armstrong et al., 2013).  
In conclusion, optogenetics has shown promise as an on-demand control for seizures 
in various animal models of epilepsy. However, there are some issues that could be 
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further improved such as the possibility of HR Cl- loading effect that could compromise 
GABA inhibition during seizure. The use of different optogenetic proteins and tailoring 
the illumination paradigm should be considered to further optimize the effectivity and 
efficiency of optogenetic application in epilepsy.  
1.10 The rationale of this thesis 
The maintenance of low [Cl-]i  in neurons is important for hyperpolarising GABA 
inhibition. It has been shown that Cl- accumulation inside the cell that promotes 
depolarising activity of GABA, contributes to epileptic pathophysiology. Although the 
implication of high [Cl-]i state during seizure is well recognized, its effect on seizure 
initiation is unknown.  
Considering the intraneuronal Cl- accumulation issue as one possible mechanism that 
could lead to the failure of inhibitory restraint, correcting high intracellular Cl- level to 
restore GABA inhibitory activity in epilepsy theoretically would be beneficial, both 
during the course of a seizure, and also during pre-ictal discharges, to prevent the 
onset of subsequent seizures. One possibility is by limiting the influx of Cl- for instance 
by using bumetanide, a NKCC1 blocker. Potential anti-epileptic effect of bumetanide is 
still being assessed on an on-going clinical trial, targeting neonatal epilepsy in which 
NKCC1 activity is relatively high. However, there was a suggestion that bumetanide 
effect could be limited, as it was shown to be inefficient in blocking the generation and 
propagation of kainate induced ictal discharges in vitro (Nardou et al., 2009). This 
could be the case as NKCC1 blockers are often not specific and it has a blocking effect 
on KCC2 too; beside the entry of Cl- during the ictal event is largely facilitated through 
GABAA channels (Isomura et al., 2003). Additionally, there is also some issue that 
bumetanide only poorly penetrates the blood-brain-barrier (Töllner et al., 2014).  
Another possible mean of correcting high [Cl-]i is by boosting the activity of KCC2 in 
extruding Cl-. Recently a KCC2 enhancer drug namely CLP257 has been developed 
(Gagnon et al., 2013). CLP257 has been shown to successfully rescue the membrane 
expression level of KCC2 and thereby reduce [Cl-]i (Gagnon et al., 2013), however the 
potential anti-epileptic effect of this drug has not been tested. A possible issue that 
could arise from using CLP257 in epilepsy would be the systemic effect of this agent 
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that would affect the [Cl-]i of all types of neurons in the brain and also other cell types 
that expresses KCC2.  
An alternative approach that could provide a more localized effect and cell-specific 
manipulation of neuronal Cl- level is optogenetic. However, so far this is only possible 
in an inward direction as to load cells with [Cl-]i by using HR Cl
- pump. A novel use of 
optogenetic tools to extrude Cl- could be beneficial in epilepsy to restore the 
hyperpolarizing effect of GABA as a natural inhibition in the brain.  
1.11 The aim of this thesis 
Accordingly, the general aim of this thesis is to investigate the effect of high 
intraneuronal Cl- in network activity, especially related to epilepsy, and to design 
optogenetic tools to extrude Cl- that could have a therapeutic effect in epilepsy.    
The specific aims of this thesis are as follows 
1. To characterize halorhodopsin Cl- pump and to assess the possibility of using 
halorhodopsin as a tool to artificially load population of cells with Cl-.  
 
2. To investigate the implication of a high intraneuronal Cl- state in the generation 
of specific pattern of epileptic activity and seizure initiation. 
 
3. To design a novel use of optogenetic proteins as a tool to extrude Cl- and assess 
the therapeutic effect of Cl- extrusion in epilepsy.  
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Chapter 2. Material and methods 
 
2.1 Dissociated neuronal culture 
Pregnant rats were ordered with a specified gestation day from Charles River 
laboratories. Primary neuronal cultures were prepared from rat pups at embryonic day 
18-20. The pregnant rat was sacrificed by cervical dislocation; a sagittal incision was 
made in the abdominal area to remove the pups. Generally, cortices and hippocampi 
from 8 pups were isolated. Dissection was conducted in the dissection media (Na2SO4 
82 mM, K2SO4 30 mM, MgCl2 5.8 mM, CaCl2 0.25 mM, Hepes 1 mM, Glucose 20 mM, 
KyMg 0.2 mM, phenol red), pH was adjusted using 0.2 M NaOH until the color of the 
solution became red.  Collected tissues were then digested twice using papain solution 
(60 units/30 ml papain latex - Sigma Aldrich) for 20 minutes by incubation at 37° C heat 
bath. Tissues were then washed twice with the dissection medium (2 mL each time) 
and twice with the growing media 2mL each time (Neurobasal A, 2% B-27 supplement, 
1% of FBS, 0.5% glutamate, and 0.5% antibiotic-antimicotic, all from GIBCO Invitrogen). 
Cells were then dissociated within the growing media by gentle agitation using a 
pipette gun with a 10 ml tip. Cells were counted using a haemocytometer and then 
diluted to the desired density in Opti-MEM containing 20µM glucose. Cells were plated 
on previously coated coverslips using poly-L-lysine with 1:10 dilution for overnight in 
room temperature (Sigma Aldrich). For calcium phosphate and viral transfection cells 
were plated in 100.000 cells/ml density as it was found to be the best for cells’ survival 
post- transfection. Cells were allowed to attach to the coverslips by incubating at 37°C, 
O2 (95%), CO2 (5%), for 2.5 hours. At that time, the media was changed to growing 
media and cells were maintained in the incubator for at least 2 weeks, with medium 
changed every 3 days, before doing the transfection (technique was adopted from  
Prof Hardingham’s group, Edinburgh University).    
 
2.2 Calcium phosphate transfection 
Some of the earlier wild type HR transfections were done using the calcium phosphate 
precipitation technique, under the sterile tissue culture hood as follows. 2 x HBS buffer 
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was prepared, aliquoted, and stored in -20°C (NaCl 274 mM, KCl 10 mM, Na2HPO4 
1.4mM, glucose 15 mM, Hepes 42 mM; pH: 7.05). The medium on the plate was 
changed to DMEM 30 minutes prior to transfection. For 1 plate of 12 wells, the 
transfection reaction A (600 µl of 2 x HBS solution) and B (50 mg of plasmid, 120 µl of 
2.5 M CaCl2, H2O to make up 600 µl mixture) were prepared.  
B was added to A drop by drop while vortexing using a low power until all mixed. The 
mixture was incubated in the dark at room temperature for 30 minutes. 100 μl of 
transfection mix was then added to each well drop by drop. The cells were incubated 
at 37°C for 20 minutes before washing away the transfection reaction. All coverslips 
were rinsed three times with pre-warmed DMEM and a fresh growth medium was 
added to the wells. Cells were grown for at least four days before doing any 
experiments to allow the cells to produce and express sufficient amount of protein. 
This protocol is adapted from (Jiang & Chen, 2006). 
 
2.3 Lentivirus Production and Transfection 
Later experiments used lentiviral transfection, because of its higher transfection rates. 
This protocol was adapted from (Zhang et al., 2010) and done as follows. Lentivirus 
vector was produced using HEK293FT cell line. Low passage cells (<P:10) were grown in 
D-10 (DMEM, 10% FBS, glutamate 6mM, 1% penicillin-streptomycin) medium 
containing 500 µg/ml geneticin until it reached 90% confluency. Cells were then split 
into four T-75 flasks and grown in geneticin free D-10 medium overnight.  
On the next day, cells were transfected using the calcium phosphate method. Plasmid 
DNA of pLenti-eNpHR3.0-EYFP (80µg), pCMVR8.74 (80µg), and pMD2.G (52µg) were 
prepared using recombinant deficient Stbl3 E.Coli strand (Invitrogen) and QIAGEN maxi 
prep kit. Plasmid DNAs were mixed thoroughly with CaCl2 to a final concentration of 
0.25 M and water was added to make up a 2 ml solution. 2 ml of BBS (borate buffer 
saline) was added and mixed by inverting the tube three times.  Transfection mixture 
was incubated for 30 minutes at room temperature, and then added to each flask (1 
ml for 1 T-75) drop by drop. Cells were incubated at 37ᵒC, 3% CO2 incubator for 18 
hours. Medium was discarded and replaced with a fresh D-10 media. The first and 
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second collections of the virus-containing media were done at 24 hours and 48 hours 
after the initial media changing. Collected media was spun down for 10 minutes (2200 
RPM) and filtered using 0.45 µm pore filter (Millipore).    
Virus was concentrated by ultracentrifugation using a Beckman SW28 rotor and 
Beckman-358156 adaptor. Virus containing media was loaded into a conical 
ultracentrifuge tube Beckman-358126 (26000 RPM, 4ᵒC, 2 hours) on top of a 4 ml 20% 
sucrose cushion. Supernatant was discarded and the pellet was resuspended in 100 µl 
PBS by gently swirling the tube. Virus was transferred to a 1 ml eppendorf, spun for 5 
minutes (7000 RPM), and aliquoted into 10 µl stocks to be stored in -80ᵒC. Culture 
transduction was done by diluting 1 µl of lentivirus in 100 µl growing medium and 
added 10 µl of that to each well (12 wells plate). Medium was changed 24 hours post 
transduction and experiments were conducted at least 4 days afterwards.  
 
2.4 Electroporation 
For my experiments with newly engineered protein sequences, electroporation 
became the favoured way of transfection as it had a better transfection rate than 
calcium phosphate technique and virus making was too time consuming for the testing 
process. Dissociated neuronal cells were prepared as explained above. Rat Neuron 
Nucleofactor kit (Lonza Amaxa) was used for electroporation. Plates with pre-coated 
coverslips using poly-L-lysine with 1:10 dilution were prepared a day before.  Before 
starting the electroporation process, growing media (2 ml per well for 6 wells plate or 
1 ml per well for 12 wells plate) was loaded into each well and plates were placed in 
the incubator. For one electroporation, five million cells were collected by 
centrifugation with 80 RCF for 5 minutes. Cells pellet was resuspended in 100 µl 
nucleofactor solution.  1-2 µg of plasmid DNA was added and mixed thoroughly. Cells 
were then transferred to an electroporation cuvette, and cuvette was placed in the 
electroporater. G-013 was used as the appropriate electroporation program for rat 
cortical neurons transfection and start button was pressed to initiate the process. 
Once finished, 500 µl of the pre-incubated growing medium was added to the cuvette 
and mixed with the cells. Finally, cells were distributed equally to every well of 6 well 
or 12 well culture plates. Medium was changed 3 hours and 24 hours post-plating. 
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Imaging / electrophysiological experiments were conducted at least 7 days post 
transfection. 
 
2.5 Patch clamp experiments 
Recordings were made using a laser spinning disc confocal microscope (Visitech) fitted 
with Patchstar micromanipulators (Scientifica) mounted on a Scientifica movable top 
plate.  Electrophysiological data was collected using a Multiclamp 700B amplifier 
(Molecular Devices) and Digidata acquisition boards connected to Dell desktop 
computers running pClamp software (Molecular Devices).  During the entire recording, 
cells were bathed in circulating oxygenated (95% O2/ 5% CO2) ACSF solution (perfusion 
at 1–3 ml/min) heated to 33–37°C by a sleeve heater element (Warner Instruments) 
around the inflow tube.  
2.5.1. Whole cell patch 
Whole cell recordings were made using 3-7MΩ pipettes made of borosilicate glass 
(Harvard apparatus). Electrode filling solution used was either low Cl- (K-methyl-SO4 
125 mM, Hepes 10 mM, Mg-ATP 2.5 mM, NaCl 6mM; 290 mOsM and pH 7.35) or high 
Cl- (KCl 135 mM, Na2ATP 4 mM, Na3GTP 0.3 mM, MgCl2 2mM, and Hepes 10 mM; 290 
mOsM and pH 7.35). Assessment of all modified HR proteins and experiment assessing 
Cl- concentration gradient on the wild-type HR were done by whole cell patch using 
high Cl- electrode filling solution whereas the initial exploration of iC1C2 versus 
slowChloC current was done using low Cl- electrode filling solution.  
During the assessment of Cl- concentration gradient on wild-type HR current, cells 
were perfused with oxygenated ACSF (NaCl 125 mM, KCl 3.5 mM, NaHCO3 26 mM, 
NaH2PO4 1.26 mM, glucose 10 mM, MgCl2 1 mM, and CaCl2 2 mM) and low Cl
- ACSF 
(Na isethionate 125 mM, KCl 3.5 mM, NaHCO3 26 mM, NaH2PO4 1.26 mM, glucose 10 
mM, MgCl2 1 mM, and CaCl2 2 mM).  
2.5.2. Perforated gramicidin patch 
Assessment of the chloride-loading effect of HR activation or the ArchT-ChloC Cl- 
extrusion effect was performed by doing perforated gramicidin patch. Gramicidin is a 
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chemical that creates a pore in cell membrane that is impermeable to Cl-. Cations can 
flow through and so high quality of intracellular recordings can be made but 
importantly Cl- cannot pass through. This type of patch is necessary to ensure that the 
Cl-  internal milieu of the cells are intact and not affected by the electrode filling 
solution in the patching pipette hence giving a more accurate measurement of the ECl- 
(Ebihara et al., 1995).  
Cells were constantly perfused with oxygenated ACSF. Gramicidin perforated patch 
recordings were made using 3–7MΩ pipettes (borosilicate glass; Harvard Apparatus) 
filled with a high Cl- electrode filling solution (KCl 135 mM, Na2ATP 4mM, Na3GTP 0.3 
mM, MgCl2 2 mM, and Hepes 10 mM; 290 mOsM and pH 7.35), so that the integrity of 
the cell membrane could be monitored. If the patch breaks through, equivalent to a 
whole cell mode, the high Cl- in the patching pipette will diffuse into the cell 
instantaneously giving an extremely depolarized EGABA. Fresh Gramicidin (Sigma Aldrich, 
G5002) stock was made daily with 5 mg/mL concentration in dimethylsulfoxide 
(DMSO). Gramicidin stock was added to the high Cl- electrode filling solution with 1:5 
dilution to achieve a final concentration of 0.1 mg/ml and mixed by 40 s vortexing and 
5 s sonication. Gramicidin electrode filling solution was then filtered using a 0.45 
millipore filter and used for patching straight away. Experiments were conducted when 
series resistance had stabilized (below 100 MΩ, approximately 30 minute after 
patching).  
Recordings were made in voltage-clamp mode, with a baseline holding potential of -
70mV, and repeated 200ms duration test ramps (triangular up-down function; peak -
50mV; trough -90mV; slope ±400mV/s; figure 1.1).  GABAA currents were induced by 
muscimol (100 µM) application delivered close to the recorded neuron through a 
patch pipette coupled to a picospritzer (Parker Instrumentation) delivering 10ms 
pressure pulses (10-20 PSI), and timing was coordinated with the illumination 
(optogenetic activation) via the pClamp software coupled to a Digitimer box.  Test 
voltage ramps were applied at baseline and also at close to the peak of GABAergic 
current (IGABA).  
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Figure 2.1 Voltage ramps protocol to measure GABA reversal potential. A. EGABA was 
measured in voltage clamp configuration with a VHold of -70 mV (top trace). Plus and 
minus 20 mV voltage ramps that lasted for 200 ms were introduced; one at the peak of 
muscimol event and one at the baseline period (bottom trace). B. Voltage and current 
relationship (I-V curve) was derived from voltage ramps introduced at the peak of 
muscimol event (black) and the baseline period (red). Estimated EGABA is the voltage 
point where the two I-V curves intercept. 
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2.6 Cortical expression of optogenetic proteins 
All animal handling and experimentation were done according to UK Home Office 
guidelines. Optogenetic proteins were expressed by doing injection of the relevant 
viral vectors or by using genetically engineered transgenic mice.  To achieve pyramidal 
expression of Halorhodopsin (HR), AAV-CamkII-cre-GFP (UNC viral vector core) was 
injected into homozygous floxed-HR mice (Ai39; B6; 129S-
Gt(ROSA)26Sortm39(CAGHOP/EYFP)Hze/J; Jackson Laboratory, stock number 014539).  For 
general neuronal expression of HR, pAAV-hSyn-eNpHR3.0-mCherry virus (UNC viral 
vector core) was injected into wild type mice (C57BL/6J). For pyramidal expression of 
ArchaerhodopsinT (ArchT), pAAV-CaMKIIa-eArchT3.0-EYFP (UNC viral vector core) was 
injected into wild-type C57BL/6J mice.  
Injections were made either into postnatal day 0-1 pups, or into young adult mice.  The 
pups had EMLA cream applied to the left top of their head, and were anaesthetised 
subsequently using isofluorane inhalation.  A single injection of virus was made using a 
10 µL Hamilton syringe, with a bevelled 36 gauge need (World Precision Instruments) 
approximately 1mm anterior to lambda, and 1mm lateral to the midline into the left 
hemisphere, at 1.7-0.8mm deep to the skin (four separate 50 nL injections, deepest 
first).  Approximately 0.2 µl (~1011 - 1012 viral particles) were injected over a 10 minute 
period.  This reliably labelled neurons or pyramidal cells throughout the hemisphere, 
and at the time of recordings, at age 5 weeks – 3 months, there was no cortical 
scarring apparent from the injection tract.  This became the preferred method for 
labelling, but for the early experiments, adult animal injections were also performed as 
follows.   
Young adult mice (5-8 weeks old) were anaesthetized by ketamine-methoxamine 
intraperitoneal injection and placed in a stereotaxic head-holder (David Kopf 
Instruments). Subsequent anaesthesia was maintained using isofluorane inhalation. 
Injections were made at 3-4 locations in an anterior-posterior row, in a single 
hemisphere, 1.5-2mm lateral to the midline, and 1-0.4 mm deep to the pia (0.6 µL, 
injected over 15 mins).  This gave an expression across all cortical layers however it 
was far more restricted laterally, extending 0.2-0.5mm in coronal slices. The 
illumination and recordings were then targeted to the centre of this area.  
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Cortical HR expression was also achieved by using genetically engineered transgenic 
mice. Brain slices were prepared from first generation cross-breeding of the floxed-
Halorhodopsin animals with CamKIIa-cre mice (B6.Cg-Tg(Camk2a-cre)T29-1Stl/J; 
Jackson Laboratory, stock number 5359).  
 
2.7 Brain slices experiments 
Coronal brain slices with a thickness of 400 µm were prepared from the injected or 
breeding animals (3-10 months), on ice-cold oxygenated (95% O2/5% CO2) artificial 
cerebrospinal fluid (ACSF: NaCl 125mM, NaHCO3 26mM, glucose 10mM, KCl 3.5 mM, 
NaH2PO4
− 1.26 mM, MgCl2 3mM, kynurenic acid 1.5mM, and ascorbic acid 0.3mM). 
After cutting, the slices were transferred to an incubation, interface chamber (room 
temperature) perfused with oxygenated ACSF (NaCl 125 mM, NaHCO3  26 mM, glucose 
10 mM, KCl 3.5 mM, NaH2PO4 1.26 mM, CaCl2 1.2mM, MgCl2 1mM) for at least 1 hour 
before transferring them to a recording interface chamber (33-36ᵒC), perfused with 
this same ACSF.  The concentration of divalent cations was used following Sanchez-
Vivez and McCormick (2000), because this allowed the reliable triggering of sustained 
bursts of activity, with a prominent high frequency discharge of fast-spiking 
interneurons (Sanchez-Vives & McCormick, 2000), by white matter stimulation 
(putative thalamic inputs).   
Single-electrode extracellular recording were made through broken-tip borosilicate 
patch pipettes (Harvard Apparatus), conducted using either Multiclamp 700B 
(Molecular Devices, California) or Axoclamp 1D amplifiers (Molecular Devices), a 1401-
3 Analog-Digital converter (Cambridge Electronic Design, Cambridge) and Spike2 
software (Cambridge Electronic Design) with sampling rate of 5-10 kHz. Multichannel 
extracellular recordings were collected at 10 kHz, using 4-channel-probe configuration 
(Q1x1-tet “tetrode”; NeuroNexus; figure 1.2) connected to a ME16-FAI-µPA-system 
and MC_Rack software (Multichannel Systems, Reutlingen). Bipolar electrical 
stimulation (0.2 ms duration) was delivered via tungsten electrodes onto the white 
matter.  
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Figure 2.2 Tetrode configuration of extracellular electrodes – from Neuronexus. 
 
 
2.8 Optogenetic illumination  
HR and ArchT were activated by 561nm, 50mW solid-state laser (Cobolt) connected to 
a fiber optic with a fine cannula (400 µm core, 0.20 NA; Thorlabs).  After optimizing the 
optic fibre coupling, the total light power at the cannula tip was measured at 15-30 
mW.  In order to achieve a comparable inhibitory effect by HR and ArchT, light 
intensity was adjusted by adding different neutral density filters (ND filters 0.2 – 0.6; 
Thorlabs) placed in the light patch between the laser and the optic fibre. Different 
filters could be used for different slices, however it was always constant at any given 
slice. After adding neutral density filter, laser output power ranged between 3-20 mW 
measured at the tip of the cannula. This gave a roughly equivalent optogenetic 
suppression of electrical stimulation as measured by a reduction in the line-length 
(cumulative voltage difference between consecutive data points) of the unfiltered 
signal 500 ms after the electrical artefact (Guo et al., 2010). Mean reduction in line-
length of evoked event: HR = 82.9 ± 2.8%, n=5; ArchT = 88.5 ± 4.4%, n = 5; n.s p<0.2.  
Patch clamp studies showed that a more stable optogenetic current could be obtained 
by co-illumination of both 561 nm and 491 nm light, thought to be due to improved 
cis-to-trans recovery of the activated retinal by blue light (Han & Boyden, 2007). 
Therefore co-illumination of the brain slices was prepared using the 561 nm laser light 
with blue epi-fluorescence light (460 +/- 20nm excitation filter) through a 4x air 
objective (0.28 NA, Nikon). It was confirmed that this co-illumination strategy provided 
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an enhanced and sustained HR current by assessing the suppressive effect on electrical 
stimulation at different times during a long illumination period (figure 3.6B); contrast 
the intermittent breakthrough discharges as the HR current wains with just 561 nm 
illumination, and the consistent suppression of electrical stimulation with the 
combined 491 nm and 561 nm illumination. 
 
2.9 Molecular biology 
2.9.1. Enzyme digestion  
All enzyme digestions were done in a 50 µl volume reaction containing 1 mg plasmid 
DNA, 1X bovine serum albumin (BSA), the appropriate buffers (as suggested by the 
company, depending on the restriction enzymes used), 0.5 – 1 µl restriction enzyme/s 
and nucleotide free water (Promega). Digestion reactions were incubated at 37° C 
incubator for 2-3 hours before agarose gel electrophoresis.  
2.9.2. Electrophoresis 
Generally 0.8% agarose was made by mixing 0.8 g agarose in 100 mL tris-acetate-EDTA 
(TAE) buffer heating it up in a microwave until all agarose was dissolved. 10 µl of 
ethidium bromide was added per 100 mL agarose mixed. Agarose mixed was poured 
onto the gel tray with the comb on and incubated in room temperature for 30 minutes 
or until it solidified. Plasmid DNA was diluted 1:6 in a DNA loading dye (Promega) and 
loaded into the wells. The hyperladder 1 was used as the DNA size indicator (Bioline). 
Electrophoresis was done in by applying 100 mV electric field using a horizontal 
electrophoresis system (Bio-rad) for 30-45 minutes.  
2.9.3. Ligation 
All ligations were done in a 20 µl ligation reaction containing 50 ng of the desired 
vector and insert with 1:3 molar ratio of vector and insert. T4 ligase and buffer were 
purchased from Promega. Reaction was then incubated in room temperature for 
overnight before proceed to bacterial transformation. 
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2.9.4. Bacterial transformation 
All pcDNA3.1 constructs were amplified by transformation of Mach1 competent cell 
(Invitrogen) while all pLenti and pAAV constructs were amplified by transformation of 
Stbl3 competent cell (Invitrogen) to avoid homologous combination of the long 
terminal repeats found in lentiviral and retroviral expression vectors. For side directed 
mutagenesis, PCR products were transformed into XL1- gold cells (Stratagene). The 
same protocol was used for all competent cells. All cells were stored at -80° C and 
thawed in the ice just before use. 50 – 100 ng plasmid DNA was added to 100 µl cells 
then incubated in the ice for 30 minutes. Cells were then heat-shocked, by 40 s 
incubation at 42° C heat bath followed by 2 minutes incubation in the ice. 500 µl pre-
warmed LB media was then added and cells then horizontally spun in 37° C room for 1 
hour. LB plates containing 100µg/ml ampicillin was pre-warmed in the 37° C incubator 
for 30 minutes. 100-200 µl of cells were then spread on the LB plate and incubated in 
the 37° C incubator overnight before transferred to the cold room (4°C).   
2.9.5. Plasmid prep  
Single colonies of transformed bacteria with the desired plasmid were inoculated in 5 
ml LB media for mini preps and 50 ml LB media for midi preps. Cells were grown 
overnight in a shaker with the temperature set to 37°C. Cells were collected by 
centrifugation at a maximum speed for 1 minute for mini prep and 5 minutes for midi 
prep. All plasmid preparations were done using Promega mini prep kit or QIAGEN midi 
prep kit.  
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2.9.6. Different constructs preparation 
For all constructs made, enzyme digestion and sequencing were done to confirm the 
exact sequence of the product.  
1. pcDNA3.1 - mutHR-EYFP 
mutHR was created by conducting two stage site directed mutagenesis on 
pcDNA3.1-HR-EYFP plasmid (gift from Karl Deisseroth).  
a. Forward primer: CGT-TTT-TAT-GAC-CGA-AGG-ACT-CGA-TGA-TC 
Reverse primer: GAT-CAT-CGA-GTC-CTT-CGG-TCA-TAA-AAA-CG (eurogentec) 
Annealing temperature: 50°C 
b. Forward primer: GAC-TCG-ATG-ATC-CAG-AGG-CAC-AAC-TTA-TTG-CTG-TGT-C 
Reverse primer: GAC-ACA-GCA-ATA-AGT-TGT-GCC-TCT-GGA-TCA-TCG-AGT-C  
(eurogentec) 
Annealing temperature: 45°C 
QuikChange XL Site-Directed mutagenesis Kit protocol was used. After 
transformation of competent cells 5 random colonies were selected, grown, and 
DNA was extracted using promega miniprep kit. DNA samples were sequenced to 
confirm the success of mutagenesis.   
2. pcDNA3.1 - mutHR-IRES-EYFP 
Not1STOP CODON-IRESNot1 was synthesised by GeneArt – life technology. mutHR-
EYFP was digested with Not1 enzyme that linearized the construct by cutting the 
Not1 site located between mutHR and EYFP. Not1STOP CODON-IRESNot1 was 
ligated with the linearized mutHR-EYFP. Since Not1STOP CODON-IRESNot1 could be 
ligated in 2 different orientations, screening had to be done by enzyme digestion 
before sequencing.  
 
3. pcDNA3.1 -LepA-GFP-HR  
Kpn1LepANot1-GFPNot1-HRXba1 DNA was synthesised by GeneArt – life technology, 
and subcloned to the multiple cloning site region of pcDNA3.1 by Kpn1 and Xba1 
enzyme digestion and ligation.  
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4. pcDNA3.1 -CD8-GFP-HR 
Kpn1CD8Not1 DNA was synthesised by GeneArt – life technology. LepA-GFP-HR 
construct was partially digested with Kpn1 and Not1 to isolate GFP-HR 
component, and CD8 was subcloned by ligation.  
 
5. pcDNA3.1 -CD8-EYFP 
EYFP with a stop codon was isolated from the original HR-EYFP construct using 
Not1 and Xba1 while pcDNA3.1-CD8 DNA was obtained from CD8-GFP-HR 
construct by Not1 and Xba1 digestion. pcDNA3.1-CD8 and EYFP were then ligated 
to get CD8-EYFP construct.   
 
6. pcDNA3.1 -CD8-HR-IRES-EYFP 
CD8-HR was generated from a complete Not1 digestion of CD8-Not1GFPNot1-HR 
construct, GFP band was removed and CD8-HR was then ligated back.  
 
7. pAAV-hSyn- ChloC-2A-tDimer and pAAV-hSyn -slowChloC-2A-tDimer 
These plasmids were purchased from Addgene, plasmid #52495 for ChloC and 
plasmid #52494 for slowChloC.  
 
8. pAAV-CAG –ArchT-GFP 
This plasmid was purchased from Addgene, plasmid #29777. 
 
9. pAAV -ChloC-2A-ArchT-GFP 
This construct was built by removing tdDimer from the pAAV-ChloC-2A-tDimer 
construct by complete digestion using BamHI and HindIII. ArchT-GFP was isolated 
from pAAV-ArchT-GFP also by complete digestion using BamHI and HindIII. 
pAAV-ChloC-2A was then ligated to ArchT-GFP.  
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2.10 Immunofluorescence staining  
Initially, dissociated neuronal culture cells attached to the coverslips were washed 
twice using 0.2 M phosphate buffer saline (PBS) with pH 7.2 – 7.4. Cells were then 
fixed using 4% paraformaldehyde (PFA) in PBS for 20 minutes at room temperature. 
Post fixation, cells were washed with PBS three times before adding a mixture of 0.1% 
gelatin and 0.1% triton in PBS, incubated at room temperature for one hour. Anti HR as 
the primary antibody used was purchased from Agrisera (AS12 1851) which was a 
rabbit polyclonal antibody. Cells were then incubated in Anti HR with 1:200 dilution in 
0.1% gelatin, 0.1% triton in PBS for 30 minutes at room temperature. Solution was 
discarded and cells were washed three times in PBS. Secondary antibody against rabbit 
antibody with red fluorescence tag was used with 1:500 dilution in 0.1% gelatin, 
0.1%triton in PBS. Added to the cells and incubated for 30 minutes at room 
temperature. Finally cells were washed again three times with PBS and mounted.       
2.11 Analysis 
Offline analysis was done using Igor (Wavemetrics, Oregon), Matlab and Microsoft 
Excel software. Boxplots were generated using online software 
(http://boxplot.tyerslab.com). 
2.11.1. EGABA measurement  
The IGABA was derived from the difference between the voltage ramp introduced at the 
peak of muscimol event and the voltage ramp introduced at the baseline period (figure 
1.1) to allow a GABAergic I-V curve to be plotted. I-V plots were derived with and 
without prior HR activation, and the effect of HR activation on EGABA was estimated 
from the shift in the x-intercept of the I-V plot (figure 2.1B). Series resistance was 
compensated offline. 
The time course of [Cl-]i modulation was assessed by measuring EGABA with an 
increasing delay after a 2-3s optogenetic activation. EGABA was calculated and 
normalized to the EGABA shift produced with the shortest delay (usually the one with 
the biggest EGABA shift) and exponentially fitted. The time constant (τ) of the curve fit 
was obtained as the time constant of HR or ArchT-ChloC variant [Cl-]i modulation. The 
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mean time course was always calculated by averaging the individual cells’  rather than 
extrapolating the pooled decay plot’s .    
2.11.2. Afterdischarge terminating oscillation 
Propagation speed of ATO was measured between the time when the peak of 
sustained potential shift was recorded in 1 electrode to the time when it was recorded 
in another electrode of the same tetrode that is 50 µm apart. Recovery time of cells’ 
activity post ATO was counted starting from the end of sustained potential shift 
observed in the LFP trace (1 -300 Hz) until the time when unit activity reappeared in 
the high pass trace (300 – 5000 Hz).  
2.11.3. Assessment of GABA modulation in IClamp recording 
GABA events were isolated based on the timing of the TTL pulse sent to the 
picospritzer to deliver muscimol puff. Amplitude of the GABA event was measured by 
averaging the amplitude of the current,  100 ms before and after the peak of the GABA 
event.   
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Chapter 3. Characterisation of halorhodopsin chloride pump 
 
3.1 Introduction 
Halorhodopsin is one of the most commonly used hyperpolarising optogenetic proteins, 
naturally found in Natromonas pharaonis. Upon light activation by illumination of 580 nm light, 
HR actively pumps chloride ion (Cl-) into the cell, driving the membrane potential to be more 
hyperpolarised (Zhao et al., 2008). In principle, the consequent changes induced by HR 
activation should affect both Cl- ion concentration and membrane potential. However, despite 
its general use as a tool to modulate membrane potential, HR had not been characterized as a 
tool to modulate Cl- concentration until just recently (Raimondo et al., 2012).  
To study the effect of Cl- in inhibition, one should have a way of modulating Cl- level 
independent of GABA and glycine, the two chloride channels that are responsible for 
inhibition.  Previously, loading cells with Cl- independent of GABA and glycine activity was only 
possible by doing whole cell patch of individual cell with the desired amount of chloride 
contained in the patching pipette solution. The continuity between the cytoplasm of the cell 
and the patching solution allows the diffusion of the patching pipette solution with the internal 
milieu of the cell. The technical difficulties set a limit on the number of cells that could be 
manipulated simultaneously. With HR optogenetic activation on the other hand, many cells 
could be targeted and activated at the same time without involving the naturally expressed 
chloride channels such as GABA and glycine. This makes HR a potential good tool as a [Cl-]i 
modulator as well as its general use as a hyperpolarizing tool.  
In this chapter, I will assess the usefulness of HR to load cells with Cl- at a single cell level, 
answering the question of whether the light activated HR current sufficient for membrane 
hyperpolarization is large enough to change the internal Cl- concentration of neurons 
significantly as to modulate GABA reversal potential (EGABA). I will then explore the optimal way 
of activating HR and describe how to implement this in the network level for the next part of 
the project.   
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3.2 Results 
3.2.1 Halorhodopsin activation causes a transient chloride loading effect 
Mixed cortical and hippocampal dissociated neuronal culture from rats were prepared 
and transfected with two different constructs of HR, the original HR (NpHR-EYFP) and 
the newer version of HR (eNpHR3.0-EYFP). The original HR gave a relatively small 
current with an average current of 13.79 ± 4.73 pA, n=6 while the new version one had 
an enhanced current with mean amplitude of 163.89 ± 108.94 pA, n=14; note that the 
same illumination paradigm was used for these two measurements. The HR Cl- loading 
effect was assessed by doing gramicidin perforated patch clamp recordings of the 
neurons that expressed HR, screened by the EYFP expression. Muscimol (GABAA 
agonist) was applied locally on the cell soma and voltage ramps were introduced one 
at the peak of the muscimol event and one at baseline as explained in chapter 2. The 
current-voltage relationship (I-V curve) was derived from the two ramps to obtain the 
EGABA.  
To assess baseline stability, three muscimol events were triggered at one minute 
intervals, for each neuron. When holding the membrane potential at -70 mV, GABAA 
activation from muscimol puff gave rise to a downward deflection (depolarizing), 
indicating that in these cells, EGABA was more positive than – 70 mV (figure 3.1Ai). The 
amplitude of the baseline muscimol events were relatively stable with a mean EGABA 
shift that lay very close to zero (-0.62 ± 1.4 mV, n=8).  Keeping the same interval, the 
following muscimol events were triggered with prior HR activation with increasing 
duration of illumination (2s-8s). Prior light activation potentiated GABA excitatory 
current (figure 3.1Aii), indicative of a more depolarized EGABA as a consequence of 
raised [Cl-]i induced by HR priming, with a mean EGABA shift of  1.03±0.18 mV/s, n=6 
(EGABA shift post 2s NpHR activaton vs baseline, p<0.01, Student’s t-test) illumination by 
the original HR and 6.95±1.5 mV/s, n=14 by the new HR (EGABA shift post 2s eNpHR3.0 
activation vs baseline, p<0.001, Student’s t-test). This positive shift in EGABA tends to be 
larger the more chloride flux there was, measured as function of the integral of the HR 
current over the entire duration of illumination.  It varied from cell to cell but it should 
be noted that the shift sometimes could be rather big (up to -23 mV, figure3.1Aiii).  
 
 41 
 
 
 
Figure 3.1 Halorhodopsin chloride loading effect. Ai. EGABA was measured by doing 
perforated gramicidin patch recording and applying muscimol with or without prior HR 
activation. Aii. Example traces from a single neuron showing a progressively larger 
muscimol excitatory event with longer duration of HR illumination. Aiii.  Scatter plot 
showing the shift in EGABA versus the total loading charge calculated as the integral of 
the current over the illumination period.  The plot includes multiple data points from 
single dissociated neurons, derived from different duration HR activations (n=14 cells) 
and 5 data points from 5 neurons (red) in adult brain slices, all from 2.5 s illumination. 
B. Duration of HR chloride loading was assessed by applying muscimol with increasing 
delay after 2s HR activation. Bi. Example measurement from a single neuron from the 
dissociated neuronal culture showing a progressively smaller muscimol event with a 
longer delay introduced between the light activation and the muscimol puff. Note that 
exponential fit to the minima of the ramps is simply for demonstration purpose, while 
the true τ was calculated from an exponential fit of the EGABA shift measurements. Bii. 
Pooled data show the recovery of EGABA following Halo activation in dissociated neuron 
cultures. Single exponential fits of the mean data are shown, but the time constants 
reported in the results section are the averages of fits made to each individual cells’ 
EGABA measurement. Mean time constant of EGABA recovery post HR activation was 28.1 
± 9.2s in dissociated neuronal cultures (n =14). 
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Figure 3.2 Estimation of the changes in [Cl-]i induced by HR activation. [Cl
-]i was 
estimated from the EGABA measurement using Nernst equation for Cl
- only. 
Temperature was considered to be constant (33ᵒ C).    
 
I then characterized the time course of this effect by activating HR for a short period 
and applying muscimol with an increasing delay. The biggest EGABA shift could be 
obeserved in the first muscimol puff that was triggered soon after the HR illumination 
(100 ms delay), a smaller potentiation of GABA current was produced following a 
longer delay between HR illumination and the muscimol puff. EGABA shift 
measurements with the different delays were exponentially fitted to derive the time 
constant of the EGABA recovery. Indeed this effect decayed over time with a mean time 
constant of 28.12s ± 9.26 s (mean ± s.e.m; n=14; figure 3.1B) for dissociated neuronal 
culture cells.  
The same characterization was also done in acute brain slices taken from 5 months old 
mice, expressing HR under CamKII promoter. Putative pyramidal cells from layer 2-5 of 
neocortex were selected, based on differential interference contrast (DIC) visualization 
(cells not filled). In these cells, EGABA recovered more rapidly post HR activation with a 
mean time constant of 8.01 ± 2.85 s (mean ± sem, n=5; figure 3.2) although this is not 
significantly different from the time constant calculated for culture neurons (acute 
brain slices vs cultures: not significant, p>0.05, Student’s t-test).  
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Figure 3.3 HR Cl- loading effect in acute brain slices taken from adult mice. The same 
protocol assessing the time constant of EGABA recovery post HR activation was done on 
acute brain slices taken from 5 months old mice. Ai. Example traces from a single 
neuron recording in which muscimol was applied with an increasing delay post a 2.5 s 
HR illumination. Note that exponential fit to the minima of the ramps is simply for 
illustration purpose, while the true τ was calculated from the EGABA measurements. Aii. 
Pooled data of the recovering EGABA was shown for data collected from dissociated 
neuronal culture (black, same data from figure 3.1B) and from acute brain slices (red). 
EGABA recovered more rapidly in the acute brain slices (mean ± sem : 8.01 ± 2.85 s, n=5) 
than in cultures (mean ± sem : 28.1 ± 9.2s, n=14).      
 
This decay should mainly depend on the neuronal chloride clearance mechanism and 
the well-established one is KCC2 co-transporter as explained in chapter 1. Based on 
this, I then performed the same experiment while blocking KCC2 using 100 µM 
furosemide. Due to the difficulty of maintaining gramicidin patch over a long period of 
time, continuous recording of baseline (ACSF), furosemide application, and washing 
out of the furosemide were only made from 3 cells. The rest of the data points were 
population based sampling. EGABA shift data points with the different delay were 
normalised to the EGABA shift produced with the shortest delay (100 ms). Data were 
pooled and plotted against the time post-HR illumination and fitted with a single 
exponential decay to compare how long the HR Cl- loading effect last with and without 
furosemide. With furosemide in the bath, the chloride loading effect from 2s 
illumination lasted almost 3 times longer than control (Pooled decay plot shows τcontrol: 
14.08 s and τfurosemide: 40 s; figure 3.3Biii).  This confirms that indeed the time course of 
HR Cl- loading effect was significantly longer when Cl- extrusion mechanism is 
compromised.  
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Figure 3.4 Furosemide prolonged the decay of HR chloride loading effect. Time course 
of Cl- clearance post HR activation was assessed when KCC2 was blocked by bath 
application of 100 µM of furosemide. A. Example of traces recorded from a single 
neuron of the dissociated neuronal culture with and without KCC2 blocker, furosemide 
(all from the same neuron). Time constant was longer in the presence of furosemide. 
Note that exponential fit to the minima of the ramps is simply for illustration purpose, 
while the true τ was calculated from the EGABA measurements. B. Pooled data shows a 
slower decay of HR effect on the EGABA shift in the presence of furosemide. Normalised 
EGABA shift data points were pooled and plotted against time post HR illumination for 
(Bi) control with ACSF only and (Bii) with furosemide on the bath. Biii. Pooled decay 
plot gave a mean τ of 14.08 s for control (black) and 40 s for furosemide (red).  
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3.2.2 Blue light stabilizes halorhodopsin current  
 
To make use of HR as a tool to modulate [Cl-]i concentration, it is essential to 
investigate how to maximize the HR current, and so its consequent Cl- loading effect on 
cells. This should be mainly dependent on the size of the HR current and the duration 
of illumination. In terms of the size of HR current, this is largely affected by the level of 
expression of the protein. Gradinaru et al (2008) has brilliantly optimized this in their 
eNpHR3.0 construct (also used in most of my experiments) by adding extra signal 
peptide into the DNA construct that assists the membrane targeting of HR from the 
endoplasmic reticulum (ER) (Gradinaru et al., 2008). This signal was originally found in 
inward-rectifier potassium channel 2.1 (Kir 2.1) and it has been shown that when this 
signal was omitted, Kir2.1 protein aggregated in the ER. This highlights the importance 
of this signal in sending a protein out of the ER and into the membrane. The addition of 
this signal peptide to the HR construct significantly improved the level of membrane 
expression and light activated current of HR (Gradinaru et al., 2008).  
Another way of loading more Cl- into the cell is by increasing the duration of 
illumination. When doing this however there was an issue of the decaying current over 
a longer period of light activation. This compromises the chloride loading effect as less 
Cl- per second is being pumped into the cell when longer illumination was applied 
(figure 3.4Ai & 3.5 orange). The decaying current could be explained by a lower 
amount of readily activated retinal chromophore over time that is needed for the 
conversion of light into the energy needed for the Cl- pump. Retinal chromophore 
exists in two forms of isomer, trans and cis configuration. Readily activated retinal is in 
the trans configuration. Once activated by light, this is converted into cis configuration 
that provides energy for the passage of a Cl-. Until retinal is reconverted back into 
trans configuration, the protein remains inactive.  
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Han and Boyden used blue light, which is known to assist the reconversion of cis-
retinal back to trans-retinal, by delivering a short pulse of blue light illumination before 
a long orange light illumination for HR activation (Han & Boyden, 2007). Applying this, I 
compared the EGABA shift after HR activation by orange light only in comparison to 
intermittent orange-blue illumination and indeed a marginal increase in EGABA shift was 
observed by about 2 mV (figure 3.4).  
To improve this further, instead of using an epifluorescence bulb with different filter 
sets in which two colours illumination is impossible, I then tried using 491 nm and 561 
nm lasers, which allows simultaneous orange and blue light illumination for HR 
activation. This strategy stabilized the HR current as shown by a linear relationship 
between duration of illumination and Cl flux (current x duration of illumination) figure 
3.5.  
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Figure 3.5 Intermittent illumination of blue and orange light optimizes HR Cl- loading 
effect.Example traces from a single neuron expressing old HR to assess the usefulness 
of blue light in optimizing HR Cl- loading effect. Ai. Conventional 8 s orange light 
illumination positively modulated muscimol event. However, at the end of the 
illumination HR current diminished to almost zero.  Aii. Intermittent blue and orange 
light illumination allowed repeated HR activation with sustained amplitude of HR 
current. Aiii. It resulted in a bigger amplitude of GABA excitatory event (blue in 
comparison to black) indicative of a bigger positive shift in EGABA (ramps are clipped). 
Aiv. This is also shown by the I-V curved derived from the ramps.  
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Figure 3.6 Co-illumination of both 561 nm and 491nm light optimizes halorhodopsin 
current. A. Voltage clamp recording of a neuron from dissociated neuronal culture 
expressing new HR: 561 nm light illumination showed a decaying HR current overtime 
(top, orange trace) whereas co-illumination of 561 nm and 491 nm light give rise to a 
more stable HR current (bottom, purple trace). Bi. HR current per second was constant 
with double illumination as opposed to the drastically decaying current with single 561 
nm illumination. Bii. Linear relationship between the duration of illumination and the 
Cl- flux using the double illumination paradigm confirms the effect of co-illumination 
using both 561 nm and 491 nm light in stabilizing the HR current.  
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3.2.3 Designing HR illumination system for field recording in the interface chamber  
So far all the collected data have confirmed that HR current necessary to hyperpolarise 
the neurons is sufficient to create an appreciable rise in the intraneuronal Cl- level. 
Moving forward from this, I wanted to make use of HR as a tool to artificially load 
subset of cells with Cl-. To do this, a way of illuminating multiple cells and assessing HR 
activity in a network level that will be done in an interface chamber rig has to be set 
up.  When working with local field potential (LFP) recording and light stimulation, an 
important issue to be noted is the light induced artifacts that appear as a large voltage 
swing seen during light activation or inactivation. This sometime could be mistaken as 
the optogenetic current (Cardin et al., 2010). It is due to a phenomenon also known as 
the Becquerel effect when there is unequal illumination of an electrode in the 
presence of electrolyte (Cardin et al., 2010). Designing a test of HR current becomes 
absolutely necessary to confirm that the optogenetic current exist, since LFP deflection 
during light illumination could be a mere artifact.  
Coronal brain slices from HR expressing animals were prepared and recording was 
done in an interface chamber perfused with oxygenated ACSF.  On top of the interface 
chamber, an epifluorescence microscope was mounted with a 4X air objective 
(Olympus, NA0.28; figure 3.6C). Initially, 4X air objective was used to deliver the 580 
nm light for HR activation. The HR current was tested by delivering electrical 
stimulation on the white matter and recording from the layer 5 of coronal slices, with 
and without HR illumination. Apart from a marked deflection during light-on and light-
off period, there was no substantial reduction in the electrically evoked event recorded 
during light illumination, suggestive of no hyperpolarising HR current induced in this 
set up. Failure to activate HR using 4X air objective could be explained by the fact that 
in this set up, light is scattered around the entire slice that consequently reduces the 
light intensity per surface area. I then changed the illumination system by using a 561 
nm laser, connected to a fibre optic that feeds into a thin cannula to be placed very 
close to the surface of the slice by a micromanipulator (figure 3.6C). This way, light 
could be delivered more focally hence maximizing the light intensity per surface area. 
When repeating the same test, light illumination suppressed the electrically evoked 
event substantially confirming that this illuminating system works in activating HR 
current (figure 3.7A). 
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Figure 3.7 Network activity recording arrangement. A. Confocal image showing sparse 
expression of HR-EYFP in pyramidal cells when expressed under CamKII promoter. B. 
Schematic showing the locations of the recording electrode in layer 5 (grey), 
stimulating electrode (blue) in the underlying white matter, and a fibre optic delivering 
561 nm wavelength light. C. Schematic (left) and photograph (right) of the illumination 
system: 561 nm light was delivered by laser connected to a fibre optic cannula that 
was controlled by a manipulator to direct it to the surface of the slice, while  491 nm 
light was delivered through 4X air objective, to stabilize the HR current.   
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The effect of blue light (491 nm) in stabilizing the HR current was also assessed on the 
LFP by doing  repetitive electrical stimulation with 30s interval and activating HR using 
561 nm light only or with co-illumination by 561 nm and 491 nm light. 561  nm laser 
was delivered via the cannula as mentioned earlier, while the 491 nm was delivered via 
the 4X air objective lens (figure 3.6C). As shown in figure 3.7B, electrical stimulation at 
0.25 Hz evoked a relatively stable amplitude of network event (figure 3.7B, black). 
These electrically evoked events show a ‘threshold effect’ where just a small reduction 
in the power of the electrical stimulation will abolish these events altogether. When 
activating HR with 561 nm alone, this electrically-evoked events were suppressed but 
rather variably with some breakthrough activity recorded (figure 3.7B, orange). This 
suggests that there is a decaying effect of the HR current. In contrast, 491 nm and 561 
nm co-illumination consistently suppress these events throughout a long period of 
illumination (up to 40 s; figure 3.7B, purple), suggesting of a more stable HR current. 
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Figure 3.8 Halorhodopsin current suppresses electrically evoked event. A. Example 
from 1 brain slice showing that 560 nm illumination greatly suppresses the electrically 
evoked neural activity, thereby demonstrating the existence of a prominent HR current. 
Blue triangles mark the onset of the electrical stimulation. Orange bar shows the onset 
of the light activation. Upward and downward deflection could be observed on the LFP 
trace at the start and the end of light activation respectively. B. Evidence of sustained 
HR current by 561 nm and 491 nm light in the extracellular recording. Electrical 
stimulation was applied every 4s. Steady baseline was recorded without light 
stimulation, showing a stable response. When HR was activated continuously with 561 
nm, the suppression was initially strong, but breakthrough bursts often recorded. With 
persistent 561 nm-491 nm light illumination, the suppression of activity was 
maintained throughout the illumination period, indicating that with this form of 
illumination, the HR current remains large, as was shown in the single cell assays 
(figure 3.5).  This effect was maintained for illumination periods of up to 40s.  
 53 
 
3.3 Discussion 
For a long time, people have been focusing mainly on the hyperpolarizing effect of HR 
while discounting its effect on the [Cl-]i modulation. One of the reason is due to the 
uncertainty of whether the light activated current that is enough to hyperpolarize the 
membrane potential could also provide a substantial change in the [Cl-]i. Earlier study 
by Tonnesen et al (2009) claimed that this is not the case as they did not see a 
significant shift in EGABA during HR activation compared to no activation (Tønnesen et 
al., 2009). The failure to see the shift in this study could be explained by the fact that 
they performed the EGABA measurement after only a very brief light activation (200 ms) 
compared to a much longer activation (in seconds duration) that they and many others 
introduced when using HR as a hyperpolarizing tool. In addition, they were using the 
original version of HR that has a relatively small current.  
In this chapter, I have demonstrated clearly that it is indeed possible to load cells non-
invasively and non-synaptically with Cl- simply by activating HR optogenetically. This is 
based on the fact that HR activation significantly alters EGABA into a more depolarized 
level indicative of a higher [Cl-]i. This effect does rely on the size of the current and the 
duration of illumination, however in our hand a positive shift in EGABA was readily 
induced when cells were primed with HR activation even with 2 s illuminations only, 
both with the original HR or the new one eNpHR3.0, depending on the cells but the 
shift could be really big (up to 23 mV). The same result has been shown also by 
Raimondo et al in hippocampal pyramidal neurons from organotypic culture and acute 
brain slices (Raimondo et al., 2012).  
HR effect on EGABA or [Cl
-]i is transient, as demonstrated by the progressively smaller 
EGABA shift with an increasing delay between HR activation and muscimol puff. The time 
constant of this decay reflects the efficiency of Cl- clearance mechanism of the cell, as 
shown by the prolonged decay when KCC2 was blocked (figure 3.3). Hence this 
experimental protocol could also be useful as an assay to measure a cell’s ability to 
clear Cl-. The time constant of Cl- clearance post HR illumination was also measured in 
acute brain slices taken from 5 months old mice, to give an insight in designing the 
illumination paradigm for the next chapter, in which HR will be used as a [Cl-]i 
modulation tool. Knowing that in these slices, EGABA  recovered with a time constant of 
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8.01 ± 2.85 s post HR illumination, any future observation about high [Cl-]i effect 
should only be made within this time period.  
HR Cl- loading effect could explain the commonly observed rebound burst of action 
potentials after HR activation in many different set up of experiments (Tønnesen et al., 
2009; Madisen et al., 2012).  However, rebound firing could also be explained by the 
activation of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel 
that is activated by hyperpolarization and gives rise to a depolarizing current (IH) 
towards the threshold of action potential. This is supported by the same rebound firing 
observation when Arch, the outward proton pump that hyperpolarizes the cell without 
changing Cl- concentration, was used (Madisen et al., 2012). Evidently, this is likely to 
be weaker than the effect of HR Cl- loading as shown by Raimondo et al (2012). HR 
activation consistently increases the spike probability in a single cell level, whereas 
Arch activation that should still activate IH but without Cl
- loading effect showed a 
variable and insignificant increased in spike probability post hyperpolarization 
(Raimondo et al., 2012). This could be due to the fact that cells vary in their IH levels.  
This is an important insight for further use of optogenetics as it is essentially an 
artificial way of altering certain ion level intracellularly. Inevitably, there could be some 
consequences on the neuronal system that naturally regulated by a certain balance 
state of the manipulated ion. For instance with HR, its Cl- inward pump results in the 
transient alteration of Cl- balance that results in the modulation of EGABA. As 
presumably for ArchT, the outward H+ pump might affect the H+ concentration within 
the cell and potentially the pH level, although this might be rapidly equilibrated by the 
buffering mechanism. 
To use HR as a hyperpolarising tool, one should be fully aware that the HR 
hyperpolarizing effect always comes with the Cl- loading effect and vice versa, hence 
careful thought in designing the experiment is important. For instance, many groups 
have tried to use HR as a tool to control epileptic seizures (Tønnesen et al., 2009; 
Krook-Magnuson E et al., 2012; Paz et al., 2012; Wykes et al., 2012; Sukhotinsky et al., 
2013) and in this situation HR Cl- loading effect could potentially contribute further to 
the hyper-excitability and promote seizure initiation. Furthermore, it has been shown 
before that in human epileptic tissue there appears to be a reduction in the KCC2 level 
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of expression (Huberfeld et al., 2007b) that based on my experimental data will extend 
the HR Cl- loading effect on cells to almost three times longer than when Cl- clearance 
mechanism is intact (figure 3.3). This is not to close the possibility of using HR in 
epilepsy as Cl- loading effect of HR is only transient and naturally HR current decays 
overtime. However this is an important consideration to be primed about. This will be 
further discussed in chapter 6.   
The same concern applies when intending to use HR Cl- loading effect as a tool to 
artificially load cells with Cl-. It should be noted that the effect is inseparable from the 
hyperpolarizing effect and hence a proper control for the hyperpolarizing effect is 
needed to isolate the Cl- dependent effect of the result such as the use of Arch by 
Raimondo et al (Raimondo et al., 2012).  
Illumination paradigms could be tailored accordingly to the ultimate goal of HR use. 
For example, when hyperpolarizing effect is desired without causing a rebound firing 
that might contribute to hyper-excitability, the naturally decaying HR current might be 
suitable however decaying the current further could also be helpful. This is possible by 
ramping down the light at the end of an illumination. This is particularly helpful for the 
new version of HR that has a large current compared to the old one. Ramping down 
the light has been shown to successfully reduced rebound firing induced by the new 
version of HR by 60% (Chuong et al., 2014). When a strong Cl- loading effect is needed 
as for what this thesis is aiming for, simultaneous orange and blue light illumination is 
favorable to stabilize the HR current hence the Cl- loading effect as shown in figure 3.5 
& 3.7.    
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3.4 Summary 
I have shown that HR activation modulates intraneuronal Cl- level significantly and 
hence could be used as a tool to artificially load cells with Cl-. The effect is transient 
with a mean time constant of 28.1 ± 9.2s in dissociated neuronal cultures and of 8.01 ± 
2.85 s in adult acute brain slices, which is the window of opportunity to observe the 
network activity when cells are loaded with Cl- before it returns back to baseline. For 
this purpose, co-illumination of orange and blue light is beneficial to stabilize the 
inward Cl- drive. I also have provided the best strategy for applying this to the network 
level to move forward to the second aim of this thesis that is to study how high [Cl-]i 
modulate network activity and how it relates to epilepsy.  
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Chapter 4. Characteristics of epileptic network activity arising from 
raised intraneuronal chloride 
 
 
4.1. Introduction 
It has been reported before that seizures are commonly associated with a marked 
increase of intraneuronal Cl- ([Cl-]i) in different in vitro models of epilepsy (Fujiwara-
Tsukamoto et al., 2006; Huberfeld et al., 2007c; Dzhala et al.; Lillis et al., 2012; Ellender 
et al., 2014; Pallud et al., 2014). It is well established that when Cl- accumulates 
intracellularly, the driving force for hyperpolarizing GABA is reduced and eventually 
becomes depolarising (Thompson & Gahwiler, 1989a; Staley et al., 1995; Ben-Ari, 
2002). However, to what extent high [Cl-]i state is really involved in the generation of 
the epileptic network activities, and whether it is by itself sufficient to trigger seizure, 
is still unclear.  
Using the HR Cl- loading effect, that has been characterised in the previous chapter, as 
a mean to load subsets of cells with Cl- at the same time, I explore how high [Cl-]i 
modulates the network activity and  investigate the role of high [Cl-]i in the generation 
of certain patterns of epileptic network activities, also answering the question of 
whether high [Cl-]i by itself could lead to seizure initiation.  
4.1.1. High frequency activity in epileptic networks 
One clinically relevant network activity, which has been associated with epilepsy, is the 
generation of high frequency oscillations (HFOs) that range from 150 to 600Hz (Engel Jr 
et al., 2009; Alvarado-Rojas et al., 2014). HFOs have been recorded in vitro or even on 
EEG recording from patients with epilepsy. This pattern of activity has been linked 
clinically as a hallmark of epileptic focus zone (Bragin et al., 2002a; Bragin et al., 2002b; 
Staba et al., 2002; Jiruska et al., 2010). 
However, not all HFOs are considered pathological as HFOs are also commonly 
recorded in healthy rodents (Buzsaki et al., 1992), monkeys (Skaggs et al., 2007), and 
humans (Le Van Quyen et al., 2008) during quiet wakefulness and slow-wave sleep. 
This physiologic HFO is suggested to play a role in memory consolidation during sleep 
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(Wilson & McNaughton, 1994). As HFO could reflect both physiological and 
pathological network activity, it is therefore important to be able to differentiate them 
by recognizing the different characteristics of those patterns of activity.  
Recent study, in which simultaneous intracellular and extracellular recording were 
performed during HFO, indicated that it is difficult to classify HFO that is <250 Hz as 
epileptic or physiologic, judging only from the extracellular recording (Alvarado-Rojas 
et al., 2014). This is because there are multiple underlying cellular and synaptic 
mechanisms that could give rise to this pattern of activity, including the physiological 
and the pathological ones (Alvarado-Rojas et al., 2014). In contrast, activity that 
is >250 Hz, also known as fast ripple, is better associated with epilepsy, as this is only 
generated in situations where there is an enhanced excitability and a failure of 
GABAergic signalling (Huberfeld et al., 2011; Alvarado-Rojas et al., 2014).  Furthermore, 
this feature has also never been recorded in healthy territories (Alvarado-Rojas et al., 
2014).  
Additionally, it  has been reported before that a highly characteristic pattern of 
epileptic fast ripples in rats (Foffani et al., 2007b; Ibarz et al., 2010a) is the notable 
harmonic feature of a prominent frequency band at 150-300Hz and another at 
approximately double the frequency, which they suggested may arise from 
subpopulations of neurons firing out of phase of each other. However, how these 
subpopulations of neurons arise is still unknown and further understanding is needed 
as these issues can impact directly on clinical practice, regarding the use of HFO as a 
hallmark of epileptic foci. Furthermore, a proper explanation of these pathological 
activity patterns may also suggest novel therapeutic avenues as manipulation that 
reduces HFO also has been shown to reduce seizure propensity at the same time 
(Grenier et al., 2003).    
4.1.2. Seizure termination 
Most of the time, epileptic network activities including seizures are transient and self-
terminating. However, the mechanism of how seizures terminate is still poorly 
understood. Typically, seizures are followed by post ictal depression that clinically 
manifests as extreme exhaustion (Löscher & Köhling, 2010). During this refractoriness, 
seizure threshold is increased (Löscher & Köhling, 2010). Several different mechanisms 
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have been suggested as possible explanations of how this might happen and all could 
be true for the different cases of seizures or epilepsy models.  
First, it has been suggested that post-ictal hyperpolarization might be responsible for 
post-ictal depression state, as commonly observed from the intracellular recordings 
(Somjen, 2004; Ilie et al., 2012). This prolonged hyperpolarization could last for several 
minutes and is mainly imposed by K+ current, which is facilitated by G-protein coupled 
receptors such as GABAB and adenosine receptors (Löscher & Köhling, 2010; Ilie et al., 
2012). Additionally, activity of voltage-gated and calcium-activated K+ channels could 
also contribute further to this hyperpolarization (Somjen, 2004).   
A second mechanism proposed is by the metabolic processes such as the depletion of 
energy and neurotransmitters pool, which limits the sustenance of further neuronal 
activity (Somjen, 2004; Löscher & Köhling, 2010). In addition, pH alteration following 
intense neuronal activity could also contribute to the post-ictal depression state. Lactic 
acid accumulation and hence acidification in the extracellular matrix could be observed 
post seizure and this has been shown to reduce neuronal excitability (Somjen, 2004; 
Löscher & Köhling, 2010).  
Lastly, spreading-depression like event due to depolarization block also has been 
suggested as a mechanism underlying the post-ictal depression phenomena at the end 
of a seizure (Somjen, 2004). Depolarization block is a situation of an extreme 
depolarization of the membrane potential due to extracellular K+ accumulation, which 
deactivates voltage-gated sodium channels, leaving the cells incapable of generating 
action potentials (Somjen, 2004). In spreading depression, the depolarization  
 
propagates slowly and so does the depression state it induces (Bragin et al., 1997). 
Post-tetanic stimulation seizures are often followed by spreading-depression like 
events that could also contribute to its termination (Somjen et al., 1985; Bragin et al., 
1997). However this might not be applicable to all seizures as mentioned earlier, since 
most intracellular recordings from a seizure show a post-ictal hyperpolarization rather 
than depolarization (Somjen, 2004).  
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It has been shown that spreading depression happens when K+ outside surpasses the 
limit of 8-12 mM (Somjen, 2004). However it still poorly understood how K+ could 
accumulate to that extent during spreading depression and how it propagates. Further 
understanding could give an explanation of why some seizures are terminated with 
spreading-depression like event while others not.     
 
4.2. Methods 
4.2.1. High frequency oscillation analysis 
Frequency band analyses were done on the raw data, whereas for multi-unit analyses, 
a band pass filter of 300-5000 Hz was applied and spikes were detected by a simple 
thresholding algorithm. Spike analyses were only performed for periods when the 
tissue was not illuminated (that is to say, not during the periods of optogenetic 
activation). Hilbert transform analysis was performed on the dominant oscillation 
signal (75-300 Hz band-pass filtered), which allows this signal to be plotted as a 
continuous circular trajectory. To analyse spike timing according to the dominant 
oscillation, detected spikes were plotted on the Hilbert transform of the corresponding 
dominant oscillation. Angle and linear histograms were derived from the Hilbert plot. 
Baseline data was centralised and fitted to a Gaussian curve to obtain the baseline 
half-width. In order to assess the action potential jitter and out-of-phase firing across 
multiple experiments, we derived a “half-width index”, which was calculated using the 
following formula:   
Half width index = 
∑(𝑠𝑝𝑖𝑘𝑒𝑠 𝑜𝑢𝑡𝑠𝑖𝑑𝑒 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝐻𝑊)
∑(𝑠𝑝𝑖𝑘𝑒𝑠 𝑤𝑖𝑡ℎ𝑖𝑛 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝐻𝑊)
 
 
Where HW is the half-width measured on the baseline period.  Note that the baseline 
HW is used for all analyses for a single experiment, including for the optogenetically-
primed data sets which have a different width modal histogram peak. 
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Figure 4.1 Measurement of half-width indices to quantify the increased jitter and 
out-of-phase firing. Half-width index measures the ratio between the numbers of out-
of-phase spikes to the in-phase spikes, which were taken to be the spikes within 
bounds set by the half-width of a Gaussian fit to the main spike peak in the histograms. 
Example from a single recording during baseline period and HR primed period: left 
panels show the centralised raster plots for baseline (top) and HR primed tissue 
(bottom), and the right panels show the centralised histograms of the spike times. 
 
 
4.2.2. Control analysis for spectral leak 
An important consideration when analysing spike phase relationships, especially when 
relating units and field recordings made in the same electrode, is spectral leak, which is 
where a very high frequency event will create a small ripple also in lower band pass 
filtered traces.  Note however, that the ripple is very small relative to the original 
signal (<1%), but because it arises from that sharp signal, it will always have a fixed 
phase relationship to it.  For this reason, it was important to assess whether, despite 
its small amplitude, the pooling of many units might produce a distribution which is 
unduly influenced by this fixed phase artefact.   
 
 
 
 62 
 
 
 
 
Figure 4.2 Spectral leak from a delta-function.  The plot illustrates the problem of 
spectral leak, with a δ function in lieu of an action potential spike.   A 75-300Hz 
bandpass filter was performed on the “raw trace” (black), which is a 10 kHz sampled 
flat data set with a single data point of unit amplitude.  The filtered version of this has 
a single cycle oscillation with approximately 0.8% peak-to-peak amplitude.  Action 
potentials will thus also create an additional oscillation in the lower frequency 
bandwidths, but as this illustrates, this effect is very small.  
 
 
In order to separate out the spectral leak from the spike-independent field oscillation, I 
reanalysed the spike-phase data in two ways: first, by amputating the spikes from the 
data; and second, by analysing the phase of oscillation at a time point 1-2 ms ahead of 
the spikes, with and without spike amputation (figures4.8A). The reasoning was that if 
the spikes were indeed embedded within genuine oscillations, then these oscillations 
would extend sufficiently far in front and after the spike that the relationship would 
still exist for time-shifted points.  A forward time-shift was chosen to avoid any 
postsynaptic influences. With 1-2 ms ahead, there was no significant difference 
between the spike time distributions for the original or amputated versions, which 
indicates that the oscillation in this time point is not influenced by the spectral leak 
from the spike. 
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4.3. Results 
4.3.1. Raised intraneuronal chloride induces high frequency oscillation  
Coronal brain slices were prepared from the animals that express halorhodopsin (HR) 
or archaerhodopsinT (ArchT) under a pyramidal cell specific promoter, CamkII 
(figure3.6Ai). Recording was done in layer 5 of somatosensory cortex and electrical 
stimulation was applied onto the white matter (figure3.6Aii). HR and ArchT current 
were assessed by applying electrical stimulation during optogenetic illumination and 
observed that this was suppressed markedly compared to baseline (chapter 3.3, figure 
3.6Bi). Only slices that showed this optogenetic suppression of electrically evoked 
events were included in the experiment.   
Generally, experiment was started with a baseline cycle that comprised of 10 repeats 
of electrical stimulations delivered every 30 s without any optogenetic activation. This 
was then followed by optogenetic priming cycle that comprised of 20 repeats of both 
electrical stimulations and optogenetic activation. Electrical stimulations were timed to 
be at 4.5 s before and 0.5 s after the optogenetic illumination that each lasted for 25 s 
(figure 4.3Ai). This allows a comparison of the electrically evoked network event before 
and post HR-priming period. Typically, a second baseline cycle and optogenetic priming 
cycle were also done at the end (figure 4.3Aii).  
 
Figure 4.3 Experimental protocols for HR priming and ArchT priming.  A. Chloride 
loading was achieved by interspersing 25s periods of 561 nm illumination to activate 
HR (“Halo priming”) while the control for hyperpolarization was conducted by 
replacing HR priming with ArchT priming. Electrical stimulations were applied during 
the dark periods (5s). One was applied 0.5s after, and one was 4.5s before the 
illumination. The interval between stimuli was always 30s.  Baseline periods had the 
same electrical stimulation frequency, but without any illumination.  Aii. Two baseline 
cycles and 2 optogenetic priming cycles were recorded one after another.  
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Baseline electrical stimulation on the white matter evoked a network activity that 
peaked at <150 Hz (figure 4.4A).  Tissues that have been primed by HR illumination 
showed a potentiation of this event especially in the high frequency oscillation (HFO) 
range (300-600 Hz; figure4.4A&C). As a control for the hyperpolarisation effect of HR 
priming in the modulation of the network activity, the same experiment was done 
using ArchT, which is another hyperpolarising optogenetic tool that pumps protons out 
(Han et al., 2011) and is therefore Cl- independent (Raimondo et al., 2012). In contrast, 
when tissues were primed with ArchT there was no change in the HFO range 
confirming that the HR-primed induced HFO was Cl- dependent and not merely due to 
rebound firing subsequent to synchronized hyperpolarisation of pyramidal cells 
(Figure4.4B&D).   
 
Power analysis of different frequency bands were done comparing 75-150 Hz, 150-300 
Hz, 300-600 Hz, and 600-1200 Hz components for HR and ArchT primed events. HR 
priming showed stronger potentiation across all frequency bands compared with ArchT, 
but only at 300-600Hz was HR modulation significantly different from ArchT (n=11 for 
both HR and ArchT, Student’S t-test p<0.01; figure 4.5). The 600-1200 Hz power for 
both HR and ArchT showed a very little deviation from baseline (figure 4.5A). This 
suggests that the modulation between 300-600 Hz was not due to a simple harmonic 
phenomenon of the lower frequency bands. Rather it was a genuine biological 
modulation due to Cl- loading, as harmonic will increase the higher frequency band 
(600 -1200 Hz) as well.  
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Figure 4.4 Halorhodopsin chloride loading induced high frequency oscillations. A. 
Representative traces and spectrograms from a single brain slice taken during two 
periods of electrical stimulation without HR illumination (baseline 1 and 2), and two 
periods with illumination (HP1 and 2). Note the large increase in power at 300-600 Hz 
during the halo-priming periods, which reversed rapidly without illumination (baseline 
2 and C). B. Representative traces and spectrograms from a single brain slice 
expressing ArchT, during baseline 1 and 2 (black traces) and during ArchT priming 1 
and 2 (red traces). In contrast to HR priming traces, no increase in power could be seen 
at 300-600 Hz with ArchT priming. C. Composites of sequential spectrograms from the 
same brain slice in A to show the changes during the entire experiment, showing the 
rise in high frequency power (200-500 Hz) induced by halo priming and the reversion 
to baseline without illumination. D.  Composites of sequential spectrograms from the 
same brain slice in B with ArchT induced a small increase in amplitude of the network 
event, but without any change in the high frequency activity.  
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Figure 4.5 Frequency analysis of HR-priming versus ArchT-priming experiments. A. 
Power spectrum of different frequency bands for HR-primed (red) and ArchT-primed 
(black). B. Boxplot of the averaged ON-periods power during HR-priming and ArchT-
priming for different frequency bands. HR activation positively modulated activity 
across all frequency bands, but only differed significantly from ArchT activation on 300-
600 Hz component (n = 11 for HR and ArchT, p<0.01 Student’s t-test).     
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Additional to this, the same experiment was repeated but with HR being expressed 
under the synapsin promoter that affects both pyramidal cells and interneurons. In 
contrast to CamKII HR expression system, when HR was expressed under synapsin 
promoter HR priming did not induce any significant modulation of the evoked activity 
across all frequency band. (HR-primed versus baseline not-significant for 75-150 Hz, 
150-300 Hz, and 300-600 Hz with p>0.05, Student’s t-test, n=10; figure 4.6C).  
 
 
 
 
Figure 4.6 When expressed under synapsin promoter, HR priming failed to induce 
high frequency oscillation. The same experiment was conducted by expressing HR on 
both pyramidal cells and interneurons under synapsin promoter. A. Representative 
traces and spectrograms from a single brain slice expressing HR under synapsin from 
the baseline period (left) and from the HR priming period (right). No modulation in 
HFO range could be observed when HR was expressed under synapsin promoter. B. 
Representative composite of sequential spectrograms from the same brain slice in A 
showed no modulation of the HFO range throughout the entire experiment. C. No 
significant modulations were induced by HR priming across all frequency range (n=10, 
p>0.05, Student’s t-test).  
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Based on a result from the previous chapter describing how blocking KCC2 with 100 
µM furosemide extends the period of high [Cl-]i state post HR illumination, I also tried 
to repeat the same experiment by supplementing 100 µM furosemide in the ACSF. In 
this situation, HR priming also did not result in any significant activity modulation 
across all frequency bands. (HR-primed versus baseline not significant for 75-150 Hz, 
150-300 Hz, and 300-600 Hz with p>0.05, Student’s t-test, n=6; figure 4.7). 
 
 
 
 
Figure 4.7 HR priming failed to induce high frequency oscillation in the presence of 
100 µM furosemide. The same experiment was conducted on slices expressing HR 
under CamKII (pyramidal cells) with 100 µM furosemide in the ACSF to block KCC2. A. 
Representative traces and spectrograms from a single brain slice taken from the 
baseline period (left) and halo priming period (right) showed no modulation in HFO 
range by HR priming when ACSF was supplemented with furosemide. B. 
Representative composite of sequential spectrograms from the same brain slice in A 
showed no modulation in the HFO range throughout the entire experiment. C. No 
significant modulations were induced by HR priming across all frequency range (n=6, 
p>0.05, Student’s t-test) 
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Figure 4.8 Neuronal Cl- loading triggered out-of-phase firing during spontaneous 
bursts of activity. Ai. Representative spectrograms of spontaneous bursts of activity 
recorded extracellularly in baseline (left) and Halo-primed (Cl--loaded) tissue from a 
single brain slice.  Note the prominent “double-frequency” signal in the HR primed 
tissue. Aii. Detected spikes (dots, red to green shows a progression of time) were 
plotted on the Hilbert transform of the dominant oscillation (75-300Hz; blue circular 
trace), and the rose-plots represent the numbers of action potentials occurring at 
different phases of the oscillation.  Note the out-of-phase spiking in the HR primed 
data set, also apparent as a second minor peak (arrowed) in the conventional 
histogram (duplicated data beyond –π and π). B. In contrast, periods of 
hyperpolarisation using ArchT caused a rebound increase in spiking (contrast the 
calibration bars for the histograms), but no change in the phase distribution of spikes. 
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From the pyramidal cells Cl- loaded data (CamKII expression of HR), I next explored 
how raised [Cl-]i affects the number of spikes and the spike time reliability with respect 
to the dominant oscillation by analysing multiunit activity recorded from the 
extracellular recording. Following HR-priming, there was a significant increase in the 
multiunit firing rate (note the different scale bars in Figure 4.8; baseline multiunit rate 
= 6.7 ± 2.5 spikes/s; HR-primed= 38.3 ± 6.6 spikes/s; n = 8; p < 0.001; HR-priming 
increase, normalised to baseline = 12.7 ± 4.8).  In contrast, ArchT-priming produced 
only a small, but non-significant, trend towards increased firing over baseline (ArchT 
baseline multiunit rate = 6.5 ± 1.9 spikes/s; Arch-primed = 10.2 ± 2.6 spikes/s; n = 6; 
n.s.; ArchT-priming increase = 2.2 ± 0.7). 
 
To assess the spike timing with respect to the dominant oscillation, the 75-300 Hz 
range was selected as the dominant oscillation based on the speculation that the 
dominant oscillation may be dictated by bursts of fast-spiking interneurons that 
entrain pyramidal cells firing, which are known to fire in this frequency range (Grenier 
et al., 2003). Also, this was the frequency range whereby HR and ArchT priming did not 
show any significant difference (figure 4.5). A Hilbert transform was done on the 75-
300 Hz band, which allows the oscillating signal to be plotted as a continuous circular 
trajectory, and then plotting histograms of the spike times with respect to this cycle 
(Figure 4.8Aii,Bii).  Both baseline period and ArchT-primed experiments showed phase-
locked spike timings confined to the lower left quadrant of the cycle representing the 
trough of the oscillation (figure 4.8A-left,B).  
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Notably, in the majority of HR primed experiments (5 out of 8 slices), spike time 
distribution were broadened, which indicates that there is an increased jitter in spike 
time reliability, reflecting a situation where pyramidal cells’ activity are less strongly 
dictated by the dominant oscillation (figure 4.9). Distinctively, in the remaining HR-
primed experiments (3 out of 8 slices), a bimodal spike time distribution was observed, 
with a dominant peak confined to the lower left quadrant and another one to the 
upper right quadrant (figure4.8A-right). This is equivalent to a bimodal distribution of 
spikes that happen at the trough and also at the peak of the oscillation (HR-expressing 
tissue, mean phase angle = 3.34 ± 0.15 Rad, n = 6; ArchT-expressing tissue, mean phase 
angle = 3.42 ± 0.09 Rad, n = 5). 
 
 
 
 
Figure 4.9 Different spike time distributions of HR priming data sets. Left: an example 
baseline spike time histogram taken from a single brain slice (grey) shows a single peak 
distribution. Note that two cycles were plotted in the histogram. Right: spike time 
distributions taken from 3 different slices showing that HR priming (blue) induced a 
broadening of the spike time distributions that sometimes result in a bimodal 
distribution.  
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To quantify the changing of spike time distributions induced by HR priming, half-width 
indices were calculated for baseline, HR primed, and ArchT primed recordings as 
explained in the method section. The mean half-width index of HR-primed spike 
distributions was higher compared to baseline and ArchT-primed spike distributions 
indicative of a significant increase of jitter in spike timing and out-of-phase firing due 
to Cl- loading (figure4.10). Pooled data show that the difference between HR-primed 
and baseline spike time distributions and also between HR-primed and ArchT primed 
spike time distributions are statistically significant, while ArchT-priming did not show 
any significant difference from its baseline.  (n=5 for HR primed and n= 6 for ArchT 
primed; HR primed versus baseline:  p<0.001; HR primed versus ArchT primed: p<0.02; 
Student’s t-test). 
 
 
 
Figure 4.10 Half-width indices from baseline, HR primed, and ArchT primed periods. 
Mean half-width indices from baseline periods versus HR primed periods and baseline 
periods versus ArchT primed periods. HR primed gave a significantly higher half-with 
indices compared to baseline (n =5, p<0.001, Student’s t-test). In contrast, there was 
no significant difference between baseline and ArchT primed periods. Furthermore, 
half-width indices from HR primed slices were also significantly different from ArchT-
primed tissue (n=5 for HR and n=6 for ArchT, p<0.02, Student’s t-test). 
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To assess whether spectral leak effect could account for the different spike-phase 
relationship observed in the HR primed tissues, spike amputation and time-shift 
analyses were performed as explained in the method section. The spike amputation 
had a small reduction in the amplitude of the oscillation (figure 4.11B, black versus 
blue traces) and the rose plots were slightly broader (figure 4.11, red versus yellow), 
indicating that there was indeed a small contribution from spectral leak.  Importantly, 
though, the spike-phase distributions were still markedly skewed and centred at the 
same phase as for non-amputated data (figure 4.8 yellow versus red).  Similarly, when 
spikes were plotted according to the dominant oscillation 1-2 ms ahead of the spike 
where it is not influenced by the spectral leak, spike distribution was broader however 
it was still skewed (figure 4.11C). Note that the shifted phase of the peak was 
introduced by the time shift analysis (figure 4.11C).  
 
 
Figure 4.11 Control analyses for spectral leak: spike amputation and time shifted. A. 
An example trace that shows the raw data, with the spikes (blue) and the amputated 
version (black). B. Left: the raw signal from A was band-pass filtered for 75-300 Hz both 
with spikes (blue) and the amputated version (black). When spikes were amputated 
(blue), the 75-300 Hz signal showed reduced amplitude peaks, but no phase shift. Right: 
The spike-phase plots were still heavily skewed albeit with a broader main peak. The 
yellow and red dots represent the detected spike times. C. Left: the same 75-300 Hz 
signal from B but with spike times indicated 2 ms ahead of the real spike times, 
compare the locations of the time-shifted spikes with the same plots in panel B. Right: 
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heavily skewed spike-phase relationships, albeit with a shifted phase, were also found 
at time points ahead of the spikes  
 
Half-width indices were re-derived for all control analyses (spike-amputated; time-
shifted; and both amputated and time-shifted). There remained highly significant 
differences, for all analyses, between the HR primed and baseline periods, and also 
between the HR-primed and ArchT-primed data (figure4.12B). In slices where HR 
priming gave bimodal distributions of spike times, after all analyses, baseline spike-
phase distribution still showed single peaks (figure 4.12A, grey), while the HR primed 
data sets consistently showed double peaks (figure 4.12A, orange).  This confirmed 
that the spectral leak issue is not the reason for the different spike-phase relationship 
observed between HR priming versus baseline and ArchT priming.  
 
 
 
 
Figure 4.12 Spike time histograms and half-width indices derived after control 
analyses. A. Example histograms derived from a single brain slice in which HR priming 
gave a bimodal distribution of spike time. Baseline spike-phase plots (grey) all had 
single peaks, while the distributions for all HR primed analyses showed double peaks 
(orange). B. There were highly significant differences between the HR-primed and 
ArchT-primed matched analyses. (* p< 0.05; ** p< 0.01; *** p< 0.001).  
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I have shown here that artificially loading neurons with Cl- by HR priming consistently 
induced modulation of network activity especially in the high frequency range (300-
600 Hz). It was initially expected that spontaneous epileptiform events would ensue 
when cells are intensely loaded by Cl- as was done during these experiments. 
Interestingly, despite evidence for a clear increase in excitability, and even with 
repeated electrical stimulation delivered to the underlying white matter, no single 
epileptiform discharge was recorded in any experiment.  This implies that while Cl- 
loading may contribute to a certain epileptic state, for these network to progress into a 
full ictal event, either the pathological loading must be far more widely experienced 
than provided by the spot-illumination, or that other pathological factors are also 
required.   
 
4.3.2. In a pro-epileptic state focal raised intraneuronal chloride initiates ictal 
activity 
 
I then followed this up by altering the basal excitability of the slices by applying a low 
concentration of 4-AP (20 µM), much lower than what is normally used to induce ictal 
activity (50-100 µM).  The main idea of using 4-AP is because this drug is known to 
block potassium channels, especially those expressed in fast-spiking interneurons, 
triggering high frequency burst of these cells (Bouchard & Fedida, 1995; Cammarota et 
al., 2013). A similar illumination paradigm was used where HR was activated as 
repeated cycles of 25s-ON and 5s-OFF but without applying any electrical stimulation 
this time. Baseline was recorded for 10-20 min before starting the optogenetic 
illumination. Indeed, in comparison to the epileptic concentration, the slices were 
much less excitable with no spontaneous full ictal discharges recorded during baseline 
period. Some variability was observed for the 20 µM 4-AP baseline with the majority of 
slices (60%, 12/20 slices) showed a stable quiescent baseline (figure 4.13A black trace), 
20% occasionally showed a brief spontaneous epileptiform discharge that was short 
lasting and smaller in amplitude (figure 4.13A, dark grey trace) compared to a 100 µM 
full blown ictal discharge (figure 4.13A, red trace), and the remaining 20% showed very 
regular non-stop epileptiform discharges since an early stage (figure 4.13A light grey 
trace).  
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Figure 4.13 Epileptic escalation by HR priming in the presence of 20 µM 4-AP. Left: 
LFP traces (1-300 Hz) of different baseline activity prior to HR priming: Red trace shows 
an example baseline activity with 100 µM 4-AP showing that within the 5 min multiple 
ictal discharges were recorded spontaneously. Baseline with 20 µM 4-AP: Black trace is 
a representative stable quiescent baseline that accounted for 60% of the slices. Dark 
grey trace shows an example baseline where some rare short discharges were 
recorded (20%). Light grey trace represents the remaining 20% of the slices that 
showed regular bursts since the early stage. Right: Representative LFP traces showing 
the outcome of HR priming of the corresponding baseline activity. Most of the slices 
with quiescent baseline and rare short discharges developed ictal events after periods 
of HR priming, while slices with regular burst did not.  
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Figure 4.14 Rapid ictal event induction by HR priming in conjuction with 20 µM 4-AP. 
Representative traces recorded from a single brain slice that showed a quiescent 
stable baseline. Units trace (300 – 5000 Hz, top trace) and LFP (1-300 Hz, bottom trace) 
of the entire length of the experiment showing a full ictal event recorded after 4 cycles 
of HR priming (25s ON/ 5s OFF), which resembled spontaneous ictal events commonly 
induced by 100 µM 4-AP application.  
 
 
In the majority of the slices (15 out of 20), HR priming successfully triggered ictal 
discharges within 4.47±1.56 minutes (n=15) from when the 25s-ON/5s-OFF HR 
activation paradigm was initiated, equivalent to 9 cycles of HR priming (25s ON/5s OFF). 
Events are categorized as ictal discharges when it lasts longer than 5s, and showing a 
pattern of activity that consists of initial tonic discharges followed by rhythmical after-
discharges. These discharges very much resembled the full ictal discharges commonly 
induced by application of 100 µM 4-AP (figure4.13&4.14). Full ictal discharges were 
not always triggered by HR priming when a long series of HR priming cycles were done. 
It was very common for the slices to later generate some spontaneous seizures 
without HR priming once an ictal discharge had been successfully triggered by HR 
activation (figure 4.14).  As a control, long baseline recordings with 20 µM 4-AP (45 to 
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60 minutes, n=4) were done to assess whether this concentration of 4-AP alone is 
enough to develop spontaneous ictal discharges over the duration of 1 full experiment, 
and evidently without any HR activation, none of them developed spontaneous full 
ictal discharges.  
4.3.3. Characteristic seizure terminating pattern 
 
An incidental observation coming from these experiments was that in 4 out of 15 slices 
in which HR successfully triggered ictal discharges, there was a distinctive pattern of 
activity recorded at the end of HR priming period. This pattern of activity has been 
documented before and named as afterdischarge terminating oscillation (ATO), which 
was a spreading-depression like event that seemed to mark the termination of in vivo 
post-tetanic stimulation seizures (figure 4.15; Bragin et al, 1997). In these 4 slices, 
illumination cannula was placed side by side from the tetrode recording instead of on 
top of the tetrode recording. The terminating event is characterised by an onset of a 
short-lasting low amplitude oscillation (40-90Hz) followed by a slow sustained 
potential shift that results in a post-ictal depression state (Bragin et al., 1997). 
 
 
Figure 4.15 Afterdischarge terminating oscillation (ATO). Left: An example of ATO 
recorded from the HR priming experiment in conjunction with 20 µM 4-AP where 
illumination cannula was placed at a distance from the recording electrode. ATO was 
recorded at the end of long repeats of HR priming. Right: This resembled what Bragin 
et al (1997) described as an ATO that they proposed as a spreading-depression like 
event that terminates seizures activity (Bragin et al, 1997). 
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To look further into this, the same experiment was repeated only this time recording 
was done using two tetrodes separated by approximately 1 mm. In this set up, more 
ATOs were successfully recorded, suggesting that the failure to observe more ATOs in 
the previous experimental set up was because ATOs were less likely to be captured 
while using only a single recording tetrode.  
ATOs were recorded after repeats of HR priming for 9.48±1.65 minutes (mean ± sem, n 
= 9) or equivalent to 19 cycles of HR priming (25s ON/5s OFF). Note that this is double 
the time needed to induce an ictal discharge and usually it only happened after 
multiple ictal discharges had been induced. ATO was generated in 9 slices in which 8 of 
them HR priming successfully triggered seizures and 1 of them had very regular 
discharges since the early stage (figure 4.13A, light grey).  In these 9 slices, ATO was 
always followed by a period of depression that resembles a post-ictal depression 
before activities reappeared in both LFP and multiunit activity trace with a mean 
recovery time of 84.4 ± 10.68 s (mean ± sem, n=9; figure 4.16). Note that recovery time 
was measured between the times at the end of the ATO event observed from the LFP 
trace until the appearance of the first unit activity. Illumination was shifted between 
the two recording tetrodes and it was found that ATOs appeared to be initiated from 
the illuminated area that then invaded the less illuminated area (figure 4.17). When 
illumination was shifted to the other tetrode, the ATO initiation focus also changed 
following the spot of illumination (figure 4.17). It was confirmed that ATOs were 
initiated from the Cl- loaded area (illuminated) that propagates to the less Cl- loaded 
area (less illuminated). 
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Figure 4.16 ATO was recorded following a long series of repeated HR priming, and is 
associated with a subsequent period of neuronal suppression. Representative traces 
recorded from a single brain slice with 20 µM 4-AP supplemented in the ACSF. Top 
trace was band pass filtered between 300-5000 Hz for multiunit activity and the 
bottom trace was filtered between 1-300 Hz for LFP. HR priming successfully induced 
ictal discharges (red bar: example ictal discharge) as shown by the epileptiform 
discharges on the LFP (bottom trace) accompanied by intense firing of cells shown in 
multiunit activity trace (top trace). ATO (blue bar) was recorded after 21 cycles of HR 
priming (25s ON/5s OFF), which was followed by a slow sustained potential shift that 
silenced the network depicted by the absence of any unit activity (top trace) that only 
recovered 141.6 s later. Representative high magnification of ictal discharge (red arrow) 
and ATO (blue arrow) were shown on the bottom.  
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Figure 4.17 ATO was initiated in the Cl- loaded area. Representative traces recorded 
by two tetrodes separated by a distance, from a single brain slice, with 20 µM 4-AP 
supplementation in the ACSF. Two traces were shown from each tetrode, recorded by 
two electrodes of the tetrode that were 50 µm apart. Orange traces were from the 
tetrode in which illumination was focussed on. HR priming successfully triggered ictal 
discharges and ATOs were recorded. A. ATO was initially observed in tetrode 1 before 
tetrode 2 when illumination was focussed on tetrode 1. B. When spot illumination was 
shifted to tetrode 2, ATO was then initiated in tetrode 2 consistent with where Cl- 
loading was introduced. C. ATO was then back generated in tetrode 1 before captured 
by tetrode 2 when illumination was shifted back onto tetrode 1 confirming that the 
ATO is first initiated in the Cl- loaded area.  
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ATO seemed to propagate slowly as shown from the dual tetrodes recording (figure 
4.17 and figure 4.18). The propagation speed of ATO was calculated by measuring the 
time difference between the peak of the potential shift in 1 electrode to the peak 
recorded by the other electrode from the same tetrode that is known to be 50 µm 
apart. The mean propagation speed of the ATO was 0.19 ± 0.02 mm/s (mean ± sem, 
n=7). Contrast the almost instantaneous event affecting the 2 tetrodes when ictal 
discharges were recorded compared to the slowly propagating ATOs (figure 4.18).  
 
 
 
 
 
Figure 4.18 Propagation of HR priming induced ictal discharge and the associated 
ATO. Representative traces from a single brain slice from HR priming experiment with 
20 µM 4-AP in the ACSF, with the same recording set up from the previous figure. A. 
An ictal discharge was initiated post HR activation that was terminated by an ATO. B. 
Ictal discharge was recorded almost simultaneously in all electrodes. C. In contrast, 
ATO was slowly propagating from 1 tetrode to another with a speed of 0.15 mm/s in 
this particular trace.   
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4.4. Discussion 
4.4.1. HR chloride loading as a model for high [Cl-]i  
Raised [Cl-]i and hence depolarising GABA has been long associated with epilepsy. 
However how far thus this contributes to ictogenesis was not clear. The 3 main ideas 
of how Cl- accumulates intracellularly during seizure are  
1. Due to a deficiency of Cl- clearance mechanism as shown by Huberfeld et al 
(2007) that resected human epileptic tissues show a reduced expression of KCC2  
(Huberfeld et al., 2007c).  
2. Via NKCC1 activity that is enhanced after repetitive seizures that drive Cl- into 
the cell (Dzhala et al., 2010b)   
3. Through intense GABA activation (Lillis et al., 2012) as part of the inhibitory 
restraint mechanism during the recruitment of new territory into a seizure.  
A combination of all 3 could potentially contribute to a high [Cl-]i state found in 
epilepsy and the level of contribution from each path might be different one case from 
another, one seizure model from another.   
In this chapter, HR Cl- loading effect was used as a model of intracellular Cl- 
accumulation to study the consequence of it in regards to the epileptic network 
activity.  The way HR activation loads cells with Cl- is by imposing an instantaneous 
hyperpolarising current that is a Cl- inward current, which consequently causes an 
abrupt change in the membrane potential. This may be different from Cl- accumulation 
brought about by co-transporters dysregulation (low KCC2 or high NKCC1) that is 
electro-neutral and hence does not result in instantaneous change of the membrane 
potential. It should be noted that inevitably the instantaneous hyperpolarisation of HR 
could also activate voltage gated channels that are activated by membrane 
hyperpolarisation. For instance, HCN channel is known to open when Em is  
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hyperpolarised giving rise to the depolarising IH; Also CLC2 channels, which are 
inwardly rectifying Cl- channels that are activated by hyperpolarisation, induce an 
outward Cl- current. IH depolarising current could bias the internal Cl
- accumulation 
effect in promoting network excitability whereas CLC2 mediated Cl
- efflux might 
attenuate the effect of HR Cl- loading on the network excitability. As a control for the IH 
imposed by HR hyperpolarisation, ArchT was used.  This however still leaves an open 
question of how ictogenic high [Cl-]i is when CLC2 is not activated by hyperpolarization 
such as those imposed by co-transporter dysregulation. This could be answered by 
repeating the same experiment with the use of CLC2 specific blocker GaTx2, or knock-
out animals.      
4.4.2. Heterogeneity of [Cl-]i explains the out-of-phase firing in the HFO 
 
To further explore the nature of the spiking patterns recorded during the HR priming 
period, Dr. Andrew J. Trevelyan conducted a computer simulation showing how this 
activity patterns could be explained by heterogeneity within the Cl- loaded pyramidal 
population using a compartmental modelling approach (Hines & Carnevale, 2001). This 
is to investigate how a fast-spiking interneuron might influence its postsynaptic 
pyramidal targets when there is also a concurrent intense glutamatergic barrage.  
Pyramidal cells were simulated to receive an intense, desynchronized glutamatergic 
drive, on to which was imposed a high frequency barrage of IPSCs on to the soma and 
proximal dendrites; figure 4.19A shows repeated simulations of postsynaptic spiking 
for a cell with a relatively hyperpolarising EGABA (-75mV), which are collated into spiking 
phase-histograms based on the cycle of IPSCs.  He next simulated how the effect of this 
same inhibitory barrage changed with EGABA shifting towards more positive levels 
(Figure 4.19B), to show that the window of opportunity for pyramidal spiking broadens, 
as the effective inhibition diminishes (EGABA shifting from -75, to -65, to -55mV).  
Eventually, when EGABA exceeds the action potential threshold, there is a sudden 180
0 
(π) phase shift in the spiking (figure 4.19B, left).   
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Previous studies have shown that the output of fast-spiking interneurons is precisely 
synchronised onto the multiple postsynaptic pyramidal cells (Miles et al., 1996; 
Trevelyan, 2009). Considering that this postsynaptic population has a distribution of 
EGABA values, as measured by Huberfeld et al.(Huberfeld et al., 2007a), and also shown 
using Cl- imaging (Dzhala et al., 2010a), he then simulated the multiunit spiking 
patterns in this heterogeneous population.  The distribution of EGABA values described 
in Huberfeld et al.(Huberfeld et al., 2007a), a negatively shifted one as the 
physiological distribution, and a positively shifted one as an extremely depolarised 
EGABA distribution were used.  The physiologically shifted distribution (mean EGABA = -
68.5mV; Figure 4.19B, top right) showed a unimodal spiking distribution with respect 
to the rhythm imposed by the basket cells.  In contrast, only a small positive shift in 
EGABA (mean EGABA = -60.8mV; Figure 4.19B, middle right) allowed a marked increase in 
spiking due to the broadening of the main peak, but also the appearance of an out of 
phase peak that was shown even more prominently when the EGABA was further shifted 
to a more depolarized level (figure 4.19B, bottom right). These distributions were 
reproduced very well by the histograms drawn from different HR-primed brain slices as 
shown earlier (Figure 4.9).   
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Figure 4.19 Heterogeneity in levels of intracellular Cl- can explain the appearance of 
out-of –phase population firing. A. Simulation using NEURON, of how a train of high 
frequency IPSCs from a fast-spiking interneuron superimposed onto a noisy, 
desynchronised glutamatergic drive, creates a patterned firing in the pyramidal cell.  
Action potential threshold was about -48mV. (courtesy of Dr. Andrew J. Trevelyan) B. 
Simulations in the same model, at four different GABAergic reversal potentials. The 
firing probability is plotted with respect to the field oscillation, which is approximately 
π/4 phase shifted from the start of the IPSC, as judged by comparisons with the timing 
of fast-spiking interneuron action potentials (Hasenstaub et al., 2005).  When these 
different probability histograms are convolved with estimates of the distribution of 
EGABA in the pyramidal population, one can derive population firing probabilities with 
respect to the cycle imposed by the fast-spiking interneuron.  (courtesy of Dr. Andrew J. 
Trevelyan)  
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4.4.3. HR Cl- loading and how ictogenic it is 
From the first experiment of this chapter, it was clear that Cl- loading by itself did not 
trigger a full seizure in brain slices, even when electrical stimulation was applied to the 
network as a putative thalamic input onto the cortex. Note that both KCC2 and CLC2 
are intact. However, in these healthy brain slices (when bathed in normal ACSF), 
loading cells with Cl- and applying electrical stimulation on the white matter give rise 
to HFO with doubling of frequency characteristic. Spike time distributions post HR 
priming showed an increased jitter by the broadening of the window of opportunity 
for cells firing. Notably, in some slices this resulted in a marked appearance of a second 
peak that was out-of-phase of the dominant peak.   
HFO with doubling of frequency characteristic has been associated with epilepsy 
before (Foffani et al., 2007a). Activity in this range could not be generated by a single 
population of pyramidal cells as this exceeds the general limit of single cell firing rate.  
Previous study then suggested that this pattern of activity comes about due to an out 
of phase firing of different populations of cells that gives the characteristic doubling of 
frequencies (Foffani et al., 2007a; Ibarz et al., 2010b). The experimental data from this 
chapter and the modelling by Dr. Andrew Trevelyan together provide a detailed 
explanation that these populations that fire out of phase of each other during HFO 
could be different in terms of their [Cl-]i. Hence our results show a clear link between 
two important concepts in epileptology: namely, raised intraneuronal chloride and 
high frequency oscillations. 
Furthermore, the multiunit analysis from the HR priming data has shown how raised 
[Cl-]i alters the spike timing of cells with respect to the dominant oscillation, increasing 
jitter in spike time reliability and eventually the likeliness of an out of phase firing as 
shown by the appearance of the second peak in the spike histogram. The modelling 
then explained how this could arise due to a heterogeneity of [Cl-]i dictating cells that 
have [Cl-]i above certain threshold to fire out-of-phase of the cells that have a relatively 
lower [Cl-]i explaining the second peak in spike histograms. This certain threshold is 
when [Cl-]i is high enough to give an EGABA that surpasses the threshold for action 
potential that was around -48 mV. Unfortunately, in our experimental set up it is not 
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possible to monitor [Cl-]i of multiple neurons such as enabled by for example Cl
- 
imaging, and so this could not be proven experimentally. 
Reaching -48 mV EGABA may seem like a high target for HR Cl
- loading effect to achieve, 
however this is made possible by the fact that pyramidal cells naturally have a broad 
range of baseline EGABA (-80 mV to -50 mV with a mean EGABA of -68.5 mV). Hence in 
some cells that originally have quite high [Cl-]i for instance with an EGABA of –50 mV, a 5 
mV shift in EGABA is enough to push it towards the threshold for action potential. It 
should be highlighted that the computer modelling has shown that this extreme EGABA 
only has to affect a small percentage of the cell population to give rise to HFO as out-
of-phase firing probability is significantly higher when EGABA reach the threshold for 
action potential.  
The next question I was asking is what happens if the interneurons also experience the 
state of high [Cl-]i  together with the pyramidal cells. I then repeated the same 
experiment using slices that express HR both in interneurons and pyramidal cells under 
synapsin promoter, hoping this will induce hyperexcitability in both classes of cells. 
Unfortunately, HFO cannot be triggered when Cl- loading was imposed onto both the 
pyramidal cells and interneurons by expressing HR under the synapsin promoter. This 
could simply be due to a lower level of HR expression under the synapsin promoter 
compared to CamKII, which is recognized as a strong promoter that drives high level of 
protein expression (Wang et al., 2013), hence insufficient Cl- loading effect to trigger 
HFO. Another possibility is because of an imbalance expression by the synapsin 
promoter with more HR expressed in interneurons than in pyramidal cells that results 
in Cl- loaded and hence more excitable interneurons that presumably increases GABA 
release but still have a hyperpolarising effect on the less Cl- loaded post-synaptic 
neurons, the pyramidal cells.  This open an interesting future experiments to assess 
what happens when only interneuron or both interneurons and pyramidal cells are 
loaded with Cl-. 
The fact that Cl- loading by itself did not trigger any seizure, led to the idea of testing 
whether together with blocking KCC2, the Cl- clearance mechanism of the neurons, will 
lead to an exacerbation of the HFO that eventually leads to seizure initiation. This 
condition theoretically should mimic a sudden influx of Cl- via GABAergic synapses into 
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the cells (by HR Cl- loading) that hypothetically already have a higher basal Cl- level due 
to a reduced functional KCC2 (by KCC2 blocker). However, when supplementing the 
ACSF with 100 µM furosemide to block KCC2, even HFO was failed to be induced by HR 
priming. When adding furosemide after a baseline recording without any HR activation, 
furosemide attenuated the baseline before HR paradigm was even started. This could 
be due to the non-specificity of furosemide that is known to also block NKCC1 in this 
concentration, the co-transporter responsible for Cl- import into the cell (Löscher et al., 
2013).  Furosemide might also affect other receptors that are essential in the 
generation of the baseline network event and consequently the HFO. It remains an 
open question then how ictogenic the intraneuronal Cl- accumulation is when Cl- 
clearance is not intact. A future experiment that could be done to answer this question 
would be by repeating the same experiment using more specific blockers of KCC2 such 
as VU0240551 or the use of a knock out animal. 
The following experiment was trying to combine Cl- loading with other pathological 
state; in this case by application of 20 µM 4-AP. 4-AP is a potassium channel blocker 
that affects mainly fast-spiking interneurons but also pyramidal cells (Cammarota et al., 
2013), inducing hyper-activation of the network.  In this situation, Cl- loading rapidly 
induces ictal activity in less than 5 minutes or 9 cycles of HR priming (25s ON/5s OFF), 
highlighting the adjunctive role of high [Cl-]i in tipping over the balance of the network 
activity into ictal activity. This cumulative effect of HR Cl- loading in seizure initiation 
could be explained by the fact that in these slices taken from adult mice, a shorter time 
constant of HR Cl- loading effect was observed compared to the dissociated neuronal 
culture (mean ± sem : 8.01 ± 2.84 s for old brain slices vs 28.1 ± 9.2 s for dissociated 
neuronal culture; chapter 3). This means that these slices clear Cl- more effectively 
explaining the need of accumulative HR Cl- loading effect over time to reach a certain 
threshold for seizure initiation. This could also suggest that seizure initiation was not 
due to rebound firing by IH, as IH is less likely to have a cumulative effect over a long 
period of time.    
As this provide a proof of principle that Cl- loading has the adjunctive role towards 
ictogenesis when combined with other pathological state, other scientifically and 
clinically relevant models of other pathological state will be worth exploring to start 
teasing out possible sets of circumstances that could result in seizure initiation. For 
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instance, maybe a focally delivered agent could give a better idea of how focal seizure 
could progress into generalised one. One possibility to assess this is by expressing and 
activating ChR2 on interneurons and HR on pyramidal cells locally. It is also interesting 
to explore the effect of Cl- in different epileptic model such as maybe brain slices taken 
from chronic model of epilepsy. 
Additionally, the fact that Cl- loading only has an adjunctive role in vitro does not close 
the possibility that Cl- could play a bigger role in seizure initiation in vivo since brain 
slices are known to be less excitable compared to an intact whole brain that 
presumably have more inputs coming from the long connections that are cut in brain 
slices preparation.  
 
4.4.4. Afterdischarge terminating oscillation 
Initially, ATO was incidentally recorded during the 20 µM 4-AP and HR priming 
experiments after multiple ictal discharges were induced. This event has been reported 
before in vivo to be associated with seizure termination (Bragin et al., 1997). In their 
study Bragin et al induced seizures in vivo by applying electrical stimulation onto the 
perforant or commissural path and did recording in the  CA1 and CA3 part of the 
hippocampus. They only observed ATO when the induced seizures were long lasting 
(over 15 s); while when seizures were short lived they terminated abruptly. Our 
experiments also show a similar phenomenon in which ATO was only recorded after a 
long HR priming that was after multiple ictal discharges were successfully recorded. 
This was after a mean duration of 9.48 ± 1.65 minute of HR priming; note that it only 
took a mean duration of 4.47 ± 1.56 minute of HR priming to induce a single ictal 
discharge.    
Bragin et al has shown that ATO happens when Vm is really positive (> -30 mV) that the 
sodium channels are deactivated leaving the neurons incapable of firing. They also 
showed that they could mimic this by injecting potassium chloride (KCl) extracellularly 
(Somjen & Giacchino, 1985; Bragin et al., 1997). In our result ATO appeared to be 
triggered locally where the HR priming was applied, suggesting that this is related with 
the Cl- loading effect of HR. One possible mechanism that links the 2 mechanisms is 
due to the fact that HR accumulates Cl- inside the cell that eventually has to be cleared 
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out. One way is through KCC2 that will extrude Cl- together with K+. Additionally, 
seizure activity is known to be associated with increased extracellular K+ due to high 
neuronal activity (Somjen et al., 1985; Somjen & Giacchino, 1985). Note that due to 
the relatively narrow extracellular space, even small compartmental movement of K+ 
could change the concentration significantly. Together this could lead to a significant 
accumulation of K+ outside that is enough to cause a depolarization block of the 
network.  To what extent KCC2 is involved in this could be further explored by 
repeating the same experiment with the KCC2 blocker.  
Lastly, both Bragin et al and our data have shown how ATOs seem to propagate in a 
slow speed (0.1-0.2 mm/s in Bragin et al and 0.19 ± 0.02 mm/s in our experiment). 
Contrast this with epileptiform discharges that tend to propagate rapidly (20-100 
mm/s when inhibition is compromised) (Trevelyan et al., 2007b). This suggests a 
different mechanism possibly non-neuronal in the spreading of ATO. Note that a 
similar speed of propagation also has been recorded for cortical spreading depression 
(Leao, 1944; Bragin et al., 1997). Bragin et al hypothesized that astrocytes might be 
involved as ATO propagation speed is comparable to the speed of calcium wave 
propagating between astrocytes. However this was still only a hypothesis that should 
be further explored. As my recordings showed rare instances where in vitro model of 
seizures are terminated by spreading-depression like event, this model could provide a 
more accessible preparation to test such a hypothesis that would be otherwise difficult 
to be done in vivo.  
It has been reported before that in several models of epilepsy, seizures are terminated 
by a spreading-depression like event that has a similar underlying mechanism with ATO, 
which is depolarization block (Somjen et al., 1985; Bragin et al., 1997). However what 
ATO involvement in seizure termination is still questionable. Especially that this is not 
regularly observed in the commonly used epilepsy models such as 0 Mg2+ or 4-AP also 
the chronic models of epilepsy such as kainic acid, picrotoxin or tetanus toxin model of 
epilepsy. This suggests that probably this is not the general terminating mechanism 
that is applicable to all seizures. However this could potentially act as a secondary 
terminating mechanism when seizure is really long or when the convulsant persists as 
a defence mechanism to prevent long seizure to turn into status epilepticus. 
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Chapter 5. Designing a new optogenetic tool to correct raised 
intraneuronal chloride in epilepsy 
 
 
5.1. Introduction 
This chapter focuses on addressing the secondary aim of this project which was to develop an 
optogenetic tool to be used to extrude chloride from neurons. This would be particularly 
valuable as a tool for chloride research and potentially an ideal strategy to halt seizures, as 
extruding chloride would restore the natural GABA inhibition.  
To date, Cl- flow conducting optogenetic proteins are available in forms of light activated 
electrogenic pumps that are halorhodopsin (HR) and the red shifted cruxhalorhodopsin known 
as jaws (Gradinaru et al., 2008; Chuong et al., 2014), or light activated Cl- channel consisting of 
iC1C2 family and ChloC family (Berndt et al., 2014; Wietek et al., 2014). Some of these proteins 
are the basic optogenetic proteins being explored in this chapter to be modified as novel Cl- 
extrusion tools. 
 
5.1.1. Reversal of light activated Cl- pump - Halorhodopsin 
 
Unlike the excitatory optogenetic protein channelrhodopsin, a cation channel in which 
ion flows is determined by the ion’s reversal potential and the membrane potential (Em) 
(Nagel et al., 2003), HR is an electrogenic inward chloride pump that uses energy from 
light to transfer chloride ions into the cell (Deisseroth et al., 2006). Consequently, HR 
has a one way Cl- flow that is inward, bringing Cl- from the extracellular space into the 
cell. We speculated that reversing the orientation of HR on the membrane would 
reverse the direction of chloride pump during its activation.   
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One important consideration before starting any attempt in reversing HR orientation is 
whether HR would still be capable of pumping Cl- in the reversed orientation. The main 
concern comes from the fact that Cl- concentration is different inside and outside the 
cells.  As extracellular Cl- is generally an order of magnitude higher than the 
intracellular Cl-, wild-type HR effectively works in the same direction with the 
concentration gradient of Cl-. If HR is reversed, it then has to work against the 
concentration gradient, which might compromise the HR Cl- pump. It is then necessary 
to start with simulating the effect of going against the Cl- concentration gradient on 
the wild-type HR current to assess whether it would still be capable of pumping Cl-.  
The next step then was to design the strategy to reverse the orientation of HR. Two 
strategies were used as an attempt to reverse HR orientation: altering the distribution 
of charged residues and protein anchoring. 
 
Altering the distribution of charged residues 
The first involved changing the transmembrane distribution of positive and negative 
charged amino acid residues of HR. This is based on the hypothesis that membrane 
proteins including HR are oriented post-translationally inside the translocon protein, 
where membrane proteins are oriented following a positive inside rule, and once it 
achieves its permanent orientation, it is released to the membrane (von Heijne, 
1992)(figure 5.1A). The positive inside rule indicates that on transmembrane helices, 
positive charges tend to be distributed on the cytoplasmic side while the negative 
charges are on the extra cellular side and it has been suggested that this signature of 
charges distribution dictates the membrane protein orientation (von Heijne, 1992).  
Supporting evidence comes from the naturally dual-oriented protein EmrE, a small 
multidrug resistant protein that is naturally expressed in 2 different orientations (Rapp 
et al., 2007). The two variants have different distributions of the positively charged 
residues that are consistent with the positive inside rule, and these orientations could 
be reversed by swapping the distribution of the positive and negative charges using 
site-directed mutagenesis (Rapp et al., 2007).  
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The same principle has also been shown in a eukaryotic system, where certain 
membrane proteins’ orientations could be reversed by changing the distribution of 
positive and negative residues  when expressed in human cervical cancer cells, Hela 
cells (Sommer et al., 2013).  This phenomenon could be explained by the natural 
tendency of the protein to forfeit its orientation to maintain the topology when the 
charge distribution is altered (Tate, 2010). Membrane protein orientation however is 
also affected by additional factors other than the distribution of positive and negative 
charges, such as the size and the folding of the N- terminal domain, and also the length 
and the hydrophobicity of the transmembrane domains (Sommer et al., 2013).   
Based on the success of these previous works (Rapp et al., 2007; Sommer et al., 2013), 
in which reversal of different membrane proteins orientation was achieved by altering 
the distribution of positively and negatively charged amino acid residues located in the 
inner and outer membrane, I hypothesised that by doing the same with HR I could 
potentially reverse the orientation of HR in the membrane and the direction of the Cl- 
flow (figure 5.1B).  
Different combinations of mutations targeting the positive and negative charged 
residues were introduced. To visualise the cells, enhanced yellow fluorescent protein 
(EYFP) was co-expressed together with the mutant HR, using several different 
strategies. First EYFP was fused to the C-terminal of the HR mutant that allows the 
mutant protein and EYFP to be produced as a single protein in all transfected cells. 
Second, to avoid any potential interference of the EYFP fusion with the HR mutant 
orientation, an extra construct was made that utilised the internal ribosomal entry 
sites (IRES) system to label the transfected cells with fluorescent marker. IRES is 
commonly used for co-expression of two proteins as this viral  origin nucleotide 
sequence enables a second protein translation initiation in the middle of mRNA (Douin 
et al., 2004) allowing two proteins to be synthesized under a single promoter. The IRES 
system would allow the expression of both mutant HR and EYFP as two separate 
proteins, hence avoiding any interaction between the two proteins.  
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Figure 5.1 Altering the distribution of charged residues strategy. A. Left: After 
translation from the ribosome, membrane protein would be folded and oriented on 
the membrane within the translocon protein according to the positive inside rule. The 
side with more positively charged residues (blue) will be positioned in the cytoplasmic 
side while the side that has more negatively charged amino acids (red) will be located 
in the extracellular side. Right: Accordingly, wild-type HR shows a pattern of charged 
residues distribution that follows the positive inside rule with more positively charged 
(blue) amino acids arginine (R) and lysine (K) found in the cytoplasmic side, while more 
negatively charged (red) amino acids, glutamic acid (E) is found in the extracellular side, 
adapted from (Kouyama et al., 2010). B. It is hypothesised that changing the 
distribution of positive and negative residues could potentially reverse HR orientation 
across the membrane.   
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Protein anchoring 
The second strategy to reverse the orientation of HR is by protein-anchoring. Protein 
translation is started from the N-terminus where it has a start codon for methionine. 
The next amino acids are then added to the C-terminus until it reaches the stop codon. 
Accordingly, HR production is started from the N-terminus that happens to be located 
on the extracellular side and finished with its C-terminus on the cytoplasmic side (Nout-
Cin) (figure 5.2A). Based on this, we speculated that by fusing a single pass membrane 
protein up stream of the HR, it would anchor the HR N-terminus to the cytoplasmic 
side, forcing the rest of the protein to be translated in a Nin-Cout manner; hence 
reversing the orientation of the HR (figure 5.2B-D). 
The anchoring protein should be a single pass membrane protein of the right length to 
anchor the N-terminal of HR to the cytoplasmic site. Additionally, it also has to be 
correctly targeted and expressed at the membrane. LepA (leader peptidase A) and CD8 
were selected as potential anchors. LepA, of bacterial origin, is a 7.4 kDA single pass 
transmembrane protein. It is a nonessential protein that separates the leader 
peptidase from its promoter. A LepA deleted mutant does not appear to have any 
defect on leader peptidase function showing its nonessential role (Dibb & Wolfe, 1986). 
LepA was chosen based on its relatively simple structure and its nonessential role. 
However the success and the stability of LepA anchoring when fused with a bigger 
protein such as HR (37 kDA) is highly speculative. Additionally, LepA is a bacterial origin 
protein, and so the success of its membrane targeting in eukaryotic systems is not 
assured. 
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The second candidate anchor protein was CD8. CD8 is a 13.5 kDA membrane protein 
that functions as a co-receptor of immune T-cells (Pascale et al., 1992). This well 
characterised protein is naturally expressed in mammalian systems making it a good 
candidate for neuronal expression. Furthermore, CD8 is equipped with a signal peptide 
that might assist membrane targeting of potentially reversed HR (Pascale et al., 1992). 
A previous study has successfully expressed CD8 in a neuronal system as a CD8-GFP-
HCN1776-910 construct, although for a different purpose (Santoro et al., 2011).  In their 
study, Santoro et al fused CD8 to the N-terminal of progressively shorter and shorter 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channel components whilst 
still ensuring that they were still anchored to the membrane. Here, we tried to adapt 
the use of CD8 to not only anchor the protein to the membrane but also to alter the 
orientation of the downstream fused protein, namely HR.  
For visualisation purposes, fluorescent marker expression is required. Green 
fluorescent protein (GFP) was fused between the anchor protein and HR (figure 5.2B-C) 
or at the N-terminus of HR. This is because GFP may not fold properly outside the cell 
(or preteolytically removed), and so might not be fluorescent if fused to the externally 
located C-terminus of HR. Finally I also considered whether the presence of GFP, could 
also provide an extra anchoring effect on HR in addition to its visualisation role. As a 
water soluble protein, GFP will be folded in the cytoplasm, thereby anchoring the HR 
N-terminus to the cytoplasmic side (figure 5.2B-C).  
We hypothesized that combining lepA or CD8 and GFP, with HR might physically 
reverse its membrane orientation, and thus the direction of the chloride pump of HR. 
LepA-GFP-HR and CD8-GFP-HR constructs were generated. On the other hand, it is 
possible that placing GFP, a soluble protein, between two membrane proteins, may 
actually cause a misfolding of the protein. Consequently, CD8-HR-IRES-GFP construct 
was also generated to separate CD8-HR from the GFP while still enabling cell 
visualisation (figure 5.2D).  
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Figure 5.2 Protein anchoring strategy. A. Wild type HR is naturally expressed in a Nout-Cin 
manner. B-C. By fusing lepA or CD8 (a single pass membrane protein) and GFP upstream to the 
HR, the anchor proteins are intended to anchor the N-terminal of HR to the cytoplasmic side, 
forcing its expression to be in a reversed orientation (Nin-Cout). D. As another alternative, CD8 
only is used as an anchor without GFP. However to assist the visualisation of the cells, a 
fluorescence marker is still needed and so this was achieved by utilizing an IRES within the 
CD8-HR-IRES-GFP construct  to allow GFP to  be expressed separately from CD8-HR.  
 
 
 
 
 99 
 
5.1.2. Light activated Cl- channel: iC1C2 and ChloC 
The development of optogenetic tools continue to progress in many different labs. 
New proteins are being discovered, generated and enhanced by modification of the 
available ones. One recent success is the mutagenesis of the originally excitatory 
channelrhodopsin into light activated chloride channels namely iC1C2 and its slow 
kinetics version SwiChRCT, also ChloCs and its slow kinetic version slow-ChloC (Berndt 
et al., 2014; Wietek et al., 2014). The slow kinetic version is a variant of the 
corresponding channel, modified to stay open for longer than the duration of 
illumination, allowing the light induced current to outlast the illumination with a time 
constant of 7.5 s for SwiChRCT and 10.5 s for slowChloC (Berndt et al., 2014; Wietek et 
al., 2014). All these channels are activated by blue light and are mainly permeable to 
Cl-. 
In contrast to HR that has a fixed direction of chloride flow (inward),  in principle the 
activity of these light activated Cl- channel should be comparable to GABAA receptor in 
which the direction and the driving force of the chloride flow is determined by the 
chloride reversal potential (ECl-) and the membrane potential. When the membrane 
potential (Em) is more positive than ECl-, Cl
- will enter the cell; while when Em is more 
negative than ECl- , Cl
- will leave the cell. This suggests that if we could modulate Em 
sufficiently to stay more negative than ECl- while opening a light activated Cl
- channel, 
Cl- would be extruded.  
Following this logic, I therefore considered a novel approach to extrude chloride by co-
expressing a light activated chloride channel together with a hyperpolarising 
optogenetic outward proton-pump. I hypothesized that co-expression of these 2 types 
of optogenetic tools will enable hyperpolarisation of the membrane potential to be 
more negative than ECl-, resulting in the extrusion of the chloride from the cell.  
The widely available Cl- independent-hyperpolarising opsins are Archaerhodopsin (Arch) 
originally found in Halorubrum sodomense and Archaerhodopsin-T from Haloruburum 
strain TP009 (Chow et al., 2010; Han et al., 2011). Both work as light activated outward 
H+ pumps. ArchT was selected as this strain has a higher light sensitivity compared to 
Arch. Both iC1C2 and ChloC variants are possible candidates to be explored as the light 
activated Cl- channel to be used for this purpose. 
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Finally, I considered ways to reliably co-express two optogenetic proteins under the 
same promoter. This is to avoid a single expression of either ArchT or Cl- channel alone 
that theoretically might give different effect on cells in regards to [Cl-]i modulation.  
Several techniques have been developed before for this purpose namely by protein 
fusion (Kleinlogel et al., 2011b), by the use of bi-cistronic expression system such as 
IRES peptide, or by using 2A peptides  (Douin et al., 2004; Tang et al., 2009). Fusion 
protein has been used widely especially for co-expression of a certain target protein 
with a florescent marker that is a water soluble protein. This technique guarantees a 
stoichiometric expression of the multiple proteins as they are basically produced as a 
single protein. This however is not easily translated for co-expression of two 
membrane proteins such as optogenetic proteins, as this might affect the orientation 
of the downstream protein and hence its function (Kleinlogel et al., 2011b). This is less 
of an issue for other expression systems such as IRES and 2A peptides, as these 
techniques allow for multiple proteins to be expressed as separate proteins rather 
than fused. The disadvantage of this technique however is that they tend to give an 
unbalanced level of expression for the different proteins (Chan et al., 2011).   
As explained earlier in this chapter, IRES sequences work by enabling initiation of a 
second protein translation under a single promoter. On the other hand, 2A peptides 
that consist of 18-22 amino acids, work by initiating cleavages of the encoded proteins 
into multiple components on translation (Chan et al., 2011). This allows separation of 
the encoded multiple proteins into different individual proteins. In contrast to an IRES 
that tends to give a much higher level of expression of the upstream protein compared 
to the downstream protein (Hennecke et al., 2001), 2A peptide has been known to give 
a more equal level of expression between the 2 proteins.  
Most commonly used 2A peptides for multiple proteins expression are from foot-and-
mouth disease virus (F2A peptide), Thosea asigna virus (T2A peptide), Porcine 
teschovirus-1 (P2A peptide), and equine Rhinitis A virus (E2A peptide) (Zhang, 2013).  
Efficiency of 2A peptides depends more on the different turnover rate of the target 
proteins to be expressed rather than the different types of 2A peptides itself (Zhang, 
2013). Here, I utilized the T2A peptide to be used for the co-expression of ArchT and 
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light activated Cl- channel based on the previous success of this 2A peptide for the co-
expression of two optogenetic proteins before namely ChR2 and HR (Tang et al., 2009).  
 
 
5.2. Results 
5.2.1. The effect of Cl- concentration gradient on HR current 
Initially, I assessed the effect of Cl- concentration gradient on wild-type HR Cl- pump. 
This is to simulate the condition which potentially reversed HR will have to face if 
successfully made, namely that it has to pump Cl- against the Cl- concentration 
gradient from inside the cell to the extracellular space. Note that [Cl-]i is always kept 
lower than outside in the neurons (Chapter 1). Cl- substitution experiments with the 
wild type HR current was done by doing a whole cell patch recording of the cells 
expressing HR using a high internal Cl- solution (Cl- = 135 mM) in the patching pipette. 
Continuity between pipette and the cells achieved by whole cell patch allows high Cl- in 
the internal to diffuse into the neuron. From each cell, HR current was then measured 
in the presence of normal (Cl- = 131.5 mM) and low level of chloride (Cl- = 9.5 mM) in 
the ACSF. The mean HR current was reduced from 97.95 ± 27.07 pA to 30.64 ± 6.03  pA 
when washing in low Cl- ACSF (p<0.05, paired t-test, n = 3; figure 5.3), indicating that 
the amplitude of HR current was markedly affected by the chloride level in the ACSF. 
However, it did not abolish the current completely, indicating that it is still capable of 
pumping Cl- against the Cl- concentration gradient that was from 9.5 mM Cl- outside to 
135 mM Cl- inside.  
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Figure 5.3 The size of HR current is affected by chloride concentration. A. Example 
trace recorded from a neuron patched with high Cl- internal (135 mM). Orange light 
illumination induced smaller HR current when washing in low Cl- ACSF (Cl: 9.5 mM) 
compared to normal ACSF (Cl: 131.5 Mm) and this was recovered during the wash out 
period. B. Pooled data gives a mean HR current of 97.95 pA when high level of chloride 
presented outside while the average current of HR was significantly reduced to 30.64 
pA when only low amount of chloride presented outside (P<0.05, n=6, paired t-test). 
 
 
 
5.2.2. The reversal of HR by altering the distribution of charged residues 
The strategy of changing the distribution of positive and negative charged residues of 
HR was then done by conducting amino acid substitutions which are located on the 
inner and outer part of the helix/helices. 4 different mutants with different 
combinations of residue mutations were generated (figure 5.4, table 5.1, designed by 
Prof. Jeremy H. Lakey). The basic principles of the mutant design is first to alter the 
distribution of positive-negative residues that is thought to be influential in protein 
orientation on the membrane, favouring the reversed orientation, and second to avoid 
residues that are known to be essential for protein folding and chloride pumping so as 
to preserve its function as a light-activated chloride pump.  
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The following mutants were generated: 
1. Mutant 1 had most of the positive and negative residues in the inner and outer 
part of helices interchanged (figure 5.4A).  
2. Mutant 2 had the positive charges on the inner part of the first helix changed 
into negative ones (figure 5.4B).  
3. Mutant 3 had the negative residues on the outer part of the first helix 
substituted into positives ones (figure 5.4C).  
4. Mutant 4 had its positive and negative residues on the first helix interchanged 
or combination of mutant 2 and 3 (figure 5.4D).  
 
The three main charged amino acids involved in the design of the mutants are the 
arginine (R) that is positively charged, glutamic acid (E) that is negatively charged, and 
glutamine (Q) that is neutral (table 5.1). Mutants 2-4 focus on charged residues of the 
first helix only as this is the helix that first enters the membrane and thus theoretically 
is the most influential orientation signal (Rapp et al., 2007; Seppala et al., 2010). 
Previously, these 4 different mutants had been expressed in E.Coli AI strain system to 
screen for their ability to fold and bind to the retinal properly. Mutant 3 and mutant 4 
were both successfully expressed and purified, but only mutant 3 bound to the retinal, 
the chromophore that allows the use of light as the energy source of HR (My Master of 
Research project). Without retinal binding, the protein loses the light sensitivity and so 
only mutant 3 was taken further to subsequent experiments.  
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Figure 5.4 Charged amino acid substitutions of HR to reverse its orientation. A. 
Mutant 1 has most of its positive and negative charges on the edge of the 
transmembrane helices completely swapped. B. Mutant 2 has the positive charges on 
the inner part of the first helix changed into negtive charges. C. Mutant 3 has the 
negative charges located on the outer part of the first helix substituted with positive 
charges. D. Mutant 4 has its charges swapped on the first helix only (combination of 
mutant 2 and 3). Figures adapted from (Kouyama et al., 2010). 
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Table 5-1 Amino acids sequence of wild-type HR and 4 different mutants HR. Amino 
acid substitutions and insertions introduced by site-directed mutagenesis are shown in 
red. 
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Mutant 3 HR (mutHR) was subcloned into a pcDNA3.1 vector and fused with EYFP 
(mutHR-EYFP) for mammalian expression and electroporated into the dissociated 
neuronal cultures. MutHR-EYFP expressing neurons (figure 5.5Ai) were patched in a 
whole cell mode using high chloride internal (Cl- = 135 mM) to facilitate an optimal 
mutHR current. Three repeats of electroporation of mutHR-EYFP were done each time 
with wild-type protein as a control for the electroporation process.  A total number of 
20 cells were patched, 5 to 10 cells per electroporation. Two out of 20 cells (10%) 
expressing the mutHR-EYFP protein gave an upward deflection (n=2, figure 5.5Aii) 
during orange light illumination indicative of an inward chloride movement as 
observed in wild type HR. The remainder of the cells (90%) gave no response at all 
during illumination (n=18, figure 5.5Aii). No obvious differences could be observed 
from the morphology and EYFP expression between these 2 differently responding 
cells. This suggests that the chloride pump of mutHR-EYFP was not successfully 
reversed in these cells.   
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If HR orientation is successfully reversed, it would have its N-terminal located inside 
and C-terminal outside. We therefore considered the possibility that fusing EYFP a 
water soluble protein to the C-terminal of mutHR might interfere with the reversion of 
mutHR orientation by anchoring the C-terminal to the cytoplasm. To test whether the 
failure of mutHR-EYFP construct reversion is not due to the fusion of EYFP to the C-
terminal, mutHR-IRES-EYFP construct was generated. Here mutHR and EYFP were 
produced separately as 2 different proteins that one should not interfere with the 
other.  When this was expressed in the neuronal culture (4 electroporations), all the 
recorded fluorescent cells showed no response to light activation (n =24, figure 5.5B).  
 
There are several possible explanations for the absence of light activated current of 
mutHR-IRES-EYFP construct. 
i. mutHR was not being produced by the cell machinery  
ii. mutHR was produced but not targeted to the membrane 
iii. mutHR was in the membrane but dysfunctional  
 
To answer this, post-hoc immunofluorescence labeling against HR in cells transfected 
with mutHR-IRES-EYFP was done (the HR antibody should also bind to mutHR as this 
construct only has 3 point mutations from the wild type HR). Staining result showed 
aggregates in the organelles that are likely to be the endoplasmic reticulum (figure 
5.5Biii). This suggests that the cells indeed produced mutHR but it was not targeted 
properly to the membrane. This tells us that the absence of light activated current of 
mutHR construct is due to the lack expression of the protein at the plasma membrane 
of the cell surface.  
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Figure 5.5 mutHR-EYFP and mutHR-IRES-EYFP expression and electrophysiology 
recording. Ai. Representative neuron expressing mutHR-EYFP imaged under 
fluorescence microscope for EYFP using 100x objective. Aii. A very small proportion of 
cells (10%; n= 2 out of 20) showed a wild-type like current (inward movement of Cl-) 
with a relatively smaller amplitude (representative trace from 1 neuron). Aiii. 90% of 
the cells (n=18) showed no light activated current with orange light (representative 
trace from 1 neuron). Bi. Cells transfected using mutHR-IRES-EYFP plasmid imaged 
under fluorescence microscope for EYFP using 100x objective. Bii. All cells patched 
(n=24) did not show any light activated current with orange light (representative trace 
from 1 neuron). Biii. Immunofluorescent staining against HR on cell expressing mutHR-
IRES-EYFP. Left panel shows the brightfield view of the cell, middle panel shows mut-
HR labelling, and right panel shows the overlay of the two showing that mutHR was 
aggregating surrounding the nucleus.  
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5.2.3. Reversion of HR by protein anchoring 
LepA-GFP-HR construct had also been previously expressed and purified in the E.Coli 
system to test that this fusion protein could fold and bind to retinal (done by Scott 
Mitchell, Master of Research project co-supervised by me). The LepA-GFP-HR 
expressing cDNA was then subcloned into pcDNA3.1 vector for mammalian cells 
expression that was then expressed in the dissociated neuronal culture by 
electroporation. Fluorescence imaging of these cells showed that the GFP labeling was 
not well diffused throughout the cell and its processes; instead it clumped within the 
cell body (figure 5.6, left).  No current could be recorded during orange light 
illumination when patched with high Cl- internal. Scott Mitchell then expressed this 
construct in Hela cells for imaging purpose and took high magnification images of the 
cells. It was clearly visible how most of the GFP appeared to aggregate within the 
cytoplasm (figure 5.6, right).  
 
 
Figure 5.6 Expression of lepA-GFP-HR construct. Left: An example neuron that 
expressed lepA-GFP-HR imaged under confocal microscope for GFP expression using a 
100X objective. Right: Example HeLa cells expressing LepA-GFP-HR imaged under 
confocal microscope for GFP expression using a 100X objective (S. Mitchell).  
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Several different factors could lead to the failure of membrane localization of lepA-
GFP-HR protein when expressed in primary neuronal culture. Firstly, this might be due 
to the incompatibility of lepA protein as an anchor protein in neuronal system. To 
answer this, CD8-GFP-HR construct was generated replacing lepA with CD8, a native 
mammalian protein that had been successfully expressed in neuronal systems in 
another study (Santoro et al., 2011).  Additionally, CD8-GFP was also generated as a 
control to further confirm that CD8 could be expressed properly in the neurons. 
Evidently the same problem remained even after replacing LepA with CD8 in the CD8-
GFP-HR construct, GFP labeling still looked spotty around the cell soma and no light 
activated current could be recorded (n = 15, from 3 different electroporations; figure 
5.7, middle). In contrast, CD8-GFP alone was expressed in the neurons throughout the 
cell body and the processes (figure 5.7, left).   This suggests that the expression 
problem was not caused by CD8 as the anchor protein or by the GFP marker.  
 
 
 
Figure 5.7 Neuronal expression of CD8-GFP, CD8-GFP-HR, and CD8-HR-IRES-EYFP. 
Representative neurons imaged under a confocal microscope for GFP or EYFP 
expression. CD8-GFP was expressed as a control (left).  
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Secondly, it could be due to a misfolding of the protein caused by the fusion of the GFP, 
a water soluble protein between two different membrane proteins. To address this, 
GFP was separated out from the fusion protein leaving the CD8 alone as the anchoring 
protein upstream of HR. To allow cell visualisation, GFP was also expressed but using 
the IRES system as CD8-HR-IRES-GFP construct in which CD8-HR and GFP were 
expressed as 2 separate proteins by the transfected cells. Cells transfected by CD8-HR-
IRES-EYFP construct however still did not show a healthy expression of the protein and 
no light activated current could be recorded with orange light (n =15, from 3 
electroporations; figure 5.7, right). To confirm that HR was being produced, a post hoc 
immunofluorescence labeling against HR was done on cells expressing these constructs. 
Similarly with mutHR protein, staining showed aggregation in the cytoplasm indicating 
that HR was produced by the cells but was not successfully passaged through the trans 
golgi network to the membrane (figure 5.8). Collectively, this data suggests that the HR 
alteration by protein anchoring led to protein aggregation and so fail to reverse the HR 
orientation.  
 
 
Figure 5.8 Immunofluorescence staining against HR in CD8-GFP-HR and CD8-HR-IRES-
GFP construct. Representative cells imaged under brightfield, GFP filter (green), red 
fluorescence filter for HR labelling, and overlay of all from neurons transfected with 
CD8-GFP-HR construct (top) and CD8-HR-IRES-EYFP construct (bottom).  
 112 
 
5.2.4. Co-expression of light activated Cl- channel and ArchT to extrude Cl-  
iC1C2 vs slow-ChloC light activated current 
Dissociated neuronal cultures were electroporated with either pAAV-CamKII-iC1C2-
EYFP or pAAV-hSyn-slowChloC-tDimer plasmid. As an initial investigation to compare 
the light activated current of both channels, whole cell patch recordings were done on 
cells 7 days post transfection. Patching pipette contained 6 mM Cl- that gives an ECl- of -
81 mV. Both iC1C2 and ChloC light activated current were depolarizing from -85 mV. 
Assuming that these channels are mainly permeable to Cl-, these depolarizing current 
should be generated by an outward flow of Cl-.  
From this initial experiment, only 2 out of 8 cells expressing iC1C2-EYFP, screened by 
EYFP expression, showed a light activated current even when changing VHold between -
90 to -30 mV. In both cells, the iC1C2 current was smaller than the slow-ChloC current 
(n=5 cells; figure 5.9). Based on this initial assessment that slow-ChloC gave a more 
reliable light activated current, all subsequent experiments were done using ChloC 
variants that were either the ChloC or the slow-ChloC (slow kinetic version of ChloC).   
 
 
Figure 5.9 Whole cell recording of iC1C2 and slow-ChloC light activated current. 
Whole cells patch was done using an internal containing 6 mM Cl- in a voltage clamp 
mode from cells expressing iC1C2 and slow-ChloC. A. A neuron expressing iC1C2 was 
patched with a VHold of -85 mV. Blue light illumination induced a downward deflection 
(EPSC) that in theory should reflect the Cl- outward flow from inside the cell. B. A 
neuron expressing slow-ChloC also showed an EPSC during blue light illumination when 
patched with a VHold of -85 mV. Slow-ChloC tends to give a bigger current compared to 
iC1C2 (traces are example from 1 neuron each).  
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Co-activation of ArchT and ChloC variants induces a negative shift in EGABA 
Co-expression was done by electroporation of the dissociated neuronal culture with 
pAAV-CAG-ArchT-GFP and pAAV-hSyn-ChloC-tDimer or pAAV-hSyn-slow-ChloC-tDimer. 
Cells that expressed both fluorescence proteins tDimer (red) and GFP (green) were 
selected for the experiment (figure 5.9 &5.13). The same experimental protocol used 
to characterise HR Cl- loading effect (chapter 3) was used for the characterisation of 
ArchT-ChloC variants effect on [Cl-]i. Gramicidin perforated patch was performed, and 
EGABA was measured, with or without optogenetic activation, by introducing a voltage 
ramp during the local application of muscimol (GABAA agonist), and another one 
during the baseline.  
 
 
 
 
Figure 5.10 Co-expression of slowChloC and ArchT on dissociated neuronal culture.  
Left: A neuron expressing slowChloC that was tagged with red fluorescence protein 
tDimer. Middle: The same neuron also expressed ArchT that was fused with GFP 
(green). Right: Overlay of both red and green resulted in yellow colour confirmed the 
co-expression of the 2 optogenetic proteins by the same neuron.    
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The first set of experiments was conducted on cells expressing ArchT and slow-ChloC 
screened by the expression of both red and green fluorescence (figure 5.9). 
Simultaneous activation of both ArchT and slow-ChloC by co-illumination using light 
with 491 nm and 561 nm wavelength readily induced a negative shift in EGABA to a 
more hyperpolarised level with a mean shift of -2.67 ± 0.47 mV (p<0.02, n=5, paired t-
test; figure 5.10D), indicative of a lower [Cl-]i post illumination. The light associated 
negative shift in EGABA was consistent regardless of the initial [Cl
-]i as indicated by the 
baseline GABA response of individual cells. Optogenetic activation of both ArchT and 
slow-ChloC consistently drove the Cl- out when baseline EGABA was depolarizing 
(downward deflection), roughly equivalent to Em (no GABAergic deflection), or 
hyperpolarizing (upward deflection) when doing a voltage clamp (VClamp) recording 
with a holding potential (VHold) of -70 mV (figure 5.10A-C).  
      
 
Figure 5.11 Co-activation of slowChloC and ArchT induced a negative shift in EGABA. 
Co-activation of the 2 optogenetic proteins consistently induced a negative shift in the 
EGABA of 3 different representative cells regardless of their initial GABA response. A. 
Representative trace from the cell that initially had a depolarizing GABA response. B. 
The representative trace from the cell that had an initial shunting (flat) GABA response. 
C. The representative trace from the cell that had an initial hyperpolarizing GABA 
response (upward deflection). D. Pooled data of the EGABA shift induced by ArchT-
slowChloC co-activation plotted relative to different duration of illumination. 
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The decay of the Cl-  extrusion effect was assessed by briefly co-activating the pair of 
optogenetic proteins, either ArchT and slow-ChloC (n =2) or ArchT and ChloC (n=3), 
and applying muscimol in an increasing delay (figure 5.11). A negative shift was again 
induced by the light activation reversing the initially depolarising baseline GABA (figure 
5.11A, black) into hyperpolarising IPSC (figure 5.11A1) in this representative cell. This 
was indicative of a Cl- clearing effect when muscimol was applied immediately (100 ms 
delay) after the optogenetic activation (figure 5.11A1). The amplitude of the IPSC was 
progressively reduced with a longer delay between light activation and the muscimol 
puff, and eventually collapsed back to a baseline-like GABA event (figure 5.11A-B). 
EGABA shift produced by different delays were normalised to the EGABA shift induced 
with the shortest delay. Data points were exponentially fitted to calculate the decaying 
time constant of the Cl- clearing effect. Pooled data decay plot was shown in figure 
5.12A with a mean time constant of 10.6 ± 2.2 s (mean ± sem, n=5), note that the 
mean time constant was calculated by averaging the  of individual cells rather than 
extrapolating from the pooled decay plot.  
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Figure 5.12 Transient effect of ArchT-ChloC co-activation in extruding Cl-. A. Example 
traces from 1 neuron in which muscimol puff was applied with an increasing 1s delay 
after a brief co-activation of ArchT-ChloC (trace 1-5). When muscimol puff applied 100 
ms post illumination, EGABA was negatively modulated resulted in an IPSC (trace 1) 
instead of an EPSC triggered without optogenetic activation (black). This modulation 
were smaller the longer the delay being introduced between the light activation and 
the muscimol puff. B. The same traces overlapped together depicted the progressively 
smaller IPSC amplitude with the longer delay with a time constant of 13.14 s in this 
particular cell. Exponential fit to the maxima of the ramps highlights the progressively 
smaller hyperpolarizing event by GABA the longer delay introduced. 
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The negative shift however was relatively small. One explanation could be due to the 
fact that there was not much extra Cl- inside available to be extruded. This is supported 
by the fact that the size of the shift was well correlated with the basal [Cl-]i, with a 
bigger negative shift is achieved by the cell that had a more depolarised baseline EGABA 
(R2: -0.72, p:0.01, n=11, linear regression;  figure 5.12B).  Furthermore, unlike HR Cl- 
loading effect (chapter 3), ArchT-slow-ChloC Cl- clearance effect does not correlate 
with the duration of illumination (R2:-0.16, p<0.5, linear regression; figure 5.10D). 
 
 
 
 
 
Figure 5.13 Pooled data of EGABA shift introduced by co-activation of ArchT-ChloC. A. 
EGABA shift was normalised to the EGABA shift from the measurement when the shortest 
delay was introduced. The average from all 5 cells was plotted and exponetially fitted, 
with the mean time constant of 10.6 ± 2.2 s (mean ± sem, n=5). Note however that 
mean  was calculated by averaging 5 individuals . B. The negative shift was well 
correlated with the baseline EGABA that represents the initial [Cl
-]i (R
2: -0.72, p: 0.01, 
n=11, linear regression). 
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Figure 5.14  Co-expression of ChloC and ArchT on dissociated neuronal culture. Left: 
Example of a neuron expressing ChloC that was tagged with red fluorescence protein 
tDimer. Middle: The same neuron also expressed ArchT that was fused with GFP 
(green). Right: Overlay of both red and green resulted in yellow colour confirmed the 
co-expression of the 2 optogenetic proteins. 
 
 
To investigate whether a bigger negative shift could be achieved when cells contain 
more Cl-internally, I attempted to load cells with Cl- by repetitive GABAA activation 
prior to the optogenetic activation. Firstly, a single GABA event was recorded at the 
start of the experiment as a baseline (figure 5.14, black). Secondly, 10 muscimol puffs 
(1 Hz, 10 s) were delivered followed by a single puff as the GABA test, following 
repeated GABAA activation, with a 4s delay, to measure how intense GABAA activation 
alters the EGABA of the cell (figure 5.14, purple). Lastly, the same paradigm was then 
repeated with 2 s optogenetic activation during the 4s delay just before the GABA test 
(figure 5.14, turquoise). Illumination of ChloC and ArchT induced hyperpolarizing 
current with a mean amplitude of 385.59 ± 90.57 pA (mean ± sem, n=7). 
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Figure 5.15 Protocol to assess the Cl- clearance effect of ChloC-ArchT Cl- when cells 
were Cl- loaded prior to the optogenetic activation. Baseline EGABA was recorded 
(black), followed by multiple muscimol puffs to load cell with Cl- and a GABA test 
(purple), the same protocol was then repeated but with 2s light activation just before 
the GABA test (turquoise). 
 
 
In the majority of the cells (71%: 5 out of 7 cells), single activation of GABAA by 
muscimol triggered an IPSC shown as an upward deflection in a VClamp recording with a 
VHold of -70 mV (figure 5.15A, black). In these cells, intense activation of GABAA by a 
train of muscimol puffs induced a positive shift in EGABA; as shown during the GABA test, 
muscimol puff triggered a reversed polarity of the initially hyperpolarizing event into a 
depolarizing one (figure 5.15, purple) with a mean shift of 7.1 ± 1.69 mV (mean ± sem, 
n=5). This indicates that there was a [Cl-]i accumulation through the intense GABAA 
activation.  
In contrast, single GABAA activation triggered an EPSC in the remaining 2 cells (29%) 
that was a downward deflected event on a VHold of -70 mV recording (figure 5.15B, 
black). In this situation, the repetitive GABAA activation actually induced a 
hyperpolarizing shift in EGABA with a mean shift of -6.35 ± 6.2 mV (mean ±sem, n=2). 
This was shown by a marked reduction of the muscimol-triggered EPSC amplitude 
(figure 5.15B, purple).   
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Figure 5.16 Hyperpolarizing and depolarizing initial EGABA gave a different effect on 
the successive EGABA during repetitive activation of GABAA receptor. A. Example traces 
from a cell that showed a hyperpolarizing GABA baseline. When initial GABA event was 
hyperpolarizing (black trace), trains of muscimol puffs caused a depolarizing shift in the 
EGABA shown by the reversed of the GABA test event from upward to downward 
deflection (purple trace, right). B. Representative traces from a cell that showed a 
depolarizing GABA baseline (black trace). In this situation, repetitive GABAA activation 
actually had the opposite effect that was inducing a hyperpolarizing shift in the EGABA 
as shown by a marked reduction in the amplitude of the depolarizing GABA event 
(purple trace, right). 
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A brief optogenetic activation of cells expressing ChloC-tDimer and ArchT-GFP 
consistently induced a positive shift in the EGABA on the GABA test (figure 5.17, 5.18A-B), 
regardless of the initial baseline GABA event and the consequently different effect of 
repetitive GABAA activation on the successive GABA event. This suggests that in all 
recorded cells, [Cl-]i was lowered post light activation. Figure 5.17 shows a 
representative trace in which 2 s activation of ArchT-ChloC rescued the depolarizing 
shift in EGABA introduced by intense GABAA activation back to become hyperpolarizing 
again and often to an even more hyperpolarized level than the baseline EGABA. 
The pooled data shown in figure 5.18 demonstrated how ArchT-ChloC co-activation 
reliably shifted EGABA to a more hyperpolarizing level, indicating a consistent Cl
-  clearing 
effect induced by light activation (p<0.0002, n=6,paired t-test). This was the case for 
both when initial GABA was depolarizing or hyperpolarizing. In this experimental 
paradigm, where the cells were primed with repetitive GABAA activation beforehand to 
raise [Cl-]i, a bigger hyperpolarizing shift was achieved (mean ± sem: -9.34 ± 1.05 mV, n 
= 6; figure 5.18C, black) compared to the hyperpolarizing shift introduced by light 
without prior train of muscimol puffs (mean ± sem : -2.67 ± 0.48 mV, n =5; figure 5.18C, 
grey). Note however that experiments with a prior train of muscimol puffs were done 
on ChloC-ArchT expressing cells whereas the one without was conducted on 
slowChloC-ArchT expressing cells. This suggests that ArchT-ChloC co-activations is 
capable of extruding more Cl- when there is more Cl- inside.  Nevertheless even with a 
low baseline [Cl-]i, the combination of ArchT and ChloC activity is still capable of driving 
Cl- out.   
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Figure 5.17 Co-activation of ChloC and ArchT rescued the EGABA to a more 
hyperpolarised level post repetitive GABA activation. In this cell, repetitive GABAA 
activation accumulated Cl- intracellularly shown by a more depolarised EGABA that 
appeared as a downward deflection during the GABA test instead of upward deflection 
like the initial GABA (purple vs black). This was readily rescued by short light activation 
that reversed back the polarity of GABA shown by the upward deflection of the last 
GABA test.  
 
 
 123 
 
 
 
Figure 5.18 EGABA measurements for baseline, post repetitive GABA activation, and 
with optogenetic activation of ArchT and ChloC. A. EGABA measurement for baseline 
GABA event, post repetitive GABAA activation by train of muscimol puffs without and 
with ArchT-ChloC activation (**: p<0.0002, paired t-test, n=6).  B. EGABA relative to the 
baseline (**: p<0.0002, paired t-test, n=6). C. EGABA relative to the baseline, this was 
without prior train of muscimol puffs for grey dots and with for the black dots. (grey: 
single activation of GABAA – results from figure 5.8 (*: p<0.02, paired t-test, n=4), black: 
hyperpolarizing baseline - multiple activation of GABAA, black-white:  depolarizing 
baseline - multiple activation of GABAA).  
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Figure 5.19 Activation of ArchT or ChloC alone does not induce a negative shift in 
EGABA in a mature neuron. A. Single expression of ArchT showed different amplitude of 
light-activated current with 461 nm, 591 nm, and combined (left). ArchT was optimally 
activated by 591 nm light and this did not cause a negative shift in EGABA (right). B. 
Single expression of slow-ChloC showed different amplitude of light-activated current 
with 461 nm, 591 nm, and both wavelenghts combined, that peaked when activated 
by 461 nm (left). In this cell, light activation induced a small positive shift in EGABA 
indicative of a Cl- loading effect (right). C. Co-expression of ArchT and ChlocC: when co-
expressed on the same cell either 461 nm, 591 nm or combined always gave rise to a 
hyperpolarizing current (left). Only green or combined green- blue light (*: p< 0.02, 
paired t-test, n=4) consistently induced a negative shift in EGABA. Together it suggests 
that any negative shift in EGABA is the consequence of co-activation of both opsins 
rather than the individual opsin.  
 125 
 
When a perforated gramicidin patch clamp was performed on cells that expressed only 
ArchT, a large amplitude hyperpolarizing current was recorded during illumination but 
this did not negatively modulate the EGABA post light activation (figure 5.18A, n=1). This 
indicated that ArchT alone did not cause a Cl- extrusion effect on the neuron.  
On cells that expressed only slow-ChloC, illumination triggered a depolarising current 
although GABA events on these cells were hyperpolarising. However slow-ChloC 
activation by blue light illumination in these cells induced a depolarising shift in the 
EGABA indicative of a small Cl
- loading effect by slow-ChloC (figure 5.18B, n=2). Although 
this is only a result from a low number of samples, this suggests the individual opsin 
activity is not enough to induce a hyperpolarising shift in EGABA or a Cl
- clearing effect 
on the cell.  
An extra experiment was done comparing the ArchT and slow-ChloC light current using 
different wavelength of light using cells that expressed only ArchT or only slow-ChloC. 
Both ArchT and ChloC variants showed light current with both 461 nm (blue) and 591 
nm (green) light. ArchT was more optimally activated by 591 nm, with only 29% from 
its maximum current was generated when illuminated by 461 nm and 88% was 
generated using combined 591 nm and 461 nm (n=3). Slow-ChloC on the other hand 
showed a bigger current with 461 nm (figure 5.18A&B), while 591 nm only produces 
17%, and the combination 461 nm and 591 nm produces 62% of the current generated 
by 461 nm light (n =3).  
From cells that co-expressed both opsins, both 461 nm and 591 nm, or combined 
illumination always gave rise to a hyperpolarising current (figure 5.18C, left). However, 
only green or combination of green and blue appeared to consistently provide a Cl- 
extrusion effect on the cell, with combination of blue and green giving a statistically 
significant shift and marginally bigger shift (mean ± sem: -1.59±0.33 mV; s: p<0.02, 
paired t-test, n =4) compared to green (mean ± sem: -1.37±0.45 mV; ns: p<0.06, paired 
t-test, n=4) whereas blue light gave a variable effect on the direction of the Cl- flow 
(mean shift ± sem: -0.45±1.07 mV; ns: p<0.8, paired t-test, n=4 (figure 5.18C).  
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Co-expression of ArchT and ChloC using the 2A system  
 
Since the Cl- clearance effect required both opsins within a single cell, I next 
considered strategies to ensure co-expression of ChloC and ArchT. The use of 2 
plasmids transfection as done in previous experiments does not guarantee 100% co-
expression level in all transfected cells, with some cells expressed only ArchT or ChloC. 
Since Cl- clearance effect rely on the activation of both proteins, a strategy to reliably 
co-express both proteins in the same cells is absolutely needed for the network level 
experiments. 
The T2A peptide was used for this purpose by building a ChloC-T2A-ArchT_GFP 
construct. In principle, this should allow an expression of the multiple proteins under a 
single promoter but produce ChloC and the fused ArchT_GFP as two separate proteins. 
The construct was electroporated into dissociated neuronal cultures; all cells were 
used for experiments at least 2 weeks post-transfection.  
Fluorescence imaging of the cells showed GFP expression across soma and processes 
(figure 5.19A). Blue and green illumination gave rise to hyperpolarizing current with 
relatively smaller amplitude compared to the dual plasmid transfection (mean ± sem, 
T2A expression: 57.74 ± 9.99 pA, n=5; dual plasmid: 385.59 ± 90.57 pA, n=7; significant, 
p<0.02). Nevertheless, co-activation of ChloC and ArchT of these cells also showed a 
hyperpolarizing shift in EGABA suggesting the successful co-expression of the two 
proteins (figure 5.19 & 5.20). Pooled data from 5 different cells showed a consistent 
trend of a negative shift in EGABA post light activation for ChloC and ArchT with a mean 
shift of -6.38 ± 1.99 mV (mean ± sem, n=5; *: p<0.04 paired t-test; figure 5.20). This 
confirms that the T2A technique could be used to co-express ChloC and ArchT under a 
single promoter and was therefore potentially useful for further application of ChloC-
ArchT as a tool to extrude Cl- in network level. 
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Figure 5.20 Co-expression of ChloC and ArchT using 2A peptide technique. A. 
Fluorescence imaging for GFP of ChloC-2A-ArchT_GFP expression of 1 example 
transfected neuron. B. Illumination using green and blue light modulated muscimol 
event to be more hyperpolarising indicative of a Cl- extrusion effect.  
 
 
 
Figure 5.21 Pooled data of EGABA shift by light activation from cells transfected with 
ChloC-2A-ArchT_GFP. EGABA post light activation for ChloC and ArchT was subtracted by 
its corresponding baseline EGABA that gave a mean EGABA shift of -6.38 ± 1.99 mV (mean 
± sem, n=5; *: p<0.04 paired t-test).  
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Current clamp recording of ChloC-ArchT Cl- extrusion effect 
GABA event modulation by ChloC-ArchT co-activation was also assessed in current 
clamp mode. ChloC and ArchT were co-expressed on dissociated neuronal cultures 
using the T2A peptide and gramicidin perforated patch was performed. Recording was 
made in current clamp mode with a holding current (IHold) ranging between 0 to -500 
pA, aiming for a depolarizing GABA response (upward deflection, figure 5.21A black 
trace). Muscimol was applied with an interval of 1 minute, with or without prior 5.8 s 
light activation interchanged.  In this mode, light activation shifted the membrane 
potential by -6.46 ± 1.63 mV (mean ± sem, n=6), confirming the hyperpolarizing effect 
of light activation on the Em. 
Two measures were made to assess the GABA event modulation: amplitude of Em shift 
elicited by muscimol puff and the Em at the peak of GABA event. Light activation 
consistently changed the amplitude of the Em shift induced by muscimol puff to a more 
negative value (mean ± sem: -5.06 ± 1.31 mV, *p<0.01, n=6, paired t-test; figure 
5.21&5.22A-B), indicative of a more hyperpolarizing GABA event. This measure 
however is also affected by the Em that tends to get more depolarized post 
hyperpolarizing event by ChloC-ArchT co-activation due to a rebound effect (figure 
5.21B).  
Additionally, Em achieved at the peak of muscimol event was also documented. This 
could give an indication to what potential GABA tends to clamp the cell. This measure 
however is affected by both EGABA and also the relative conductance for other ions such 
as Na+ and K+.  Light activation gave a mean negative shift of -2.19 ± 0.97 mV at the Em 
value reached during the peak of muscimol event; however this was not statistically 
significant (n=5; ns, p>0.05, paired t-test; figure 5.22C).  
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Figure 5.22 Current clamp recording of ChloC-ArchT co-activation effect on GABA 
activity using the T2A co-expression system. Example traces recorded from a single 
neuron co-expressing ChloC and ArchT using T2A peptide. A. Gramicidin perforated 
patch was performed and recording was made on current clamp mode with a current 
holding of -30 pA. Muscimol was applied with 1 minute interval. Left: The baseline 
GABA event without any light activation (black trace). Right: GABA event after 
illumination for ChloC-ArchT co-activation (turquois). B. Isolated muscimol events 
without (black) and with prior ChloC-ArchT co-activation (turquois) showed a change in 
polarity of the event from depolarizing (black) to hyperpolarizing (turquois). Note the 
more depolarized initial Em prior to muscimol puff for the optogenetic trials.    
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Figure 5.23 Pooled data of current clamp recording showing GABA modulation by 
ChloC-ArchT co-activation expressed using T2A peptide system. A. Amplitude of GABA 
event without and with prior ChloC-ArchT activation. B. Amplitude of GABA event post 
light activation relative to baseline. Light activation consistently showed a negative 
shift in GABA event amplitude with a mean shift of -5.06 ± 1.31 mV (mean ± sem, 
*p<0.01, n=6, paired t-test). This measurement however might be affected by Em as 
well. C. Em at the peak of GABA event triggered by muscimol puff with and without 
prior ChloC-ArchT activation relative to baseline. There was a slight negative shift trend 
with a mean of -2.19 ± 0.97 mV (mean ± sem, n=5; ns, p>0.05, paired t-test), however 
this is not statistically significant. Note that this is not the accurate EGABA measurement.      
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5.3.  Discussion 
5.3.1. Attempts to reverse the orientation of HR  
We tried two different strategies to reverse HR orientation in the membrane that 
could potentially reverse the direction of the Cl- pump: charged residues mutation and 
protein anchoring. Unfortunately neither strategy managed to reverse HR, with 
evidence of expression problems for most of the modified proteins. 
Immunofluorescence staining show aggregates in the cytoplasm suggestive of the 
protein being retained in the endoplasmic reticulum, leading to a conclusion that the 
protein failed to be targeted to the membrane (figure 5.5-5.7). This could be due to a 
lack of ER export signal hence retention of the protein in the ER as originally shown by 
the wild-type HR (Gradinaru et al., 2008) or due to misfolding of the protein.   
Indeed in all these constructs (mutHR-EYFP, mutHR-IRES-EYFP, lepA-GFP-HR, CD8-GFP-
HR, CD8-HR-IRES-EYFP), the ER export signal that was introduced by Gradinaru et al 
(2008) to improve the original HR expression was not included. In our hands, this ER 
export signal resulted in an improved wild-type HR current with a mean of 163.89 ± 
108.94 pA, n=14 compared to the original wild-type HR construct that only gave a 
mean current of 13.79 ± 4.73 pA, n=6 (chapter 3). This ER export signal (FCYENEV) is 
originally found in the C-terminal end of an inward-rectifier potassium channel 2.1 (Kir 
2.1). Omission of this signal by site directed mutagenesis leads to intracellular protein 
aggregation of Kir2.1 expression (Gradinaru et al., 2008).  
This ER export signal was not incorporated in our construct due to the uncertainty of 
how this signal actually works, making it difficult to know where exactly to place this 
within the construct that was designed to have a reversed orientation. This is 
especially the case because a reversal will swap the position of the originally Nout-Cin 
HR into Nin-Cout HR (figure 5.1&5.2) that also will change the position of the c-
terminally located ER export signal. However, even without this signal, wild-type HR 
still consistently gave a light activated current of about 13.79 ± 4.73 pA. This suggests  
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that the aggregates of our constructs and the absence of light activated current are 
likely due to misfolding of the protein rather than a mere lack of ER export signal.  
However, this is not definitive and could be clarified in the future by adding the ER 
export signal into the construct in either the C-terminal or N-terminal and assess the 
quality of the expression and the light activated current.  
Finally, reversal of HR Cl- flow without reversing the HR orientation could be another 
option to explore in the future. As changing orientation of a membrane protein that 
affects the whole protein might lead to misfolding, another strategy would be by 
targeting the Cl- pump machinery component of the protein only.    
5.3.2. Light activated Cl- channel as a tool to extrude Cl- 
ChloC variants were selected based on the fact that light activated current was more 
reliably induced compared to iC1C2. Furthermore the size of iC1C2 current was rather 
small compared to slow-ChloC. This could be due to the fact that there are more 
mutations introduced for the construction of iC1C2 (9 nucleotides substitution) that 
might affect the expression level of the protein on the membrane compared to ChloC 
and slow-ChloC that only have 2-3 mutations respectively. Additionally, in both ChloC 
variants the T159C mutation was introduced specifically to optimize the current as it 
has been shown before that it improves the membrane targeting and retinal binding in 
the chromophore pocket that might underlie its larger current size (Wietek et al., 
2014). However, recently a new version of iC1C2 with an enhanced current named 
iC1C2 3.0 has been generated, this could be another candidate to be used for this 
purpose in the future.     
In this chapter, some recordings used ChloC while others used slow-ChloC. ChloC is a 
ChR2 variant that has two point mutations: at E90R, which is believed to affect the ion 
selectivity of ChR2, and at T159C for membrane targeting improvement. Slow-ChloC 
was then generated by adding an extra point mutation at D156N that confers the slow 
kinetic property to the channel (Wietek et al., 2014). The main difference between the 
two proteins is the kinetic of the channel; ChloC closes almost instantaneously 
whereas slow-ChloC current outlast the light with a time constant of 10.5s (Wietek et 
al., 2014). Additionally there is a slight difference in the reversal potential between 
ChloC and slow-ChloC, -61.8 mV and -68.2 mV respectively. Finally slow-ChloC also 
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shows a higher light sensitivity and a slightly bigger current compared to ChloC (Wietek 
et al., 2014). As there are differences between the two, ideally the same experiment 
should be done with both ChloC and slow-ChloC to compare if one is more suitable for 
Cl- clearance purpose than other, but due to limitations of time this has not been done.  
Wietek J et al (2014) has conducted ion replacement studies to show that the reversal 
potential for ChloC variants are mainly affected by the concentration of Cl- inside and 
outside the cell more than other ions such as Na+, K+, H+, or Ca2+. However, my results 
from gramicidin patch recording of cell expressing only slow-ChloC, showed that when 
GABA was generating IPSCs (inward Cl- flow) with an EGABA of -68.39 mV, slow-ChloC 
current was actually depolarizing with an Eslow-ChlOC   of -48 mV when measured by 
introducing voltage ramps during the activation of slow-ChloC by light. However, slow-
ChloC activation was still inducing a depolarising shift in EGABA (figure 5.18B), indicating 
that in regard to Cl-, slow-ChloC indeed had the same effect as GABA that in this cell 
was driving an inwardly directed Cl- flow during activation. This suggests that although 
ChloC variant reversal potential could also be affected by other ions, evidently it is still 
conducting a significant flow of Cl-.    
Both ArchT and ChloC variants have quite broad activation spectra (400 – 650 nm for 
ArchT and 350 – 500 nm for ChR2 family including the ChloC variants) (Nagel et al., 
2003; Han et al., 2011). Testing different wavelength for the opsins activation could 
give insightful information in choosing the best illumination strategy, especially 
because for the Cl- clearance purposes the right combination of two opsins current is 
needed. Experiments done on cells that express both opsins reveal that with both 491 
nm and 561 nm or combined, light activation always produce a hyperpolarising current 
albeit with different amplitude, regardless of the VHold (figure 5.18C). Basically this 
could be explained by the heavily overlapping activation curve of the two opsins and 
the masking effect of large ArchT current (can be up to 1000 pA) that overwhelms the 
current generated by ChloC variants (maximum current recorded -81 pA). From this 
experiment, it becomes clear that when co-expressing ArchT and ChloC variants, it may 
not be possible to activate each opsin independently, at least when using 491 nm or 
561 nm light. Hence any future experiment that intends to use ArchT-ChloC variants 
co-activation should have a single expression of each opsin as control since different 
wavelength of light is not enough to separate out the activity of the 2 opsins.  
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First characterisation of Cl- extrusion effect of combined ArchT and ChloC variant 
activity was done using slow-ChloC. The mean negative shift in EGABA induced was 
relatively small (-2.67 ± 0.47 mV) and unlike HR Cl- loading effect, this did not change 
significantly with longer illumination. The small shift could be explained by the fact 
that the slow-ChloC current outlasts the light for over 10s whereas the ArchT current 
stops instantaneously. This residual slow-ChloC current post light activation might have 
a reversed effect on the EGABA due to the lack of the hyperpolarizing ArchT current 
effect on the Em. Note that there was 100 ms delay between light illumination and 
muscimol puff in which Cl- might go in an outward direction without ArchT activation. 
A precise temporal matching of the currents is likely to be desirable.  
The illumination strategy for optogenetic co-activation of ArchT and ChloC variants 
affects the Cl- clearance effect of the two opsins. Blue light (491 nm) activation of 
ArchT-slow-ChloC that consistently gave a net hyperpolarizing current of 103.5 ± 27.69 
pA (mean±sem, n= 5) did not give a consistent direction of EGABA shift: 2 out of 4 cells 
gave an outward Cl- flow (negative EGABA shift) and the other 2 gave an inward Cl
- flow 
(positive EGABA shift).  This suggests that this amplitude of hyperpolarising current is not 
always enough to shift the Em to be more negative than the EGABA. Whereas, green (561 
nm) or combined green and blue illumination gave a mean hyperpolarising current of 
441.38 ± 87.41 pA and 442.79 ± 92.84 pA respectively, and reliably induced a negative 
shift in EGABA. This further supports the essential need of an ArchT hyperpolarizing 
effect on the Em to allow the ChloC variants to exert a Cl
- clearance effect on the cell 
rather than a Cl- loading effect. It should be noted however that these experiments 
were done in a voltage clamp mode and so the Em modulation was not perfect.   
More control experiments with single expression of ArchT and ChloC variant in EGABA 
modulation are needed. However, it has been shown before by Raimondo et al (2012) 
that Arch (which has the same properties as ArchT, except for its light sensitivity) 
activation does not significantly modulate EGABA. In principle, this should be the same 
with ArchT effect on EGABA. Additionally, unlike the consistent effect of green-blue light 
(that gave large ArchT current) on EGABA, blue light activation of the ArchT-slow-ChloC 
that only showed a small ArchT current, did not give a consistent negative shift in EGABA. 
This further supports the requirement of both ArchT and ChloC to produce a more 
consistent outward Cl- flow.   
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To see whether the ArchT-ChloC variant could impose a bigger negative shift when 
cells have extra [Cl-]i to begin with, I primed the cells by repetitive activation of GABAA 
channel by trains of muscimol puffs. This has been shown to have a depolarising effect 
in the EGABA (Thompson & Gahwiler, 1989a). Indeed, in this situation co-activation of 
ArchT-ChloC drove more Cl- out, shown as a bigger mean of negative shift in EGABA (-
9.34±1.05 mV) compared to on cells that have not been primed beforehand (mean 
shift of -2.67±0.47 mV when it was done using ArchT-slow-ChloC).  This confirms that 
ChloC variants are capable of extruding more Cl- when there is higher Cl- inside the cell.  
Finally, I have shown that we could co-express ChloC and ArchT using theT2A peptide 
that allows expression of multiple proteins under a single promoter. This technique 
required a longer expression to achieve a comparable optogenetic current compared 
to the conventional dual plasmids transfection. The need for longer expression time of 
the 2A peptide system has been documented before (Tang et al., 2009). However, 
even when patched 3 - 4 weeks post electroporation, the amplitude of the 
hyperpolarizing current by the T2A construct was still smaller (mean ± sem: 57.74 ± 
9.99 pA, n=5) than the dual plasmid electroporation of (mean ± sem: 385.59 ± 90.57 pA, 
n=7).  
This could be explained by the issue of an unbalanced expression level of the different 
proteins when using 2A peptide. Relatively lower expression of the protein 
downstream of the 2A peptide has been reported before. Two reasons could underlie 
the smaller hyperpolarizing current recorded from the ChloC-2A-ArchT_GFP. Firstly, it 
is due to a lower ArchT level of expression and consequently smaller hyperpolarizing 
current of ArchT. Secondly, the higher level of ChloC will give a bigger depolarizing 
current, at least when co-activated together with ArchT, hence counteracting the 
hyperpolarizing current of ArchT. The second explanation is more likely to underlie the 
smaller hyperpolarizing current, because when using blue light on the 2 plasmids 
transfection method, the elicited 103.5 ± 27.69 pA hyperpolarizing current did not 
show a consistent Cl- extrusion effect whereas the 2A peptide expression that only 
gave a hyperpolarizing current of 57.74 ± 9.99 pA seemed to consistently induce a 
negative shift in EGABA (mean ± sem: -6.38 ± 1.99 mV n=5; figure 5.18). This negative 
shift was even bigger than the slow-ChloC-ArchT co-activation by the 2 plasmid 
transfection method (mean ± sem: -2.67 ± 0.47 mV n=5; figure 5.8).  
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To further optimize the co-expression of ChloC and ArchT, a fusion protein strategy 
should be considered in the future. This will eliminate the unbalanced expression issue 
as the 2 proteins will be produced as a single entity. Furthermore, this will allow a 
precise co-localization of the 2 proteins in the membrane in which every one ChloC will 
be associated with one ArchT side by side. This could potentially give a better Cl- 
extrusion effect and furthermore allows a compartmental Cl- extrusion in subcellular 
level for instance by spot illumination of only the dendritic spine or axon initial 
segment, etc. This will not be optimal with other non-stoichiometric co-expression 
system in which the 2 proteins might not be uniformly distributed across the cell 
membrane and hence the Cl- extrusion effect is brought about collectively from the 
ChloC and ArchT proteins in the entire cell membrane.   
Ernst Bamberg has tried to co-express excitatory and inhibitory optogenetic proteins in 
neurons before by protein fusion strategy. He successful did this by fusing the two 
proteins using a specific length of linker to assure both proteins are oriented properly 
and function well (Kleinlogel et al., 2011b). Adopting this linker to combine the ChloC 
and ArchT for co-expression purpose (figure 5.19) is one possible strategy for co-
localization with a strong point of a guaranteed 1:1 expression level of both proteins.  
 
 
Figure 5.24 Co-expression of ChloC and Arch to extrude chloride. Arch (green) 
activation hyperpolarises the membrane potential that will provide a driving force for 
chloride to leave the cell when the ChloC (blue) is light-activated. The two optogenetic 
proteins are linked together by EYFP and an additional transmembrane helix from the 
β subunit of the rat gastric H+,K+-ATPase (grey) for expression of a single fusion 
protein, adopted from (Kleinlogel et al., 2011b). 
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Finally, I would like to address the issue of how voltage clamp mode recording might 
not allow strong Em modulation as actually required to be imposed by ArchT for Cl
- 
extrusion purpose. This is due to the design of this recording mode that tries to clamp 
the cell Em into the desired VHold by injecting positive and negative current. The fact 
that we could still measure a consistent negative shift in the EGABA using this mode 
suggests that the quality of the voltage clamp was poor and hence Em was still 
modified sufficiently by ArchT activation, to allow Cl- extrusion via ChloC. This could 
happen when the contact between the patching electrode and the internal of the cell 
is very limited, which gives a relatively high series resistance (Rs). This is indeed the 
case when doing perforated gramicidin patch clamp recordings. In this situation, the 
injected current’s effect on the voltage shift will shrink due to the high Rs (V = I x R) 
and voltage clamp becomes less efficient. 
Additionally, the efficiency of voltage clamp also diminishes with distance from where 
the patching electrode is. As optogenetic proteins were distributed widely throughout 
the cell soma and also the processes, it is likely that ArchT could still hyperpolarize the 
cell quite efficiently in the processes, with an increasing efficiency further away from 
the soma where patching electrode was placed. Furthermore, the large instantaneous 
hyperpolarizing current of ArchT could also overwhelm the VClamp system, allowing 
some Em modulation. Nevertheless, it should be noted that voltage clamp mode could 
actually attenuate the ArchT effect in Em modulation and this possibly explains the 
relatively small effect of slowChloC-ArchT co-activation effect in EGABA.  
Current clamp mode (IClamp) on the other hand is a more suitable option when Em 
modulation is desired. IClamp experiments were then done to assess the Cl
- extrusion 
effect of ChloC-ArchT co-activation. First, the amplitude of GABA event was measured 
with and without prior ChloC-ArchT co-activation. A significant change in the 
amplitude could be observed post light activation with a mean negative shift of -5.06 ± 
1.31 mV (mean ± sem, *p<0.01, n=6, paired t-test). This test however could be 
confounded by the fact that Em tends to be slightly shifted to a more depolarized level 
post light activation, due to rebound effect post ArchT hyperpolarization. A second 
measure was then done by measuring the Em at the peak of muscimol event. This 
should be less affected by the initial Em. A slight negative shift trend post light 
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activation was shown with a mean of -2.19 ± 0.97 mV (mean±sem, n=5; ns, p>0.05, 
paired t-test), however this was not statistically significant.  
Based on these two measures derived from the current clamp experiments, there was 
a suggestion that ChloC-ArchT indeed induced a hyperpolarizing shift in GABA activity. 
However, this is still not a definitive prove. For the first measure, an important 
question to ask is whether the depolarized Em prior to muscimol puff could account for 
the negative shift in the GABA amplitude post light activation and more experiments 
are required to clarify this. As for the second measure, the main issue is, although IClamp 
is a better set up for ArchT hyperpolarizing effect on the Em, it is not the best mode to 
measure the ECl- as an indicator of [Cl
-]i. GABAA activation will bring the cell’s Em close 
to the EGABA, however it might not always reach the EGABA depending on the 
conductance for other ions and the leakiness of the cell. This factor was taken into 
account when EGABA is measured on a VClamp using ramps. A better design of 
experiments to clarify this in the future would be to perform illumination for ChloC-
ArchT co-activation under current clamp mode while measuring the EGABA under 
voltage clamp mode. 
 
5.3.3. Reverse HR strategy versus ArchT-ChloC co-activation strategy 
 
The different nature between an electrogenic pump and a channel make HR and light 
activated Cl- channel such as ChloC differ in their way of modulating [Cl-]i. The first one 
is that electrogenic pump activity is independent of the Em whereas Cl
- channel driving 
force is set by Em as well as ECl-. This will give a benefit for the reversion of HR Cl
- flow 
strategy as a tool to extrude Cl-, if successful. As HR is an electrogenic pump and not a 
channel, its activity is not regulated by the Em. This means that its activity will be less 
dependent on any synaptic event such as glutamatergic that modulates Em. In contrast, 
the ArchT-ChloC strategy will be more likely to be affected by glutamatergic events 
that shift Em to be really positive. Note that if Em is more positive than ECl-, opening of 
any Cl- channel including ChloC will lead to an inward Cl- flow. Therefore, glutamatergic 
activity in principle will attenuate the ArchT-ChloC effect in Cl- extrusion by setting a 
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higher starting Em for ArchT hyperpolarization to shift to be more negative than ECl-, 
creating a smaller driving force for Cl- extrusion. 
Both HR and ChloC activity are affected by Cl- concentration. As shown by the low Cl- 
ACSF experiment of wild-type HR current (figure 5.3), low Cl- concentration outside 
does change the driving force of the pump by 70% however it does not completely 
abolish the current (HR mean current: 30.64 pA) when there is about 9.5 mM Cl- 
outside compared to 131.5 mM Cl- in normal ACSF (HR mean current: 97.95 pA). 
SlowChloC-ArchT Cl- extrusion effect was well correlated with the EGABA indicative of 
the higher initial [Cl-]i the bigger the driving force for ChloC activity.   
The added benefit of ChloC-ArchT co-activation strategy is that the clearing of chloride 
will not be associated with depolarisation as the membrane potential is kept 
hyperpolarised by ArchT. In addition, a chloride channel opening has a shunting effect 
on the cell shown by a drop in input resistance to almost 50% (Berndt et al., 2014). 
Theoretically, this strategy will enhance inhibition by its hyperpolarising effect, 
shunting effect, and also correction of the high [Cl-]i. Whereas with HR reversion 
strategy, hypothetically the Cl- extrusion will be associated with a depolarization. In 
summary, I suggest that the ChloC-ArchT co-activation approach is a better candidate 
for correcting Cl- levels in epileptic tissue.  
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Chapter 6. General Discussion 
 
 
6.1.  Summary of experimental findings 
The first aim of my thesis was to investigate the role of raised [Cl-]i, a feature of 
epileptic network that has been documented by many studies before, in the 
generation of certain epileptic activity. However it has proved difficult to separate this 
out from other contributing factors in a complex system phenomenon such as a 
seizure. To address this, I made a novel use of the hyperpolarising optogenetic protein 
HR (light activated Cl- inward pump) to artificially load neurons with Cl-. The ability of 
HR in modulating [Cl-]i  was characterised in chapter 3. There I have shown that brief 
HR activation (2 – 10s) readily induced positive shifts in EGABA, and since GABA is mainly 
permeable to Cl-, this strongly indicates that HR activation accumulates Cl- into the 
cells. EGABA then recovered back to its initial baseline with a time constant of 8.01 ± 
2.85 s in acute brain slices, made from adult mice. This appears to be faster than in 
dissociated neuronal culture of more immature cells in which [Cl-]i recovered with a 
time constant of 28.1 ± 9.26 s. The faster decay of HR Cl- loading effect in acute brain 
slices could be explained by the different age of the cells that consequently affect the 
different level of KCC2 expression.    
Based on this knowledge, in chapter 4 HR was used to load a subset of cells with Cl- 
using a 25s ON/5s OFF illumination paradigm, while monitoring any modulation being 
imposed onto the network event triggered by electrical stimulation during the OFF 
period. The results from chapter 4 suggest that long repeats of HR Cl- loading into 
pyramidal cells alone was not enough to trigger ictal activity even when applying 
electrical stimulations into the white matter to  mimic a thalamic input. This however 
is sufficient to induce high frequency oscillation (HFO) with a characteristic doubling of 
frequencies, increased jitter in spike timing, and out-of-phase firing. This is consistent 
with certain features of HFOs that have been recorded from animal models of epilepsy, 
and which has been regarded as one of the hallmarks of epileptic foci.  
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Only when combined with low, sub-epileptic levels of 4-AP (20 µM) did Cl- loading 
rapidly trigger full ictal activity. This suggests that high [Cl-]i has an adjunctive effect  in 
seizure initiation, at least in vitro brain slices. In this situation, when longer Cl- loading 
was maintained in the presence of 20 µM of 4-AP, multiple ictal discharges were 
triggered and often  a spreading-depression like event was triggered, which had a 
terminating effect on the ictal discharge. This is similar to what is described by Bragin 
et al (1997) termed afterdischarge terminating oscillation (ATO). This manifested as a 
depression state that silenced the network transiently. The ATO appeared to be 
initiated in the HR illumination foci suggesting that this event could be directly or 
indirectly influenced by Cl- loading of the neurons.   
Lastly, the second aim of my thesis was to design optogenetic tools to extrude Cl-. This 
has potential use both as a research tool and clinically as a treatment option for 
epilepsy, if bioengineering technology advances to allow optogenetic activation for 
human use. In chapter 5, several different approaches were explored mainly trying to 
reverse the orientation of HR, and thereby reverse the Cl- flow direction of this pump 
to be outwardly directed. A second approach was to couple the effect of 
hyperpolarizing ArchT current on the Em and opening of a light activated Cl
- channel to 
provide both the driving force and the conductance for an outward Cl- flow. The first 
approach was not successful, mainly due to membrane localization problem that could 
be caused by the lack of endoplasmic reticulum (ER) export signal in the cDNA of 
modified HR or a misfolding of the protein. The second approach on the other hand 
showed a positive effect as a Cl- extrusion tool, based on the fact that brief co-
activation of ArchT and ChloC consistently shifted EGABA to a more hyperpolarizing level. 
This shift was well correlated with the baseline [Cl-]i , with bigger shift tends to be 
achieved by cells that had higher initial [Cl-]i.  
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6.2. HR chloride loading effect as a model of raised intraneuronal chloride 
HR Cl- loading effect was used as a model of raised intraneuronal chloride. As this 
could be a good model of Cl- loading via intense GABAA activation that is also 
associated with hyperpolarization, this may not be directly comparable to high [Cl-]i 
induced by co-transporter dysregulation for several reasons. 
First, Cl- co-transporters such as NKCC1 and KCC2 are electroneutral (Kaila et al., 2014) 
meaning that ion movements across the membrane via these co-transporters will not 
impose abrupt changes in the membrane potential. In contrast, HR Cl- loading is always 
accompanied by an instantaneous membrane hyperpolarization and so it could impose 
some downstream consequences such as the activation of HCN channel that gives rise 
to the depolarising IH current or the activation of CLC2 channel that gives an outward 
Cl- flow post hyperpolarisation.   
Second, co-transporter dysregulation not only affects a cell’s initial [Cl-]i, but moreover 
it affects the time course of Cl- fluxes in a cell. For instance, when KCC2 was blocked 
using 100 µM furosemide, HR Cl- loading gave a comparable EGABA shift with control, 
however the time constant of the HR Cl- loading effect was three times longer 
compared to baseline. This indicates that when KCC2 function is blocked, the cells’ 
capability in restoring [Cl-]i back to their preferred [Cl
-]i is compromised. In the HR Cl
- 
loading experiment, KCC2 was intact, at least initially, and so was the cells’ ability in 
restoring their [Cl-]i back to baseline. However, this process
 is slow as shown that EGABA 
was recovering with a mean τ of 8.01 ± 2.85 s post HR priming in adult brain slices. 
Furthermore, it should be noted that when KCC2 is intact, intraneuronal Cl- 
accumulation could promote excitability not only by depolarizing GABA, but also by 
raising K+ in the extracellular space (Viitanen et al., 2010). This is because 
intraneuronal Cl- accumulation increases the driving force for KCC2 activity, which will 
extrude Cl- together with K+ to the extracellular space. Consequently, this could result 
in an extracellular accumulation of K+ that will shift the membrane potential into a 
more depolarizing level and hence increasing excitability of the cell.    
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Lastly, the effect of co-transporter dysregulation on [Cl-]i is long lasting, while HR Cl
- 
loading is a transient effect that decays over time. Due to the transient nature of HR Cl- 
loading, electrical stimulation was used to induce ripple like activity rather than the 
spontaneous ripple model that was used by Foffani G., et al (Foffani et al., 2007a). 
Electrical stimulation was timed to be elicited 0.5s post HR activation to make sure that 
HR Cl- loading effect was still close to its maximum. Although this is slightly artificial, 
the mechanism is still valid, as HFO induced by HR Cl- loading and the electrical 
stimulation share the same characteristic as shown by Foffani et al, which will be 
elaborated in the next section. Furthermore, the effect was also well predicted by the 
computer model simulation.   
 
6.3. The role of raised [Cl-]i in generation of high frequency oscillation 
Network events in high gamma range (>80 Hz) could be observed both in healthy and 
epileptic brains. However, in contrast to activity <250 Hz range that could be both 
physiological or pathological, network activity in 250-600 Hz range termed fast ripple, 
has been mainly regarded as epileptic (Alvarado-Rojas et al., 2014). Fast ripples have 
been shown in patients with mesial temporal lobe epilepsy (Bragin et al., 1999), in 
neocortical tissues resected from epileptic patients (Roopun et al., 2010), and in 
animal model of epilepsy (Foffani et al., 2007a). This HFO often precedes seizure onset 
(Jirsch et al., 2006) and also has been associated with interictal activity in the EEG 
recording (Schevon et al., 2009). 
The results in chapter 4 revealed a direct cause and effect relationship between high 
[Cl-]i and the modulation of high frequency activity (250-600 Hz). When neocortical 
tissues were challenged with HR Cl- loading, modulation of the network activity could 
be observed especially in the high frequency oscillation range (250 -600 Hz). This 
frequency is roughly the doubling of the frequency of the dominant oscillation (figure 
6.1B) as shown in baseline network activity (<250 Hz). This characteristic doubling of 
frequencies is consistent with the specific feature of epileptic HFO described by Foffani 
et al (2007) (figure 6.1A). The Cl- induced high frequency modulation was rapid and 
reversible when Cl- loading was terminated.   
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Figure 6.1 Striking resemblance between spontaneous epileptic HFO and HR priming 
tissue. A. Representative spectrogram showing HFO recorded from healthy animal (left) 
and epileptic one (right) shown by Foffani et al (Foffani et al., 2007a). Epileptic HFO 
shows as a second harmonic event or doubling frequency of the baseline event. B. 
Only HR priming (right) but not ArchT priming (left) resulted in HFO events with a 
similar second harmonic characteristic that shown in HFO recorded from epileptic 
animal by Foffani et al.  
 
 
Likewise, raised intraneuronal chloride too has also been linked to epileptogenic region. 
Supporting evidence mainly comes from epileptic tissue resected from patients with 
temporal lobe epilepsy, in which significant reduction of KCC2 expression was found in 
about 30% of the pyramidal cells (Huberfeld et al., 2007c). They then found that most 
of the cells that lacked the expression of KCC2 showed a depolarizing event during 
interictal event whereas all cells that were hyperpolarized expressed KCC2. Similar 
findings were also found from human epileptic tissues surrounding human glioma and 
in peritumoral epileptic tissue in mice when injected with human gliomas (Pallud et al., 
2014; Campbell et al., 2015).  
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My result then provides direct evidence that these two phenomena namely raised 
intraneuronal chloride and HFO, which are associated with epileptogenic area, are 
actually linked to each other. This result also links the Foffani et al study and Cohen et 
al study that described the underlying mechanism of epileptic HFO. Cohen et al 
reported that during HFOs associated with interictal discharges, underlying excitation 
comes from both glutamatergic activity and GABAergic activity (Cohen et al., 2002). 
They further showed that during these events interneurons were highly active in a 
bursting mode, while pyramidal cells showed two different responses; either receiving 
a small excitation followed by larger hyperpolarisation, or were excited, resulting in 
their firing at the time of the event. Foffani et al on the other hand suggested that 
epileptic HFOs arise from a desynchronized mechanism rather than hypersynchrony, of 
populations of cells that fired out-of-phase of each other (Foffani et al., 2007a). My 
results from chapter 4 give an explanation that the different populations that fire out-
of-phase of each other are determined by their [Cl-]i, one population with an EGABA 
below the threshold for action potential, and the other above. Since EGABA dictates 
whether cells are inhibited or excited during GABA activation, cells with healthy EGABA 
will only be excited by glutamatergic drive during the refractory period of inhibitory 
conductance, while cells with depolarizing EGABA can also be excited by GABA during 
the peak of inhibitory conductance itself. When the mixture of both is present, out-of-
phase firing of the 2 different groups results in the generation of HFO. This fits the 
observation by Cohen et al that during HFO bursts, interneurons fire almost at the 
same time with some pyramidal cells (pyramidal cells with depolarizing EGABA that fires 
by GABAergic drive) while some other pyramidal cells were hyperpolarized during the 
burst preceded by small excitation (pyramidal cells with healthy EGABA that fires by 
glutamatergic drive with a jitter from the interneuron’s burst of action potential).    
This mechanism completely relies on interneuronal activity especially fast-spiking 
interneurons, as explained by the computer model.  However, epileptic activity has 
been recorded before when there is a local loss of inhibition or in a preparation 
without any synaptic function intact in which ephaptic or gap-junction mediated 
spread has been implicated (Traub & Bibbig, 2000). This suggests that other 
mechanisms could exist too. 
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Furthermore Cl- loading experiments also showed evidence of increased jitter in spike 
timing (5 of 8 slices) and even out-of-phase firing (3 out of 8 slices) when spike-phase 
relationship was assessed according to the dominant oscillation. This also provide an 
explanation to the puzzling observation of increasing jitter of action potential timing 
during recruitment of cortical area into a seizure (Netoff & Schiff, 2002), that seemed 
to contradict the hypersynchrony nature of epilepsy. The computer model further 
explains how progressive Cl- loading initially results in increasing jitter in spike timing 
that after a certain threshold will eventually induce out-of-phase firing. Cl- loading that 
positively shifts EGABA but not sufficiently to give an EGABA beyond the threshold for 
action potential, will result in an increased jitter in spike timing, by broadening the 
window of opportunity for pyramidal cells to spike as inhibition becomes weaker. 
However as soon as the EGABA reaches the threshold for action potential, a very high 
probability of cells to spike in the opposite phase from the baseline was observed, as 
suddenly GABA is triggering action potential, favouring a hyper-synchrony state.     
The question still remains of whether tissues with HFO and raised [Cl-]i are actually 
indicative of the initiator of seizure activity or rather a secondary local response of 
tissue to the actual trigger. Answering this is particularly important especially since 
HFO has been regarded as one of the hallmarks of epileptic foci in clinical setting. It has 
been documented before that there are two types of HFO which can be recorded from 
human epileptic patients implanted with multi electrode array (MEA): macrodischarges 
that are widespread, and microdischarges that instead are very local, affecting only a 
single electrode (Lee et al., 2005; Schevon et al., 2009). This suggests that it is possible 
that HFOs could be generated by the initiator (presumably the one with local 
microdischarge) but also as a secondary response of the tissue towards something else 
as macrodischarges seemed to be synchronized in wider areas and also 80% of the 
times are associated with interictal discharges.  
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Similarly for high [Cl-]i, evidence has shown that glutamatergic activity could readily 
trigger GABA release that will rapidly induce an increase of intracellular Cl- via GABAA 
activation (Lee et al., 2005). This suggests that high [Cl-]i could be induced as a local 
response towards an excitatory drive. This initial transient high [Cl-]i, as a local 
response towards excitatory drive, could induce changes of co-transporter expression 
and function that could result in a more persistent high [Cl-]i state. Supporting 
evidence comes from the in vitro low Mg2+ model in which after repetitive interictal 
discharges, reduction of KCC2 expression was observed and it appears to be mediated 
by calcium activated protease calpain (Puskarjov et al., 2012). Therefore it is possible 
that later on, this tissue could become more prone to be the initiator, as shown by my 
results that high [Cl-]i state lowered the threshold for 4-AP to induce seizure.  
It should be noted that based on the results described in chapter 4, HFO could be 
associated with Cl- dysregulation when it shows the characteristic doubling of 
frequencies. Potentially, this feature could be used as a hallmark for tissues associated 
with Cl- dysregulation and might provide an insight whether Cl- targeted treatment 
could be useful for certain patients or not. However, so far the observation of the 
doubling of frequencies feature of epileptic HFO has only been observed in animal 
model of epilepsy, in which recording was made using a high quality deep penetrating 
microelectrodes. Whether such a quality of recording could be made in the clinical 
setting or whether this feature could be captured by non-invasive tools suitable for 
patients remains to be seen.     
Lastly, as [Cl-]i clearly modulates activity in the gamma oscillation range by controlling 
the GABA post-synaptic response of pyramidal cells, it is an interesting question 
whether Cl- dysregulation would have a significant impact on information coding and 
memory processing, given the fact that gamma oscillation has  an important role in 
spike timing dependent plasticity and sensory information processing (Buzsáki & 
Draguhn, 2004). Furthermore, it is an interesting possibility that cells might use their 
[Cl-]i as a mean to modulate their response to GABA activity that will have implication 
on synaptic input integration in a single cell level that is still remained to be explored. 
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6.4. The adjunctive role of raised [Cl-]i  in seizure initiation 
Synaptic inhibition is the key mechanism that restrains the spread of activity and 
seizure recruitment of a new territory (Prince & Wilder, 1967a; Trevelyan et al., 2006a; 
Schevon et al., 2012).  Altered inhibitory function is therefore regarded as an 
important facet of epilepsy that could lead to seizure initiation. Raised [Cl-]i is one of 
the factors that could lead to a failure of inhibitory restraint by reducing the driving 
force for GABA hyperpolarizing current and even switching its polarity to be 
depolarizing (Thompson & Gahwiler, 1989a; Kaila et al., 1997; Ben-Ari, 2002). However 
to what extent raised [Cl-]i is contributing to seizure initiation has not been fully 
explored.     
Results from chapter 4 as summarised earlier, are consistent with previous study that 
has shown when full ictal discharges were induced by 50-100 µM 4-AP application and 
removal of Mg2+ from the bath, GABAergic blockers had a significant reduction effect 
on seizure activity, which is comparable to the effect of glutamatergic blockers (Lillis et 
al., 2012). The use of either GABAergic or glutamatergic blockers both resulted in a 
conversion of full ictal discharges into interictal like burst (Lillis et al., 2012). This 
indicates that ictal activity depends on both glutamatergic acitivity and also GABAergic 
activity.  
GABAergic excitatory effect is especially dominant in the clonic phase or the 
afterdischarge phase of post-tetanic stimulation induced ictal events (Fujiwara-
Tsukamoto et al., 2006; Ellender et al., 2014). In this model GABAergic blockers tend to 
be more potent in abolishing afterdischarges than glutamatergic blockers. Recent 
study then explained how GABAergic contribution to seizure is mainly imposed by 
parvalbumin (PV) positive interneurons (Ellender et al., 2014), the soma targeting 
interneuron that is also known to have the capability to synchronize a wide range of 
pyramidal cells’ activity (Tamas et al., 2000). Using post-tetanic stimulation induced 
ictal events, Ellender et al showed that when PV was optogenetically activated using 
ChR2, GABA release from PV cell was actually triggering an afterdischarge rather than 
inhibiting it. In contrast, when PV cell was inactivated optogenetically by Arch 
activation, the frequency of afterdischarges was significantly reduced. The idea is that 
the synchronizing effect of PV cells on the post-synaptic pyramidal cells, together with 
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high [Cl-]i that leads to depolarizing GABA activity, will impose a synchronized 
excitatory effect on the post-synaptic pyramidal cells manifested as the afterdischarge. 
These studies, together with my results, suggest that GABAergic activity is indeed 
required in a full ictal discharge and furthermore it could actually contribute as an 
excitatory drive in a seizure when [Cl-]i is high. However, equally important, other 
pathological state is also required for the generation of full ictal activity, as shown that 
only when 20 µM 4-AP was added in the bath, high [Cl-]i  triggered full ictal discharges. 
Based on the Ellender et al study, it could be speculated that this other pathological 
state should involve hyper-excitability of PV interneurons, as what might have also 
been imposed by low concentration of 4-AP in my experiments as well. Note that high 
[Cl-]i could not trigger a seizure just in combination with glutamatergic activity 
triggered by electrical stimulation. Contrast this with HFO which also requires both 
glutamatergic and GABAergic activity, but electrical stimulation triggered release of 
glutamate and GABA are enough to accompany high [Cl-]i state to trigger HFO.  
It is therefore interesting to explore the exact underlying mechanism of 20 µM 4-AP’s 
contribution to ictogenesis when combined with Cl- loading. The first possibility is due 
to the widespread effect of bath application of 4-AP that affects the entire slices in 
contrast to electrical stimulation that is relatively focal. A second possibility could be 
simply because 20µM 4-AP provides stronger excitatory drive than an electrical 
stimulation. Lastly, it could also be explained by the fact that 4-AP blocks potassium 
channel (Kv3.1 and Kv1.1) that are mainly expressed by fast-spiking interneurons, 
hence triggering burst firing of these interneurons. It also expressed by pyramidal cells, 
so could further enhance excitability of the network this way (Martina et al., 1998; 
Rudy & McBain, 2001). An interesting future work that could be done to answer this is 
by expressing HR in pyramidal cells and ChR2 in PV cells, and assessing whether focal 
activation of PV cells while loading the pyramidal cells with Cl- is enough to trigger ictal 
discharges.    
My finding also shows a clear parallel with recent studies of human brain tissue 
resected during epilepsy surgery (Huberfeld et al., 2007c; Pallud et al., 2014), which 
show spontaneously occurring interictal events when bathed in conventional ACSF. 
These interictal events are sensitive to GABAergic blockade, suggestive of a Cl--loaded, 
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excitatory GABAergic state, but to trigger full ictal events in these slices required 
excitability to be further enhanced by bathing in raised K+ (Pallud et al., 2014).  
Importantly, the subsequent ictal activity appeared to arise out of a fundamentally 
different type of transient discharge which was not sensitive to GABAergic blockade.  
Pallud et al has shown that in tissues associated with Cl- dysregulation, a second 
pathological state such as raised extracellular K+ resulted in full ictal discharges.  
Conversely, my result showed that in tissues that were predisposed to a certain 
pathological state such as sub-epileptic level of 4-AP, high [Cl-]i and hence excitatory 
GABA, could tip the network activity over the balance into a seizure.  
 
6.5. After discharge terminating oscillation  
One incidental finding of the HR Cl- loading experiment in conjunction with low level of 
4-AP was the observation of a characteristic seizure terminating event also known as 
afterdischarge terminating oscillation (ATO).  This pattern of activity has been reported 
and discussed before as one possible way in which seizures terminate (Bragin et al., 
1997). In their study, Bragin et al was applying tetanic stimulation onto the perforant 
path and commissural path in vivo that manifested as seizures that either short lasting 
(<10s) or long lasting (>30s). In their hand, only long lasting seizures were terminated 
by the ATO whereas the short lasting seizures tend to terminate abruptly without any 
sign of ATO or post-ictal depression.  
Bragin et al has demonstrated that ATO happened when cells’ Em was shifting into a 
depolarized level, triggering cells to fire intensely, which in the network level 
manifested as the low amplitude fast oscillation (40-90 Hz). Further depolarization of 
the cells then prevented sodium channel de-inactivation, leaving cells incapable of 
firing. This manifests as the sustained potential shift that is followed by a depression 
state. Activity only recovers after Em is back to normal. Bragin et al also showed that 
they could successfully mimic ATO by local injection of KCl extracellularly, highlighting 
the role of high extracellular K+ in the generation of ATO. 
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The role of ATO in seizure termination still remains elusive. Especially because ATO is 
not commonly reported in popular seizure models such as 0 Mg2+, 4-AP, spontaneously 
developed seizures of organotypic cultures, or chronic model of epilepsy such as the 
one induced by kainic acid, tetanus toxin, or pilocarpine; although it could possibly 
occur in these model too. However, several other studies have documented ATO 
before, to be associated with seizure termination (Somjen et al., 1985; Rafiq et al., 
1995; Bragin et al., 1997); it should be noted that in all these studies, seizures were 
induced by focal application of tetanic stimulation in hippocampus. In these studies, 
ATO was not recorded in all seizures with long seizures tend to be associated with ATO 
more than short ones.  
Bragin et al (1997) and Somjen G et al (1985) both showed that only long seizures were 
terminated by ATO; similarly in my results ATO tend to be recorded only after long 
repeats of HR priming in which most of slices had generated multiple seizures 
beforehand. This might suggest that although ATO is not the general terminating 
mechanism that could be applied to all seizures, it is possible that it is a secondary 
terminating mechanism generated by the network when the first line terminating 
mechanism fails or when the convulsant persists.  
The mechanism of ATO has been mainly explained as the consequence of K+ 
accumulation in the extracellular space due to intense firing of cells during seizure 
(Somjen & Giacchino, 1985; Bragin et al., 1997). However, HR priming induced ATO in 
my experiment suggests that intracellular Cl- accumulation could also contribute to the 
generation of ATO. It is probably not a coincidence that excitatory GABAergic activity 
(Fujiwara-Tsukamoto et al., 2006; Ellender et al., 2014) and ATO associated seizure 
(Somjen et al., 1985; Rafiq et al., 1995; Bragin et al., 1997) are both particularly 
prominent in the focal post tetanic stimulation seizure model, as both may share a 
common contributing factor, which is the high [Cl-]i. The most likely explanation would 
be as Cl- builds up inside the neurons, the driving force for KCC2 to extrude Cl- 
increases (figure 6.2A). As KCC2 extrudes Cl- together with K+, Cl- clearance leads to a 
greater K+ extrusion and hence significantly increases the extracellular K+ to a level that 
is sufficient to induce the generation of ATO (figure 6.2B). However it is not impossible 
that Cl- by itself could also have a direct effect in the generation of ATO. To what 
extent extracellular K+ accumulation and the consequent ATO generation is actually 
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related to Cl- clearance is an interesting question that still need to be resolved and this 
could be explored by repeating the same experiment and using a specific KCC2 blocker.  
A recent study has shown using computer modelling how the transition between 
normal spiking activity to seizure and to spreading depression could be explained by a 
progressive increase in extracellular K+ (Wei et al., 2014). Experimentally it has been 
shown how physiologically, [K+]o is kept low around 3-4 mM, while during seizure this 
goes up to 8 – 12 mM (Heinemann & Lux, 1977), and may even reach 20 – 40 mM 
during spreading depression (Somjen & Giacchino, 1985). Wei et al showed that when 
[K+]o is between 12 – 18 mM, tonic firing behaviour is produced (Wei et al., 2014). This 
fits with the observation of the ATO or low amplitude fast oscillation (40-90Hz) that 
precedes the sustained potential shift or depression state (flattening of the recording). 
This suggests that seizure could be followed by ATO or not depending on the level of 
extracellular K+. Accordingly, the different tendency for different slices to generate 
ATO post seizure might be related to the local regulation of K+, such as ATP or energy 
supply that is needed by the sodium potassium ATPase pump (Na+K+ATPase) to bring 
K+ back into the cell (Bragin et al., 1997; Wei et al., 2014) or possibly Cl- loading that 
might facilitate extracellular K+ rises via KCC2 activity. To answer these questions, it will 
be interesting in the future to monitor both internal chloride and external potassium 
level simultaneously during seizure and ATO to tease out the interplay of these 2 ions 
that could underlie the generation of ATO and potentially give an important insight for 
seizure termination. 
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Figure 6.2 Hypothetical underlying mechanism of ATO that terminates an ictal 
discharge. A. Cl- accumulation, facilitated by HR activation and also via GABAA activity, 
increases the driving force for KCC2 Cl- extrusion, which progressively accumulates K+ 
in the extracellular space, as Cl- is being extruded. B. Progressive increase of 
extracellular K+ makes the transition from an ictal discharge into a spreading-
depression like event when extracellular K+ is sufficiently high to trigger a 
depolarization block.  
 
Another interesting observation is that some slices, and some area in the brain, tend to 
generate ATO more easily than others (Somjen et al., 1985; Bragin et al., 1997), as also 
the case with my observation during the ATO experiments. ATO is very similar to the 
phenomenon of spreading depression, first described by Leao (Leao, 1944). Spreading 
depression is a condition of an extreme depolarisation of populations of cell that is 
associated with ionic imbalances resulting in a silencing of normal on-going activity. 
Spreading depression has been linked to seizures before (Somjen, 2004). It came back 
to the first spreading depression recording by Leao (1944), in which he applied tetanic 
stimuli in vivo to induce a focal seizure but instead of generating seizures, it actually 
induced the silencing of the network and the flattening of the ECoG. From then on, 
spreading depression has commonly been induced in vitro and in vivo by the same 
stimuli that are used to trigger seizures, including electrical stimulation, mechanical 
injury, alkaline pH, low osmolarity, high extracellular potassium, or even by glutamate 
(Somjen, 2004). However it has proved difficult to predict whether seizure or 
spreading depression or both is going to occur (Somjen, 2004). This highlights the 
overlapping underlying mechanisms behind these two phenomena, and also how 
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neuronal networks seem to vary in their tendency to go into spreading depression only 
pathway, seizures only pathway, or seizure that is terminated by ATO.  
Parallel to the animal work recording, there seems to be a link between seizure and 
spreading depression in clinical setting as well. Clinically, cortical spreading depression 
has been associated with migraine that often started with an aura like phenomenon. It 
has been shown that sometimes migraines could induce seizures, seizures often 
followed by post-ictal headache like migraine, also there has been evidence of the 
usefulness of antiepileptic drug as prophylactic drug for migraine (Rogawski, 2010). 
Additionally, there were some familial genetic conditions such as mutations with genes 
encoding for CACNA1A, ATP1A2, and SCN1A that manifested differently in different 
patients with either seizure, migraine or both (Rogawski, 2010).  
In their paper, Bragin et al (1997) also proposed the possibility of glial involvement in 
the generation of ATO mainly due to the slowly propagating event that is around 0.1-
0.2 mm/s (in my experimental data 0.19 mm/s) resembling the speed of calcium wave 
propagation in the glial network (Cornell-Bell et al., 1990). Glia are likely to be involved 
mainly due to their role in K+ buffering. It has also been shown that neuronal activity 
associated with K+ release can induce Ca2+ waves in the glial gap-junction coupled 
network (Cornell-Bell et al., 1990). One mechanism of glia K+ buffering system is by 
diffusion, where K+ is absorbed from the extracellular space by the glia where there is a 
local excess of K+, and K+ then diffuses through the interconnected glial network to the 
less concentrated area, where it is eventually released back to the extracellular space 
(Somjen, 2004). Bragin et al then hypothesized that to accumulate K+ enough to reach 
the concentration suffice to induce ATO, glial involvement is needed. If Bragin et al’s 
theory of glial K+ buffering mechanism involved in ATO generation is correct, this could 
explain why ATO has never been recorded in an in vitro model of epilepsy where the 
epileptic agent is affecting the entire slice (e.g the 0 Mg2+ model or 50-100µM 4-AP), 
and why it only has been recording in focally induced seizures (by electrical stimulation 
of in my case HR priming). Presumably, the generalised hyper-excitability will raise 
extracellular K+ throughout the slice hence glial diffusion mechanism to buffer K+ could 
not work due to the lack of K+ concentration gradient.     
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6.6. The use of HR to control epilepsy 
Earlier studies have tried to use HR as a tool to control epileptic seizures based on its 
hyperpolarizing effect. These studies showed that HR activation had a significant 
suppressive effect on seizure activity both in vitro and in vivo that often results in early 
termination of seizures (Tønnesen et al., 2009; Krook-Magnuson E et al., 2012; Wykes 
et al., 2012). This might seem to contradict the observation that HR Cl- loading could 
actually contribute to seizure initiation when combined with sub-epileptic level of 4-AP 
as described in chapter 4. 
Two different illumination paradigms have been used by two different studies that 
were done on in vivo chronic model of epilepsy. The first one was expressing the 
original HR protein (NpHR)  and activation done by a 20s ON/20s OFF illumination 
paradigm (Wykes et al., 2012). The second one was expressing the enhanced  HR 
protein (eNpHR3.0) and activation was done using a closed-loop paradigm in which 
computer algorithm was used to detect seizure initiation that automatically activates 
light illumination for 5,10, or 30s (Krook-Magnuson E et al., 2012).  
There are several possible explanations how HR could show a suppressive effect rather 
than promoting seizure in the first system. Firstly, Wykes et al used the original HR 
protein which drives a relatively small current. In chapter 3, I showed that original HR 
protein gives a markedly smaller current compared to the enhanced version (original 
HR:  13.79 ± 4.73 pA, enhanced HR: 163.89 ± 108.94 pA) and consequently the HR 
priming induced depolarizing shift in EGABA (original HR: 1.03±0.18 mV/s, enhanced HR: 
6.95±1.5 mV/s). It should be noted however that this EGABA shift was calculated with 
the orange-blue co-illumination paradigm in which HR current was stabilized for a 
longer time.  
On the other hand in their study, orange light only was used for 20 s long HR activation. 
Result from chapter 3 shows that this illumination paradigm will result in a decaying 
HR current over the duration of illumination. Based on this, it is possible that Cl- 
loading effect in this study was relatively small and so the hyperpolarizing effect of HR 
undermining the mild Cl- accumulation issue.      
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The second study (Krook-Magnuson E et al., 2012) on the other hand was using the 
enhanced HR protein that has larger current and Cl- loading effect. However, in their 
study, a close-loop illumination paradigm was used, in which light activation is only 
delivered when a computer algorithm detects a seizure initiation. This means that HR 
was only activated whenever seizure had already been initiated. It has been shown 
before that Cl- rises within the pyramidal cells almost instantaneously when the seizure 
starts (Lillis et al., 2012) and so with the close-loop paradigm HR was only activated 
whenever Cl- accumulation has already happened. My result indeed suggests that Cl- 
loading could lead to seizure initiation, however whether HR Cl- loading can do further 
harm when seizure has been initiated is unknown. Em and [Cl
-]i  are dynamic in the 
neuronal network especially during seizure and depending on these 2 factors further 
Cl- influx that imposes hyperpolarizing effect on Em but depolarizing shift in EGABA could 
potentially be promoting or suppressing seizure activity. Additionally, these 2 studies 
were done in vivo in which Cl- dynamics have not been explored.  
 
6.7. A novel use of optogenetic tools to extrude Cl- 
In chapter 5, I showed that co-activation of ArchT and ChloC consistently imposed a 
hyperpolarizing shift in the EGABA indicative of a Cl
- extrusion effect. Ultimately, we 
would like to assess the potential therapeutic effect of ArchT-ChloC Cl- extrusion in a 
context of epilepsy. Since seizures are network phenomena, the next aim is to apply 
this strategy in the network level.  Ideally a set protocol that guarantees an optimised 
outward flow of Cl- is needed especially when intended to be used for network activity 
studies where monitoring [Cl-]i in all cells is not trivial. Optimization could be achieved 
by finding the best combination of the light activated Cl- channel and the Cl- 
independent hyperpolarising tool, finding the best co-expression system, and assessing 
the best illumination paradigm.  
To date, the available light activated Cl- channels are iC1C2 and the bistable version 
called SwiChRCT, and two variants of ChloC with fast or slow kinetics respectively 
(Berndt et al., 2014; Wietek et al., 2014). At least in our hand, the light activated 
current of iC1C2 was variable and rather small and so ChloC is more favourable. 
However there is a new version of iC1C2 channel namely iC1C23.0 that has an 
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improved membrane expression and consequently the light activated current that 
could also be a good candidate to be tested in the future (unpublished – Karl 
Deisseroth, personal communication, August 7, 2014). The slow kinetic versions are 
less suitable for this purpose. This is due to the fact that the residual current post light 
termination by the light activated Cl- channel might not give a Cl- extrusion effect since 
ArchT hyperpolarizing effect does not outlast the duration of illumination as well.    
As for the Cl- independent hyperpolarising tool, this mainly comes from the light-driven 
outward proton pump family such as Mac, bacteriorhodopsins (BR), or 
archeorhodopsins (Arch or ArchT). ArchT makes a really good, Cl—independent, 
hyperpolarising tool to be coupled with the Cl- channel, for several reasons. Firstly is 
the really good level of expression of the protein that results in a large light activated 
current (up to 900 pA), and with the improved light sensitivity of almost three times 
than the original version of Arch. That significantly enhances the photocurrent, when 
using light with the power of 1-10 mW/mm2.  
Additionally, Wietek et al has described that external binding of H+ enhances the 
conductance of the ChloC without the transport of H+ itself (Wietek et al., 2014). This 
suggests that by using ArchT that is an outward H+ pump hence provides an external 
binding of H+ to the ChloC might actually optimizes the conductance of the ChloC.  
 Co-localization of multiple proteins can be achieved mainly in 2 different ways, as a 
fused protein or by bicistronic expression system such as the use of internal ribosomal 
entry site (IRES) or a self-cleaving 2A peptide (Chan et al., 2011; Kleinlogel et al., 
2011b). Only the former but not the latter could provide a stable 1:1 expression of the 
different proteins. 2A peptide has been used to co-express ChloC-ArchT and there 
were evidence that this system could induce a Cl- extrusion effect on cells during 
illumination. However it was apparent that the hyperpolarizing current generated 
during illumination was markedly smaller compare to the 2 plasmids transfection. One 
possibility is that there is lower expressions of the second protein compared to the 
first one, and so for this case, less ArchT expression compared to ChloC.  
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One way to further improve this is to use the fusion strategy so that both ChloC and 
ArchT are expressed as a single entity. Theoretically, this would maximize the effect of 
ArchT by localizing it to ChloC and hence optimizing the Cl- extrusion effect of ChloC-
ArchT co-activation. Furthermore fusion protein of ChloC and ArchT will also allow a 
compartmental Cl- extrusion in subcellular level. In contrary to the bicistronic 
expression system or dual plasmids transfection system, fusion protein will allow a 
precise stoichiometric side by side expression of the two proteins, assuring that every 
ChloC protein will be associated with a single ArchT protein. This will be a more reliable 
way to exert a Cl- extrusion effect in a more confined area, compared to bicistronic 
expression or dual plasmids transfection system in which the 2 proteins will be 
distributed quite randomly along the cell membrane. It has been reported before that 
there are subcellular differences in Cl- concentration within the cytoplasm. For 
instance, axon initial segment has been shown to have higher Cl- that might affect the 
post-synaptic activity of chandelier cell interneuron that specifically innervates this 
region (Szabadics et al., 2006). Another example is that there is an evidence of 
transient Cl- increase in the dendritic spine when glutamate is applied (Waseem et al., 
2010). Compartmental Cl- extrusion might be useful to investigate the implication of Cl- 
subcellular differences.     
Finally, the best illumination paradigm should also be investigated to achieve the 
optimal Cl- extrusion effect from this strategy. This is especially important when trying 
to use it in the seizure context in which optimal Cl- extrusion and hyperpolarization is 
probably required to exert a therapeutic effect. It should be noted that there might be 
differences between how a light activated channel and a light activated pump work in 
modulating ion level as this affect what is the best illumination paradigm to be used.  
The size of current passing through a channel or in this case ChloC depends on the 
reversal potential for the permeable ion (Cl-) and the Vm. While the role of light in this 
case is only to open the channel to provide a conductance for the ion flow but not 
directly regulating the amount of ion that flows through. Once the Cl- reversal 
potential is achieved, no more Cl- flow will take place even when the channel still open. 
On the other hand, light activated pump such as HR works by using about 20% of a 
photon energy to translocate one Cl- ion into the cell (Pfisterer et al., 2009). This 
means that the amount of light will directly affect the number of ion being 
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translocated and the more photons from light hits the protein the more Cl- being 
translocated. Note however that this is also affected by the availability of the trans-
retinal (the ready to use form of the chromophore that converts the light into the 
energy needed for the Cl- transport). Based on this, it is known that unlike HR, longer 
illumination does not always result in more Cl- flow through a Cl- channel such as ChloC. 
This is also supported by the results from chapter 5 that shows no correlation between 
ChloC-ArchT Cl- extrusion and duration of illumination, but instead showed better 
correlation with the baseline level of [Cl-]i.  
Similarly to HR, ArchT is a light activated pump in which the number of H+ ions 
extruded depends on the amount of light. However, for the Cl- extrusion purpose 
ArchT is used to modulate Vm rather than to modulate ion concentration. Just like HR, 
the ArchT current also decays with time (chapter 5), possibly explained by the reduced 
amount of ready-to-use form of the chromophore, and so the longer the illumination 
the weaker Em modulation is being imposed by ArchT. Together, it suggests that a long 
duration of illumination is not a favourable approach to optimize the Cl- extrusion 
effect of ChloC-ArchT co-activation. Rather, multiple repeats of short illumination are 
more likely to exert a stronger Cl- extrusion effect. Further investigation is needed to 
select the best illumination paradigm for this purpose.  
Finally, the ultimate goal will be to assess the therapeutic effect of ChloC-ArchT Cl- 
extrusion in the context of epilepsy. ChloC-ArchT is potentially useful for epilepsy in 2 
different ways; acutely as an on-demand control when seizures take place, and 
chronically to reduce the probability of having more seizures. The acute effect of 
ChloC-ArchT Cl- extrusion effect hypothetically could outperform the use of HR to stop 
seizures for several reasons. Firstly, ChloC-ArchT co-activation gives a comparable 
hyperpolarizing current with HR but without loading cells with Cl-. Secondly, Cl- 
extrusion effect of ChloC-ArchT co-activation would shift EGABA to a more 
hyperpolarized level and hence boosting the inhibitory effect of GABA during the 
course of a seizure. Lastly, ChloC activation will have a shunting effect as when a 
channel opens cells becomes leakier; this also will have an extra inhibitory effect to the 
cells.  
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Chronically, we also hypothesize that ChloC-ArchT Cl- extrusion might have a positive 
effect on epileptogenesis and ultimately reducing the seizure frequency. This is based 
on the adjunctive effect of high [Cl-]i in seizure initiation as shown that it lowered the 
threshold for 4-AP to induce seizure. If we believe that high [Cl-]i leads to a higher 
propensity for seizure initiation it could be implied that Cl- extrusion would then have 
an opposite effect that is  reducing the propensity for seizure generation.  
So far the use of optogenetic to control epilepsy has focused mainly on seizure 
termination and the long term effect on seizure frequency has never been assessed. 
The use of ChloC-ArchT Cl- extrusion will be a novel way of using optogenetic tools to 
control epilepsy that goes beyond seizure termination but more importantly to 
actually prevent the generation of more subsequent seizures.        
 
6.8. The prospect of gene therapy and optogenetics as a treatment for epilepsy 
Approximately, 65 million people or 1% of the world population suffer from epilepsy 
(Moshé et al., 2014). Patients with epilepsy often have to face a life-long health and 
socioeconomic burden. This is particularly devastating for the 30% of the patients who 
do not respond to the available anti-epileptic medication. The number of treatment 
options available for this group of patients is limited and often show a relatively low 
efficacy (Kullmann et al., 2014; Moshé et al., 2014).  
One of the most promising candidates as a new treatment option for the 
pharmacoresistant patients of epilepsy is gene therapy. In general, gene therapy is 
preferable as it allows region specific and cell-type specific modulation of neuronal 
excitability (Kullmann et al., 2014). Research has focussed on the viral gene therapy. 
Lentiviral and adeno-associated viruses (AAV) vectors are the most common ones to be 
used to deliver the target gene into the cells, for the expression of the desired proteins. 
Both of these viruses are considered to be safe for this purpose based on prior animal 
research (Kullmann et al., 2014). Target genes that have been tested vary from 
endogeneous genes such as human potassium channel protein (Kv1.1), to exogeneous 
or engineered genes such as genes encoding for optogenetic proteins and designer 
receptor exclusively activated by a designer drug (DREADD) proteins (Krook-Magnuson 
E et al., 2012; Wykes et al., 2012; Kätzel et al., 2014).  
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Overexpression of endogeneous protein Kv1.1 has been proven effective in reducing 
the excitability of pyramidal cells in the epileptic foci of animal model of epilepsy 
(Wykes et al., 2012). However, in this situation, the effect of Kv1.1 overexpression 
would persist regardless of the excitability state of the tissue. The desire for a 
temporally controlled modulation of neuronal excitability, which suits the transient 
nature of epileptic seizure, leads to the concept of using DREADDs or optogenetic 
proteins where neuronal modulation only takes place when a certain chemical agent 
or light are presented respectively (Deisseroth et al., 2006; Armbruster et al., 2007; Pei 
et al., 2008). 
DREADDs are engineered receptors that could only be activated by an artificial ligand; 
there are both excitatory and inhibitory DREADDs (Armbruster et al., 2007; Pei et al., 
2008). This technology allows transient modulation of neuronal activity, whenever the 
specific ligand is presented.  The activation of inhibitory DREADD receptor in pyramidal 
cells has also been shown to be effective in suppressing seizure activity in animal 
model of epilepsy (Kätzel et al., 2014). Despite the possibility of a limited temporal 
control over neuronal activity, it is apparent that there is always a delay between the 
times when the drug is administered to the times when the receptors’ action actually 
take place. In this aspect, optogenetics stands out as a better option, as neuronal 
activity could be controlled with miliseconds precision (Deisseroth et al., 2006).  As 
discussed earlier in chapter 1, several different groups have provided evidence that 
show seizure suppressive effect of different optogenetic approach to control epileptic 
seizures in animal model of epilepsy, by only short activation of the proteins (Krook-
Magnuson E et al., 2012; Wykes et al., 2012).  
The translation of these different approaches into clinical practice however is not an 
easy matter. The main issue to address for gene therapy is the safety of the viral 
vectors gene delivery and the possible long term consequences of overexpressing a 
certain gene on the expression of other endogeneous genes (Kullmann et al., 2014). 
Extra challenges have to be overcome when temporal control is desired. With 
DREADDs technology, limited temporal control is made possible, but extra safety issue 
has to be clarified such as the potential non-specific effect of the artificial ligand on the 
endogeneous receptors. Additionally, in animal model, the seizure suppressive effect 
was only observed 10 minutes after drug delivery (Kätzel et al., 2014), suggesting that 
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this approach might not be applicable as an on-demand control for short epileptic 
seizures, although this could still be advantageous for patients with status epilepticus 
or to hinder epileptogenesis in a long run.  
So far, optogenetics is the only technique that allows for a high temporal precision of 
neuronal activity modulation. However, to translate this into human application, an 
extra hurdle has to be overcome, which is to deliver light into the epileptic focus. This 
system has to be biocompatible, energetically efficient, and as less invasive as possible. 
Some advancement has been made over these recent years towards achieving this 
such as improving light sensitivity of the opsins (Han et al., 2011; Zhang et al., 2011), 
designing opsins activated by red light that has better optical penetrance for the brain 
tissue (Zhang et al., 2008; Chuong et al., 2014) and the continuing development of 
biocompatible micro-LEDs or lasers as light sources specifically design for optogenetics 
(Degenaar et al., 2009). Until these issues are fully addressed, optogenetics remain a 
mere research tool, which even so is still really valuable for the neuroscience field. 
Further investigation is also needed to evaluate whether it is necessary to take the 
extra mile in overcoming all the technical difficulties associated with optogenetics, in 
exchange for a better temporal control, when more achievable options such as 
endogenous genes therapy or DREADDs technique are available.   
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6.9. Conclusion 
High intraneuronal Cl- has been associated with epileptogenic area before. In this 
project I have shown that when high [Cl-]i state was induced in healthy tissues, 
epileptic high frequency oscillation was generated, which showed some unique 
features such as doubling of frequency, increased jitter in spike timing, and out of 
phase firing. These are consistent with the characteristic of epileptic HFO commonly 
recorded from epileptic tissue taken from animal model of epilepsy. However it was 
evident that high [Cl-]i on its own has  never triggered a full ictal discharge in vitro. 
Further exploration then showed that although high [Cl-]i alone was not triggering 
seizure, however it lowered the seizure threshold for the convulsant 4-AP to develop 
full ictal discharges. This highlights the adjunctive effect of high [Cl-]i in seizure 
initiation. Realizing the important contribution of high [Cl-]i in ictogenesis, a way to 
extrude Cl- was explored mainly focussed on the optogenetic technology. Combining 
the ArchT hyperpolarizing effect and the opening of light activated Cl- channel ChloC, 
Cl- extrusion with high temporal control was made possible. This provides a new 
strategy of utilizing optogenetics to control epilepsy, to be tested in the future.     
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Appendix 
Sequence of ChloC-T2A-ArchT_GFP 
atggattatggaggcgccctgagtgccgttgggcgcgagctgctatttgtaacgaacccagtagtcgtcaatggctctgtact
tgtgcctgaggaccagtgttactgcgcgggctggattgagtcgcgtggcacaaacggtgcccaaacggcgtcgaacgtgct
gcaatggcttgctgctggcttctccatcctactgcttatgttttacgcctaccaaacatggaagtcaacctgcggctgggagg
agatctatgtgtgcgctatcaggatggtcaaggtgattctcgagttcttcttcgagtttaagaacccgtccatgctgtatctag
ccacaggccaccgcgtccagtggttgcgttacgccgagtggcttctcacctgcccggtcattctcattcacctgtcaaacctg
acgggcttgtccaacgactacagcaggcgcaccatgggtctgcttgtgtctgatattggctgtattgtgtggggcgccacttc
cgccatggccaccggatacgtcaaggtcatcttcttctgcctgggtctgtgttatggtgctaacacgttctttcacgctgccaa
ggcctacatcgagggttaccacaccgtgccgaagggccggtgtcgccaggtggtgactggcatggcttggctcttcttcgtat
catggggtatgttccccatcctgttcatcctcggccccgagggcttcggcgtcctgagcgtgtacggctccaccgtcggccac
accatcattgacctgatgtcgaagaactgctggggtctgctcggccactacctgcgcgtgctgatccacgagcatatcctcat
ccacggcgacattcgcaagaccaccaaattgaacattggtggcactgagattgaggtcgagacgctggtggaggacgagg
ccgaggctggcgcggtacccgcggccgagggcagaggaagtcttctaacatgcggtgacgtggaggagaatcccggccct
gcaccgggatccgccaccatggaccccatcgctctgcaggcaggatacgacctgctgggcgacggaaggccagagaccct
gtggctgggaatcggaaccctgctgatgctgatcggcaccttctacttcatcgtgaagggctggggcgtgaccgacaagga
ggccagggagtactacagcatcacaatcctggtgcccggcatcgccagcgccgcctacctgagcatgttcttcggcatcggc
ctgaccgaggtgaccgtggccggcgaggtgctggacatctactacgccagatacgccgactggctgttcaccacccctttgc
ttctgctcgacctggccctgctggctaaggtggacagggtgagcatcggaaccctggtgggagtggacgccctgatgatcgt
gaccggcctgatcggcgccctgagccacaccccactggctaggtacagctggtggctgttcagcaccatctgcatgatcgtg
gtgctgtacttcctggctaccagcctgagggctgctgctaaggagaggggaccagaggtggctagcaccttcaacaccctg
accgccctggtgctggtgctgtggaccgcctaccccatcctgtggatcatcggaaccgagggagctggagtggtgggactgg
gaatcgagaccctgctgttcatggtgctggacgtgaccgccaaagtgggcttcggcttcatcctgctgaggagcagggccat
cctgggcgacaccgaggcccccgagccccgaccggtagtagcagtgagcaagggcgaggagctgttcaccggggtggtgc
ccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctac
ggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacg
gcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtcca
ggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtga
accgcatcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacag
ccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacg
gcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacc
tgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccg
ggatcactctcggcatggacgagctgtacaagtaagaattcgatatcaagctt  
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